POSTER SESSION GUIDELINES

OVERVIEW NUMBERING SYSTEM

Poster sessions are designed to give presenters an opportunity to discuss Note: Each poster board will be numbered. Presenters informally their research with colleagues interested in their research. The Neither ISPE nor the Hynes should attach their posters to the board number purpose of the posters is to visually stimulate interest in the research, Convention Center will be corresponding to the number assigned to their to present sufficient information for viewers to understand the methods, responsible for any poster that poster on that day as listed in the Final Program. results, and significance of the research, and to promote conversations is left up overnight or is lost or The POSTER BOARD number is the first number and networking among conference participants. damaged. listed. The PUBLICATION NUMBER, for use in locating abstracts in the Final Program or in Abstracts2view, is listed after the abstract title in POSTER SESSION brackets [ ].

Posters will be displayed in Hall D of the Hynes Convention Center, August 24-26. Each day will have a Example separate poster session. All posters for a specific day’s session must be removed at the end of that day. 97 Characteristics of Patients with Depression Who Initiate Antidepressant z Monday, August 24...... Poster Session A and Benzodiazepine Therapy z Tuesday, August 25...... Poster Session B Simultaneously, Compared with z Wednesday, August 26...... Poster Session C Antidepressant Monotherapy [176] Greta A Bushnell, Alice White, Til Stürmer, 1. SET UP: Bradley N Gaynes, Virginia Pate, Deborah 7:00am-8:00am; all posters must be in place by 8:00am. Poster sessions will be held in Azrael, Matthew Miller. (United States) Hall D of the Hynes Convention Center. Key 2. HOURS: 97 POSTER BOARD Number Posters will be displayed from 8:00am-6:00pm on Monday and Tuesday, and 8:00am- 176 PUBLICATION Number 1:45pm on Wednesday.

3. DISCUSSION TIME: 1. Poster Specifications General: Presenters should be at their posters between 12:15-1:15pm on Monday (A) and Posters must be designed to fit a Wednesday (C); and between 11:45-12:45pm on Tuesday (B). freestanding poster board approximately 4 feet WIDE x 8 feet HIGH (1.2 meter WIDE Spotlight Sessions: Organized by the ISPE Special Interest Groups (SIGs). Presenters should be x 2.4 meters HIGH). Only VERTICAL/ at their posters between 12:15-1:15pm on Monday (A) and Wednesday (C); and between 11:45- PORTRAIT posters will be allowed. 12:45pm on Tuesday (B).

Spotlight Session Prizes 2. Disclosure Statement A group of judges will select the best poster for each Spotlight Session. The best presenters A disclosure statement must accompany will receive an invitation to display their poster for the duration of the ICPE. The winners will be each abstract. This statement should follow announced and certificates presented during The Final Word at 4:45pm, Wednesday, August 26. the title page and should be a positive disclosure of all funding sources for the The spotlight sessions offer pre-selected presenters the opportunity to present their work and to current project as well as other potentially discuss their results with an audience. When the session chair and audience stop at your poster, conflicting relationships that existed at any please give a brief, 3-minute, presentation and be prepared to answer questions about your research. time during the conduct of the study, or at a minimum, the one-year period before the Monday z Biologics annual meeting. Non-financial conflicts z Drug Utilization/Health Services Research (e.g., a close relationship with, or a strong z Molecular Epidemiology, Biomarkers and Pharmacogenetics antipathy to, a person whose interests may z Vaccines be affected) should also be disclosed. Tuesday z Asian Pharmacoepidemiology Network (AsPEN) z Comparative Effectiveness Research 3. Call4Posters z Medical Devices Posters ordered through Call4Posters z Pediatrics can be picked up in Hall D of the Hynes z Pregnancy Convention Center beginning Sunday afternoon, August 23, at 1:00pm. Wednesday z Adherence z Benefit Risk Assessment, Communication and Evaluation (BRACE) Poster Pick Up Schedule: z Database Sunday, August 23rd: 1:00pm to 5:00pm Monday, August 24nd: 7:00am to 1:00pm Tuesday, August 25th: 7:00am to 1:00pm 4. TAKE DOWN: Wednesday, August 26th: 7:00am to 12:00pm z All posters must be taken down by 6:30pm on Monday and Tuesday, and by 5:00pm on Wednesday. 61 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

Spotlight Session-Biologics Biologics 15. Spontaneous Adverse Event Reports Associated With Apixaban and Potentially 1. Risk of Non-Melanoma Skin 8. Insulin Treatment and Breast Cancer Risk; Inappropriate Medicine Use: An Cancer Recurrence With the Use of a Systematic Review of In Vitro, Animal and International Comparison [197] Immunosuppressant and Biologic Agents Epidemiological Evidence [87] Gillian E Caughey, Lisa M Kalisch Ellett, John in Autoimmune Disease [80] Heleen K Bronsveld, Bas ter Braak, Øystein D Barratt. (Australia) Frank I Scott, Ronac Mamtani, Colleen M Karlstad, Peter Vestergaard, Jakob Starup- Brensinger, Kevin Haynes, Zelma C Chiesa- Linde, Marloes T Bazelier, Marie L de Bruin, 16. Patterns of Intravenous Corticosteroid Fuxench, Jie Zhang, Lang Chen, Fenglong Anthonius de Boer, Christine LE Siezen, Utilization in Patients Undergoing Coronary Xie, Huifeng Yun, Mark T Osterman, Timothy Bob van de Water, Jan Willem van der Laan, Artery Bypass Grafting Surgery in the US Beukelman, David J Margolis, Jeffrey R Curtis, Marjanka K Schmidt. (Netherlands) [198] James D Lewis. (United States) Macarius M Donneyong, Joshua J Gagne. 9. Patient-Reported Health Utility Scores (United States) 2. Active Surveillance of Skin Toxicities (HUS) in Non-Small Cell Lung Cancer Through Web-Based Patient-Reported (NSCLC) Patients With Epidermal Growth 17. Antiepileptic Drug Utilization Across 15 (PRO) Toxicity Reporting Tool in Outpatient Factor Receptor (EGFR) Mutations By Drug Years for Epilepsy and Non-Epilepsy Cancer Patients on EGFR Tyrosine Kinase Therapy [88] Indications in a Canadian Province: A Inhibitors (TKI): A Feasibility Study [81] Erin L Stewart, Catherine Labbe, Catherine Population-Based Study [199] Tian Qi Wang, Hagit Bergman, Catherine M Brown, Andrea Perez-Cosio, Ashlee Vennettilli, Christine Leong, Muhammad M Mamdani, Tara Brown, Ashlee Vennettilli, Devalben Patel, Devalben Patel, Nicholas Cheng, Mindy Gomes, David N Juurlink, Erin M Macdonald, Jack T Seki, Andrea Perez-Cosio, Doris Liang, Gursharan Gill, Yvonne Leung, Nicole Marina Yogendran. (Canada) Howell, Geoffrey Liu. (Canada) Mittmann, Hiten Naik, Geoffrey Liu. (Canada) 18. Trends in the Consumption of Antiepileptic 3. Patterns of Granulocyte Colony-Stimulating 10. Frequency and Trends of Disease- Drugs in Portugal, 2004-2014 [200] Factor Use Among Older Women With Modifying Antirheumatic Drug (DMARD) Carla Torre, Jose Pedro Guerreiro, Marta Breast Cancer: An Analysis of SEER- Use in Germany [89] Gomes, Suzete Costa. (Spain) Medicare Linked Data, 2001-2009 [82] Alexander M Fassmer, Edeltraut Garbe, Niklas Wan-Ju Lee, Stephen M Schwartz, Gregory S Schmedt. (Germany) 19. National Use of Testosterone Replacement Calip. (United States) Therapy: Annual Trends and Response To 11. Clotting Factor Utilization Among the U.S. Recent Evidence [201] 4. Occurrence of Acute Renal Failure (ARF) Elderly as Recorded in Medicare Databases Eleanor Lucas, Matthew Daubresse, Sonal on the Same Day as Immune Globulin (IG) During 2008-2013 [90] Singh, Randall Stafford, G Caleb Alexander. Product Administrations During 2008-2014 Mikhail Menis, Steven A Anderson, Stephen (United States) [83] McKean, Rob Warnock, Mikhail V Ovanesov, Bola Ekezue, Gayathri Sridhar, Richard Paul D Mintz, Sumit Verma, Natalie Norton, 20. Risk of Fall-Injury Associated With Forshee, Nandini Selvam, Dorothy Scott, Zebulin Kessler, Hector S Izurieta, Christopher Psychotropic Drugs Among People Aged Steven Anderson, Mikhail Menis. M Worrall, Jeffrey A Kelman, Richard A 65 Years or Older in Sweden [202] (United States) Forshee. (United States) Annica Bergendal, Pinelopi Lundquist, Julius Collin, Gudrun Jonasdottir Bergman, Peter 5. Occurrence of Hemolytic Reactions (HRs) 12. Comparison of Patients Initiating Abatacept Salmi, Natalia Borg, Bengt Danielsson. on the Same Day as Immune Globulin (IG) and TNFs Enrolled in MarketScan and the (Sweden) Product Administrations During 2008-2014 ARTIS Registry [91] [84] Nicole Baker, Thomas Frisell, Johan Askling, Drug Utilization Research Bola Ekezue, Gayathri Sridhar, Richard Hugh Kawabata, Teresa A Simon. Forshee, Nandini Selvam, Steven Anderson, (United States) Health Services Research Mikhail Menis. (United States) 21. Dyslipidaemia in HIV-Positive Patients Spotlight Session-Drug Treated With Protease Inhibitors in the 6. Majority of Patients Do Not Store Their Utilization Research/Health Cape Metropole Region: Preliminary Biological Disease Modifying Antirheumatic Results [92] Drugs Within Recommended Temperature Services Research Pierre Mugabo, Richard Madsen. (South Africa) Range [85] Nicolaas D Vlieland, Helga Gardarsdottir, 13. Did the Introduction of Mandatory Offer of Generic Substitution Have a Quantifiable 22. Changes in Glucose Lowering Drug Use Marcel L Bouvy, Antoine CG Egberts, Bart JF Before and After a Cancer Diagnosis van den Bemt. (Netherlands) Effect in South Africa? [195] Andrew L Gray, Yared Santa-Ana-Tellez, Among Individuals With Diabetes [93] Veronika J Wirtz. (South Africa) Marjolein Zanders, Harm Haak, Myrthe van 7. Prevalence and Overlap of Asthma Herk-Sukel, Ron Herings, Lonneke van de Phenotypes in a General Asthma Poll-Franse, Jeffrey Johnson. (Netherlands) Population [86] 14. Identifying Potential Spill-Over Effects of the Maryland Prescription Drug Monitoring Trung N Tran, Christine K Ward. 23. Implementation of a Comprehensive (United States) Program [196] Ting-Ying Huang, Patience Moyo, Sarah Tom, Treatment Center on Hemophilia CITH With Linda Simoni-Wastila. (United States) Follow-Up Results at the First Year [94] Fernando Guerrero, Carlos Ramirez, Juliana Jacome, Victor Machado, Diana Ramos, Fabian Beltran. (Colombia)

62 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

24. Impact of a Decree on ACE Inhibitors/ARBs 34. Impact of Academic Detailing Program 43. Natural Behavioral Triggers of Adherence: in Cardiovascular Secondary Prevention in To Primary Care Providers About Evidence from Time Shocks [114] the Lazio Region: A Pre-Post Analysis [95] Antipsychotic Medication [105] Zirui Song, Macarius M Donneyong, Niteesh K Flavia Mayer, Ursula Kirchmayer, Mirko Di Eimir Hurley, Connie DiCocco, Michael Choudhry. (United States) Martino, Nera Agabiti, Danilo Fusco, Maria Fischer, Niteesh Choudhry, Jerry Avorn. Davoli. (Italy) (United States) 44. Gender Differences in Early Access To Medicines: The Case of Diabetes Trials 25. Withdrawn By Author 35. Induction Agent Use in Older Kidney [115] Transplant Recipients [106] Yaser T Bazargani, Anthonius deBoer, Hubert 26. Impact of a Public Intervention in the Media Mara A McAdams-DeMarco, Xun Luo, Dorry GM Leufkens, Aukje Mantel-Teeuwisse. on the Use of Statins in Patients at Various Segev. (United States) (Netherlands) Cardiovascular Risks [97] Julien Bezin, Florence Francis, Nam Vinh 36. Antibiotic Utilization Trends in the Veterans 45. Compliance To National Directives from the Nguyen, Nicholas Moore. (France) Affairs (VA) New England Healthcare French Ministry of Health for the Control System [107] of Antibiotic Utilization in Healthcare 27. The Impact of Direct-to-Consumer Ajinkya M Pawar, Haley J Morrill, Kerry L Organizations of Paris City and Inner Advertising on Testosterone Testing and LaPlante, Aisling R Caffrey. (United States) Suburbs [116] Initiation in the United States [98] Jean-Frederic Westphal. (France) J Bradley Layton, Yoonsang Kim, Glen 37. Effectiveness of Interventions for Drug Szcypka, G Caleb Alexander, M Alan Prescribing Improvement in Primary Health 46. Regional and Setting Variation of Brookhart, Matthew Daubresse, Sherry L Care [108] Antipsychotic Prescribing To Elderly Emery. (United States) Marco A Zavala-Gonzalez, Carlos E Cabrera- Patients Across Ontario [117] Pivaral, Maria J Orozco-Valerio. (Mexico) Mina Tadrous, Diana Martins, Zhan Yao, 28. Patient Characteristics and Prior Total Knee Kimberly A Fernandes, Nathan Herrmann, Arthroplasty Opioid Use Are Associated 38. Effects of Over-The-Counter Sales David N Juurlink, Muhammad M Mamdani, With Post-Operative Opioid Use [99] Restriction of Antibiotics on Substitution Tara Gomes. (Canada) Maria CS Inacio, Robert S Namba, Anshuman With Analgesics, Non-Steroidal Anti- Singh, Cheetham T Craig, Elizabeth W Paxton. Inflammatory Products and Cough and 47. Effect of Florida’s Prescription Drug (Australia) Cold Medication in Mexico and Brazil [109] Monitoring Program and Pill Mill Law on Yared Santa-Ana-Tellez, Aukje K Mantel- Opioid Prescribing and Utilization [118] 29. Acetaminophen Overdosing in Hospitalized Teeuwisse, Hubert GM Leufkens, Veronika J Matthew Daubresse, Lainie Rutkow, Hsien-Yen Patients: Retrospective Analysis and Wirtz. (Netherlands) Chang, Daniel Webster, Elizabeth Stuart, G Implementation of Preventive Semi- Caleb Alexander. (United States) Automated Alerts [100] 39. Drug Safety Manager - Development of an David F Niedrig, Guido Bucklar, Michael Integrated Concept and Application for 48. Prescription Drug Monitoring Program and Fetzer, Sarah Maechler, Carmen Goett, Gerd A Drug Safety Analyses, Interventions and Drug Arrests in Florida: Spatial Analysis Kullak-Ublick, Stefan Russmann. (Switzerland) Outcomes Research in Hospitals [110] [119] Stefan Russmann, David F Niedrig, Gyorgy Juan M Hincapie Castillo. (United States) 30. Changes in US Oral Anticoagulant Drug Olah, Luzi Zappa. (Switzerland) Prescription Patterns During Period of FDA 49. The 2010 FDA Drug Safety Actions [101] 40. Improving Use of Medicines By Using Recommendations and LABA Dispensing Cathy Anne Pinto, Yong Chen, Jianmin Wu, Commitment Questions in Patient Pattern Changes in Adult Asthma Patients Tarek Hammad. (United States) Response Forms: An Evaluation [111] During 2003–2012 [120] Nicole L Pratt, Lisa M Kalisch Ellett, Janet Esther H Zhou, Elizabeth M Kang, Sally 31. Impacts of Established Academic Detailing K Sluggett, Emmae N Ramsay, Mhairi Kerr, Seymour, Margie Goulding, Solomon Iyasu. Programs on Prescribing Across Canada Vanessa T LeBlanc, John D Barratt, Elizabeth (United States) [102] E Roughead. (Australia) David Blackburn, Nancy Blythe, Michael Allen, 50. Hospital Discharge Medicines Information: Anne Nguyen, Tanya MacLeod, Loren Regier, 41. Retrospective Mass-Analysis of Hospital From Trial To Policy [121] Michelle Boudreau, Tom Briggs, Malcolm Prescription Data for Medication Errors Alice V Gilbert, Michael Roberts, Des Williams, Maclure. (Canada) and Subsequent Development of Highly Andrew L Gilbert. (Australia) Specific Alert Algorithms With ID PHARMA 32. Effect of Prescription Drug Coupons on CHECK® [112] 51. Diabetes Secondary Prevention: Are We Statin Utilization and Expenditures: A David F Niedrig, Andre Sander, Daniel Getting the Right Services To the Right Retrospective Cohort Study [103] Diekmann, Stefan Russmann. (Switzerland) People at the Right Price? [122] Matthew Daubresse, Martin Andersen, Kevin R Eric Romo, Kate L Lapane, Aimee R Kroll- Riggs, G Caleb Alexander. (United States) 42. Pharmacists’ Perspective of Self- Desrosiers, Allison B Rosen. (United States) Medication With Prescription Only 33. An Intervention To Optimise Medication Medicines, Among Patrons of Community Use in Nursing Home Residents With Pharmacies in Jos, Nigeria [113] Advanced Dementia: OptimaMed [104] Maxwell Patrick Dapar, Benjamin Nasara Edeltraut Kroeger, Machelle Wilchesky, Josepth, Mohammed Umar, Meshak Alex Philippe Voyer, Michèle Morin, Nathalie Dayol, Noel Nenman Wannang. (Nigeria) Champoux, Johanne Monette, Anik Giguère, Michèle Aubin, Pierre Durand, Marcel Arcand, René Verreault. (Canada) 63 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

52. Evaluation of Antimicrobial Stewardship 61. Oncopharmacoepidemiology: 10-Year 71. Drug Utilization Patterns of Azilsartan Programs in Makkah Region Hospitals, Experience of a French Research Platform Medoxomil in Primary Care Setting in Kingdom of Saudi Arabia [123] [132] Germany [142] Abdul Haseeb, Mohamed Azmi Ahmed Pernelle Noize, Magali Rouyer, Angela Birgit Ehlken, Margarita Shlaen, Juliana Rex, Hassali, Abdulrahman Bakhsh, Hani Saleh Grelaud, Cécile Droz, Régis Lassalle, Jérémy Paul Dolin. (Germany) Faidah, Waleed Hassan Almalki, Mahmood Jové, Marie-Agnès Bernard, Amandine Essam Uddin El Raggal. (Saudi Arabia) Gouverneur, Pauline Bosco-Lévy, Julien Bezin, 72. Association Between Analgesic Use and Denis Smith, Alain Ravaud, Nicholas Moore, Daytime Sleepiness in People With and 53. Proton Pump Inhibitors – Should More Annie Fourrier-Réglat. (France) Without Dementia in Aged Care Facilities Care Be Taken With Prescribing for Older [143] Women? [124] 62. Utilisation and Safety of Deferasirox Edwin CK Tan, Renuka Visvanathan, Sarah N Susan E Tett, Marielle MC van der Hoorn, (Exjade®): Results from an Observational Hilmer, Agnes Vitry, J Simon Bell. (Australia) Annette J Dobson, Geeske GMEE Peeters. Cohort Study in England [133] (Australia) Vicki Osborne, Miranda Davies, Deborah 73. Potential for Underdosing of Antipsychotics Layton, Saad AW Shakir. (United Kingdom) (AP) in Primary and Mental Health Care: 54. Metformin Utilization Patterns in Pediatric Findings from Post-Authorisation Safety Population Aged 10-19 Years in the US: 63. Anticoagulant Treatment After VTE in the Studies Conducted on Seroquel XL © [144] 2009-2013 [125] Netherlands [134] Deborah Layton, Vicki Osborne, Miranda Tongtong Wang, Ann Marie McNeill, Yong Chen, Irene D Bezemer, Elsa J van den Berg, Kerstin Davies, Ian Ratcliffe, Sarah Clarke, Saad AW Ravi Shankar. (United States) Folkerts, Luke Bamber, Fernie JA Penning-van Shakir, Joe Reilly, Tony Hale. (United Kingdom) Beest, Michiel Coppens, Ron MC Herings. 55. The Irrational Use of Antibiotics in Sudan (Netherlands) 74. Factors Associated With High [126] Anticholinergic Burden in Aging Adults Isam Eldin Mohammed Ali Mustafa. (Sudan) 64. Antihypertensive Drug Use and Blood With Intellectual Disabilities: A Cross- Pressure Control in Nigeria [135] Sectional Study [145] 56. Pharmacist-Led Educational Interventions Onyinye O Akunne, Aduragbenro D Adedapo. Maire O’Dwyer, Ian Maidment, McCallion on Antibiotics Use and Their Resistance (Nigeria) Philip, McCarron Mary, Henman Martin, Among Geriatric Diabetes Patients in Kathleen Bennett, Jure Peklar. (Ireland) Malaysia [127] 65. Impact of Comorbid Diabetes Mellitus on Muhammad Shahid Iqbal, Muhammad Adjuvant Chemotherapy Selection in Older 75. Use of Benzodiazepines in Combination Waseem Iqbal, Muhammad Zahid Iqbal, Mohd Rectal Cancer Patients [136] With Other Addictive Drugs [146] Baidi Bahari. (Malaysia) Phyo T Htoo, Hannah K Sanoff, Jennifer L Christian Berg, Svetlana Skurtveit, Solveig Lund. (United States) Sakshaug, Vidar Hjellvik, Marte Handal. 57. Prescribing Quality of Antimalarial (Norway) Medicines in Sudan: A National Study at 66. An Investigation of the Concomitant Use of National Health Insurance Fund in 2013 Angiotensin-Converting Enzyme Inhibitors, 76. Patterns and Predictors of Persistent [128] Non-Steroidal Anti-Inflammatory Drugs and Opioid Use Following Hip or Knee Isam Eldin Mohammed Ali Mustafa. (Sudan) Diuretics in Romania [137] Arthroplasty [147] Camelia Bucsa, Daniela C Moga, Andreea Seoyoung C Kim, Jessica M Franklin, 58. Evaluation of Vancomycin Farcas, Cristina Mogosan, Dan L Dumitrascu. Katsiaryna Bykov, Huichuan Lii, Michael Pharmacokinetics in Coronary Care Units, (United States) A Fischer, Niteesh K Choudhry, Brian T Kingdom of Saudi Arabia [129] Bateman. (United States) Abdul Haseeb, Abdulrahman Bakhsh, Hani 67. Evaluating Prescriber Concordance With Saleh Faidah, Aljoharh Abdulrahman Alziady, Prescribing: Results from a Post-Marketing 77. Description of Antiparkinsonian Drug Walaa Dhaifallah Alnemari, Marwah Hassan Study [138] Use in US Medicare Claims Database: A Mustafa Barnawi, Rozan Mohammed Radwan, Deborah Layton, Naseer Qayum, Claire Doe, Feasibility Assessment [148] Mahmood Essamuddin El Ragal. Shayne Freemantle, Saad AW Shakir. Catherine B Johannes, Brian Calingaert, (Saudi Arabia) (United Kingdom) Catherine W Saltus, Sigal Kaplan, Elizabeth Grubb, James A Kaye, Elizabeth B Andrews. 59. Antimicrobial Prescribing Pattern for Upper 68. Effect of Hospital Admission on (United States) Respiratory Tract Infections in Ambulatory Antihypertensive Medication Utilization Care Settings, Kingdom of Saudi Arabia Among Older Persons [139] 78. Utilisation of a New Once Weekly Injection [130] Tariq M Alhawassi, Ines Krass, Lisa G Pont. for Type 2 Diabetes Mellitus (T2DM): Interim Abdul Haseeb, Abdulrahman Bakhsh, (Australia) Results from an Observational Cohort Muhammed Tarique Imam, Jehan Rostom, Study of Exenatide (Bydureon®) in England Shahd Khan, Shehana Aljarbou, Rehab 69. Concomitant Prescription of QT-Prolonging [149] Alotaibi, Amal Alotaibi. (Saudi Arabia) Drugs in Dronedarone Users [140] Vicki Osborne, Naseer Qayum, Abigail Chuntao Wu, Andrew Koren, Jane Coughtrie, Deborah Layton, Saad AW Shakir. 60. First-Line Therapy of Metastatic Colorectal Thammakhoune, Hayet Kechemir Kechemir, (United Kingdom) Cancer in Elderly Patients: Experience of a Stephanie Tcherny-Lessenot, Stephen Lin, French Centre [131] Juhaeri Juhaeri. (United States) 79. Withdrawn By Author Amaury Daste, Pernelle Noize, Magali Rouyer, Eric Terrebonne, Alain Ravaud, Annie Fourrier- 70. Aspirin and Risk of Cancer Among French Réglat, Denis Smith. (France) Population: A Population Based Cohort Study [141] Aya Ajrouche, Candice Estellat, Carine Roy, 64 David Hajage, Marie Dalichampt, Florence 2015 ICPE Tubach. (France) POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

80. Utilisation of Asenapine in the Mental 88. Adherence To Evidence-Based 97. Availability of Essential Medicines for Health Care Setting in England and Wales: Pharmacological Therapies in Patients With Children in Armenia [168] First Results from a Specialist Cohort COPD: A Multilevel Analysis of Patient, Irina Kazaryan, Lusine Vardanyan. (Armenia) Event Monitoring (SCEM) Study [151] General Practitioner and Hospital of Vicki Osborne, Jan Slade, Deborah Layton, Discharge [159] 98. Real-World Analysis of Taxane Use in the Saad AW Shakir, Joseph Reilly. Martina Ventura, Mirko Di Martino, Danilo First-Line Setting and Prior Comorbidities (United Kingdom) Fusco, Nera Agabiti, Giovanna Cappai, Marina Among Female Metastatic Triple-Negative Davoli. (Italy) Breast Cancer Patients [169] 81. Adherence To Guidelines and the Shih-Wen Lin, Dixa Thakrar, Joseph Simpson, Screening Tool of Older Persons’ 89. Clinical Provider Experiences With Roel Funke, Stephen Chui. (United States) Potentially Inappropriate Prescriptions Medication Discontinuation [160] Criteria for Colchicine Dosing for Gout Amy Linsky, Steven R Simon, Kelly Stolzmann, 99. Withdrawn By Author Treatment in Beneficiaries of the Nova Mark Meterko. (United States) Scotia Seniors’ Pharmacare Program [152] 100. Questionable Care: Use of Memantine Emily Black, Ingrid Sketris, Chris Skedgel, 90. Non-Compliance With Guideline on NSAID Hydrochloride and Cholinesterase Erica MacLean, John Hanly. (Canada) Use and Gastroprotection in Hospitalized Inhibitors in Patients With Advanced Surgical Patients Who Are Prescribed Dementia at the End of Life Who Were 82. Ontario MedsCheck Annual Pharmacy NSAIDs [161] Enrolled in Hospice [171] Medication Review Service: A Comparison Naoual Chaaouit, Michael HJ Verhofstad, Jacob N Hunnicutt, Jennifer Tjia, Kate L Between Initial and Well Established Esther MM van Lieshout, Patricia MLA van den Lapane. (United States) Implementation Periods [153] Bemt. (Netherlands) Lisa Dolovich, Giulia P Consiglio, Lusine 101. Withdrawn By Author Abrahamyan, Elizabeth A Bojarski, Linda D 91. Hypertension Management and Control in MacKeigan, Petros Pechlivanoglou, Nedzad Older Persons on Admission To an Acute 102. Withdrawn By Author Pojskic, Valeria E Rac, Jiandong Su, Murray D Care Setting [162] Krahn, Suzanne M Cadarette. (Canada) Tariq M Alhawassi, Ines Krass, Lisa G Pont. 103. Withdrawn By Author (Australia) 83. Pharmaceutical Opinions in Ontario: A 104. Agreement Between Self-Reported Descriptive Analysis Using Administrative 92. Study of Drug Utilization Pattern of Medication from Patient Questionnaires Claims Data [154] Antidiabetic Agents: Analysis on the With Physician Information: Results from Lisa Dolovich, Giulia P Consiglio, Elizabeth Brazilian Longitudinal Study of Adult a Long-Term Cohort With Coronary Heart A Bojarski, Andrew J Calzavara, Linda D Health (ELSA-Brasil) [163] Disease [175] MacKeigan, Nedzad Pojskic, Lori MacCallum, Roberta Carvalho de Figueiredo, Thaís Dietrich Rothenbacher, Andrea Jaensch, Ute Suzanne M Cadarette. (Canada) Resende Batista, Raiany Thaimeny Nery. Mons, Lutz Breitling, Dhayana Dallmeier, Harry (Brazil) Hahmann, Hermann Brenner. (Germany) 84. Predictors of Ontario’s Medication Review Program (MedsCheck Annual Service) 93. Results of the European Science 105. Concordance Among Anticholinergic Utilization Among Ontario Seniors [155] Foundation Exploratory Workshop on Burden Scales [176] Petros Pechlivanoglou, Lusine Abrahamyan, Quality and Safety of Pharmacotherapy Jennifer G Naples, Zachary A Marcum, Linda MacKeigan, Lisa Dolovich, Giulia P in Old Age: A Focus on Potentially Subashan Perera, Shelly L Gray, Anne B Consiglio, Valeria E Rac, Jiandong Shin, Paul Inappropriate Medication (PIM) Lists [164] Newman, Eleanor M Simonsick, Kristine Yaffe, Grootendorst, Elizabeth A Bojarski, Suzanne M Majda Azermai, Monique Elseviers, Robert Ronald I Shorr, Joseph T Hanlon. Cadarette, Murray Krahn. (Canada) Vander Stichele, On Behalf of the European (United States) Science Foundation Exploratory Workshop 85. Incidence of Medication Errors in the Peri- Members. (Belgium) 106. An Assessment of the Basic Medication Operative Period: A Retrospective Study Safety Practices in Sudan [177] [156] 94. Evaluation of a Rapid Implementation Mansour A Mahmoud, Shihabeddin Siddig, Sarah Khayyat, Sara Qureshi, Li Wei. Quality Improvement Program for Medicine Alnada Mohamed, Hisham Aljadhey. (Saudi Arabia) Security [165] (Malaysia) Alice V Gilbert, Michael Roberts, Des Williams, 86. Hypothyroidism and Thyroid Hormone Use Andrew Leigh Gilbert. (Australia) 107. Applicability of a Systematic Tool To in Older Adults in Lazio, Italy [157] Reduce Inappropriate Prescribing in Adults Ursula Kirchmayer, Flavia Mayer, Raffaele 95. A Multinational, Drug Utilisation Study To With an Intellectual Disability: A Pilot Study Antonelli Incalzi, Mario Barbagallo, Giuseppe Investigate the Use of Dexmedetomidine [178] Paolisso, Gianpaolo Ceda, Marina Davoli. (Dexdor®) in Clinical Practice in the EU Rianne J Zaal, Susan Ebbers, Mirka Borms, (Italy) [166] Bart de Koning, Patricia MLA van den Bemt, Susana Perez-Gutthann, Mary Weatherall, Heleen M Evenhuis. (Netherlands) 87. Prevalence and Risk Factors for Adverse Chris Garratt, Pasi Pohjanjousi, Riku Aantaa, Drug Reactions in Older Adults in the Acute Giorgio Conti, Michael Lewis, Nicholas Moore. 108. Medications Prescribed and Stopped Care Setting [158] (Spain) at Hospital Discharge and Filled Tariq M Alhawassi, Ines Krass, Lisa G Pont. Medications in the Community: Medication (Australia) 96. An Academic Detailing Program To Reduce Discrepancies 30-Days Post Hospital Antipsychotic Medication Use in Nursing Discharge [179] Homes [167] Daniala L Weir, Aude Motulsky, Maria-Teresa Eimir Hurley, Connie DiCocco, Michael Moraga, Robyn Tamblyn. (Canada) Fischer, Niteesh Choudhry, Jerry Avorn. (United States) 65 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

109. Completeness of Medications 118. Trends of Use of Non-Insulin Blood 127. Geographic Variations in Use of Cancer Prescriptions: Prescription Errors Study in Glucose Lowering Drugs in Europe and Targeted Therapies in Taiwan [206] Hail Region (PeSHR) [180] USA [189] Jason C Hsu, Yea-Huei Kao Yang, Jin-Ding Ali F Altebenaui, Mubarek Alrashedi, Thamir M Ingrid Leal, Cormac Sammon, Gwen MC Huang, Christine Y Lu. (Taiwan) Alshammari, Mohamad Aljofan. (Saudi Arabia) Masclee, Lorenza Scotti, Giorgia De Berardis, Irene Bezemer, Miguel Gil, Elisa Martin, Anita 128. Utilization and Trends of Molecularly 110. Prevalence of Potentially Inappropriate McGrogan, Niklas Schmedt, John D Seeger, Targeted Therapies in Cancer Treatment: A Medication Prescribing Among Older Gianluca Trifiro, Serena Pecchioli, Cristina 2006-2010 NAMCS Analysis [207] Adults in Emergency Department in Chile Varas-Lorenzo, Mark M Smits, Peter Rijnbeek, Donna R Rivera, Kelly Filipski, Andrew N [181] Miriam CJM Sturkenboom, Silvana Romio. Freedman. (United States) Marcela Jirón, Luis Herrada, Alex Rojas, (Netherlands) Andrés Lueiza, Elena Vega, Erwin Buckel, 129. Impact of Cancer Diagnosis and Treatment Hernán Acuña, José Luis Santelices, Renato 119. Survey on Management of GERD: Clinical on Glycaemic Control Among Individuals Maynard, Ricardo Quezada. (Chile) Experience With Esomeprazole and With Colorectal Cancer Using Glucose Levosulpiride [190] Lowering Drugs [208] 111. Potentially Inappropriate Medication Mayuresh Fegade, Chetan Mehndiratta. (India) Marjolein Zanders, Myrthe van Herk-Sukel, Among Chilean Older Inpatients: Ron Herings, Lonneke van de Poll-Franse, Comparison Between a 2012 Beers Criteria 120. 11-Year of Outpatient Antibiotic Utilization Harm Haak. (Netherlands) and STOPP [182] in Portugal – Utilization Pattern and Marcela Jirón, Mariangel Tapia, Tamara Regional Comparison Between 2004-2014 130. Real World Treatment Pattern Trends in Sandoval, Daniel Palma, Sebastián Orellana, [191] Patients With Multiple Myeloma in the US Leslie Escobar, Isabel Huala, Elena Vega. Marta V Gomes, Carla Torre, José Guerreiro, [209] (Chile) Paulo Nogueira, Cristina Furtado. (Portugal) Xue Song, Ze Cong, Kathleen Wilson. (United States) 112. Factors Associated With Medication Errors 121. Prevalence of Prescription and Dosage of in Hospitalized Patients in Chile [183] Antibiotics in Outpatients from Mexico City: 131. Pattern of Chemotherapy Dose Delay and Ann-Loren Smith, Inés Ruiz, Marcela Jirón. Pilot Study [192] Dose Reduction [210] (Chile) Ramiro Sánchez-Huesca, Jesús-Oswaldo Hairong Xu, Chun Chao, Lanfang Xu, Kimberly García-Ávila, Claudia Lerma. (Mexico) Cannavale, Olivia Sattayapiwat, John H Page, 113. Effect of No Technological Interventions for Roberto Rodriguez, Leila Family. Reducing Medication Error [184] 122. Survey To Understand Role of Angiotensin (United States) Ann-Loren Smith, Inés Ruiz, Tamara Yañez, Receptor Blockers (ARBs) in the Mónica Catalán, Marcela Jirón. (Chile) Management of Hypertension [193] 132. Patterns of Antiplatelet Use in Patients Mayuresh Fegade, Chetan Mehndiratta. (India) With Myocardial Infarction and Subsequent 114. Incidence of Intravenous Medication Errors Acute Coronary Syndrome Events [211] in a Chinese Hospital [185] 123. Prescription Profile of Cefpodoxime Alfi Yasmina, Anthonius de Boer, Olaf H Qian Ding, Kenneth Barker, Elizabeth Flynn, Proxetil in Patients With Various Infections Klungel, Patrick C Souverein. (Netherlands) Ming Chang. (United States) [194] Mayuresh Fegade, Chetan Mehndiratta, Jejoe 133. Statins Prescription Rates in a Population- 115. Prevalence and Determinants of Potentially KaranKumar. (India) Based Cohort of Amyotrophic Lateral Inappropriate Medication Prescribing Sclerosis: Comparison With the General Among Older US Adults According To Drug Utilization Research Population [212] STOPP Criteria [186] Francesca Palese, Paolo Battiston Giacomelli, Marcela Jirón, Virginia Pate, Laura C Hanson, Health Services Research Silvia Ussai, Manuela Giangreco, Lorenzo Michele Jonsson Funk, Til Stürmer. (Chile) 124. Treatment Patterns and Characteristics Verriello, Fabio Barbone, Giancarlo of Post-Menopausal Women With HR+/ Logroscino, Federica E Pisa. (Italy) 116. Drug Utilization and Characteristics of New HER2- Metastatic Breast Cancer Receiving Users of Prucalopride in a UK Primary Care Everolimus [203] 134. The Temporal Trend of Concomitant Setting [187] Francis Vekeman, Yanni Hao, Wendy Y Prescription of Contraindicated Drugs in Ana Ruigómez, Luis-Alberto García- Cheng, Jonathan Fortier, Marie-Noëlle Dronedarone Users [213] Rodríguez. (Spain) Robitaille, Mei Sheng Duh. (Canada) Chuntao Wu, Andrew Koren, Jane Thammakhoune, Hayet Kechemir, Stephanie 117. Patterns of Use of Incretin-Based Therapies 125. Nationwide Time Trend Analysis of Cancer Tcherny-Lessenot, Stephen Lin, Juhaeri in Europe and USA [188] Targeted Therapies in Taiwan (2009-2016) Juhaeri. (United States) Ingrid Leal, Cormac Sammon, Gwen MC [204] Masclee, Giovanni Corrao, Giorgia De Jason C Hsu, Yea-Huei Kao Yang, Jin-Ding 135. Impact of New Oral Anticoagulants Berardis, Irene Bezemer, Miguel Gil, Elisa Huang, Christine Y Lu. (Taiwan) (NOACs) on Therapy of Patients With Martin, Anita McGrogan, Niklas Schmedt, John Japanese Patients: Descriptive Study Using D Seeger, Gianluca Trifiro, Serena Pecchioli, 126. Which Types of Cancer Account for the Commercially Available Database [214] Cristina Varas-Lorenzo, Mark M Smits, Peter Highest Use of Targeted Therapies in Kiyoshi Kubota, Nobuhiro Ooba, Yukari Rijnbeek, Miriam CJM Sturkenboom, Silvana Taiwan? [205] Kamijima, Kuniyasu Sato, Daisuke Koide. Romio. (Netherlands) Jason C Hsu, Yea-Huei Kao Yang, Jin-Ding (Japan) Huang, Christine Y Lu. (Taiwan)

66 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

136. Use of Overactive Bladder Medications in 146. Psychopharmacological Treatment 156. Estimating the Impact of a Breast Cancer the Adult Population of the UK: A Cohort Patterns in Bipolar Disorder – A Nationwide Diagnosis on Antidepressant Adherence Study in the Clinical Practice Research Register-Based Study [225] [235] Datalink [215] Louise Bjørklund, Henriette Thisted, Ole Yi-Ting Chou, Aaron N Winn, Donald L Andrea V Margulis, Lisa J McQuay, Susana Mors, Søren D Østergaard, Christiane Gasse. Rosenstein, Stacie B Dusetzina. Perez-Gutthann, James A Kaye, Alejandro (Denmark) (United States) Arana. (Spain) 147. Pattern Mining of Drug Prescriptions 157. Trends in the Utilization of Warfarin and 137. Use of Oral Non-Steroidal Anti- Suggests Complications from Chronic the New Oral Anticoagulants in Atrial Inflammatory Drugs in People With Asthma Opioid Use [226] Fibrillation Patients [236] [216] Yen Low, Tanya Podchiyska, Nigam Shah, Abdullah Abdulaziz Alalwan, Stacy A Voils, Daniel R Morales, Peter T Donnan, Bruce Anna Lembke. (United States) Abraham Hartzema. (United States) Guthrie. (United Kingdom) 148. Prescribing Patterns of Proton Pump 158. Utilization and Predictors of Psychotropic 138. Use of Antipsychotics (AP) in Mental Health Inhibitors in Patients With NSAID Use – A Polypharmacy in Adult Patients With Secondary Care Setting Vs Primary Care Comparison Between Switzerland and the Attention-Deficit/Hyperactivity Disorder [217] UK in Primary Care [227] [237] Deborah Layton, Vicki Osborne, Miranda Fabienne AM Biétry, Oliver Reich, Susan S Wei Liu, Xinyue Liu, Paul Kubilis, Yan Li, Davies, Ian Ratcliffe, Sarah Clarke, Saad AW Jick, Christoph R Meier. (Switzerland) Yanmin Zhu, Almut G Winterstein. Shakir, Joe Reilly, Tony Hale. (United States) (United Kingdom) 149. Determining Exposure of Newly Initiated Antipsychotic Medication in a Cohort of 159. Withdrawn By Author 139. Sex Difference in Antidepressant Use in Elderly Dementia Patients [228] Brain Injury Rehabilitation Centres [218] Kimberly A Fernandes, Mina Tadrous, Diana 160. Withdrawn By Author Veronica Campagnol, Silvia Ussai, Giorgia Martins, Zhan Yao, Samantha Singh, Nathan Cosano, Manuela Giangreco, Tullio Giorgini, Herrmann, Muhammed Mamdani, David 161. Dispensing of Non-Tamper-Deterrent Emanuele Biasutti, Fabio Barbone, Federica E Juurrlink, Tara Gomes. (Canada) Brands of Oxycodone Close To the Pisa. (Italy) Canadian USA Border [240] 150. Drug Switches in Antiretroviral Regimens: Tara Gomes, David Henry, Mariam Mukati, 140. Trends in Prescribing Patterns for Results of a 5-Year Historical Cohort [229] Michael Paterson. (Canada) Cabergoline in 4 European Countries [219] Cristiane A Menezes de Pádua, Letícia P Cynthia de Luise, René Schade, Gianluca Braga, Débora C Hilário, Míriam M Lima 162. Prevalence of Switching from Brand Trifirò, Lars Pederson, Ron Herings, Miriam Souza, Lorenza N Campos Dezanet. (Brazil) To Generic Asthma Medications in the Sturkenboom. (United States) Netherlands [241] 151. Dose and Duration of Use Among Marjolein Engelkes, Nico C van Blijderveen, 141. Drug Utilisation (DU) Study of Seroquel® Commercially Insured Adults Prescribed Katia MC Verhamme, Jetty A Overbeek, Josine Extended Release (XR) Prescribed By Immediate-Release (IR) or Extended- G Kuiper, Ron CM Herings, Miriam CJM Psychiatrists as Treatment for Major Release (ER) Oxycodone [230] Sturkenboom, Johan C de Jongste, Hettie M Depressive Disorder (MDD) in Selected Angela DeVeaugh-Geiss, Paul Coplan, Aditi Janssens. (Netherlands) Countries in the European Union (EU) [220] Kadakia. (United States) Robert S Brody, Charlie L Liss, Wray Heather, 163. Withdrawn By Author Anneli Thurreson, Leigh Jefferies. 152. Medicare Part D’s Impact on Pain (United States) Management in Dual-Eligible Nursing Home 164. Using Group-Based Trajectory Models Residents With Cancer: An Interrupted To Characterize Longitudinal Patterns of 142. Risk of Injury With Sedative Hypnotic Use Time-Series Study [231] Spending Phenotypes and Predict High- in an Over-65 Population [221] Camilla B Pimentel, Kate L Lapane, Allison B Cost Patients Using Medication Use and Sanket Shah, Julieta Scalo, Karen Rascati. Rosen, Jerry H Gurwitz, Becky A Briesacher. Comorbidity Characteristics [243] (United States) (United States) Julie C Lauffenburger, Jessica M Franklin, Alexis A Krumme, William H Shrank, Olga S 143. National Trends in Adult Bipolar Disorder 153. The Potential Impact of the Leucovorin Matlin, Claire M Spettell, Gregory Brill, Niteesh Subtypes and Prescribed Psychotropic Shortage on U.S. Medicaid Utilization and K Choudhry. (United States) Medications [222] Spending from 2008 To 2013 [232] Thiyagu Rajakannan, Dinci Pennap, Daniel J Ying Xia, Boyang Bian, Christina ML Kelton, 165. Diagnosis and Management of Safer, Julie M Zito. (United States) Jeff J Guo. (United States) Premenstrual Syndrome in UK General Practice: A Study Using the Health 144. Patterns of Prescription Refill and 154. Utilization and Spending Trends for Improvement Network [244] Pregabalin: A Five-Year Prospective Cohort Diuretics in the U.S. Medicaid Program: Cormac J Sammon, Irwin Nazareth, Irene Study on High Consumption [223] 1991 - 2011 [233] Petersen. (United Kingdom) Micaela Tjäderborn, Carola Bardage, Staffan Amarsinh M Desai, Jeff J Guo, Christina Hägg, Elisabet Nikolic, Anna K Jönsson. ML Kelton, Pamela C Heaton, Teresa M 166. Therapeutic Class Differences in Generic (Sweden) Cavanaugh. (United States) Usage [245] Jodi B Segal, Matthew Daubresse, Chia-Ying 145. Use of Varenicline in a Canadian Province: 155. Type 2 Diabetes Treatment Patterns Across Lee, Mischka Moechtar, Sarah Duchter, Wenlei A Population-Based Study [224] Europe [234] Jiang, Robert Romanelli. (United States) Noor Breik, Shelley Derksen, Silvia Alessi- Edith M Heintjes, Jetty A Overbeek, Severini. (Canada) Patrick Blin, Gillian C Hall, Francesco Lapi, Daniel Prieto Alhambra, Irene D Bezemer. 67 (Netherlands) 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

167. Analgesic Use in a Norwegian General 179. Attitudes in Statins Use in Greece [258] 190. Survey on Management of Severe Intensive Population: Change Over Time and High- Paraskevi Papaioannidou, Achilleas Ntaralas. Care Unit (ICU) Infections: Clinical Risk Use. A Repeated Cross-Sectional (Greece) Experience With Imipenem+Cilastatin [269] Study: The Tromsø Study [246] Chetan Mehndiratta, Pradip Gore, Mayuresh Per-Jostein Samuelsen, Lars Slørdal, Ulla 180. Drug Use Among Elderly in the Year Before Fegade. (India) Dorte Mathisen, Anne Elise Eggen. (Norway) Colon Cancer Diagnosis Versus Matched Cancer-Free Controls [259] 191. Prescription Event Monitoring of 168. HIV Treatment Strategies in Europe (EU): Felice N van Erning, Marjolein MJ Zanders, Doripenem Therapy in Management of Adoption of Single Tablet Regimen (STR) Myrthe PP van Herk-Sukel, Josine G Kuiper, Serious Infections [270] [247] Valery EPP Lemmens. (The Netherlands) Chetan Mehndiratta, Pradip Gore, Jejoe Siva Narayanan, Camelia M Graham, Sarah KaranKumar. (India) Brown, Samantha Fernando. (United States) 181. Prevalence of Low Cost Generic Program Use in a Nationally Representative Cohort 192. Effects of Sex and Alcohol Use on 169. Polypharmacy Among Older Individuals of Privately Insured Adults [260] Antiretroviral Therapy Outcomes in With Diabetes in Quebec, Canada [248] Joshua D Brown, Nathan J Pauly. Botswana [271] Caroline Sirois, Marie-Eve Gagnon, Céline (United States) Robert Gross, Scarlett L Bellamy, Bakgaki Plante, Marc Simard, Isabelle Larocque. Ratshaa, Xiaoyan Han, Andrew P Steenhoff, (Canada) 182. Gaps in Ethical Policies for the Conduct Mosepele Mosepele, Gregory P Bisson. of Drug Utilization Studies To Assess (United States) 170. Withdrawn By Author the Effectiveness of Risk Minimization Interventions [261] 193. Systemic Treatment of Metachronous 171. Trends in Asthma-Related Pharmacy Fills Caroline Tremblay, Alia Yousif, Aurore Metastases After Curative Treatment of [250] Bergamasco, Yola Moride. (Canada) Breast Cancer [272] Karen E Wells, Haejin Kim, Suzanne Havstad, Josephina G Kuiper, Myrthe PP van Herk- Kimberley J Woodcroft. (United States) 183. Prescriptions Errors in a Random Sample Sukel, Yvette RBM van Gestel, Adri C Voogd, of Egyptian Community Pharmacies of the Valery EPP Lemmens, Sabine Siesling. 172. Utilization, Price, and Spending Trends City of Alexandria [262] (Netherlands) for Fluoroquinolones in the US Medicaid Omnia AbdelRahman, Aida Reda, Nessrin Program: 1991-2013 [251] Elnimr, Adel Abou-Ali. (Egypt) 194. Generic and Essential Medicines Towards Xiaomeng Yue, Jeff J Guo, Ying Xia, Ziyad S a More Efficient Use of Resources Almalki, Patricia R Wigle. (United States) 184. Assessing the Completeness of Data in the Prevention and Treatment of Included on a Random Sample of Medical Cardiovascular Diseases in Portugal [273] 173. Trends of Systemic Antibiotics (AB) Prescriptions Dispensed at Local Helena Gama, Carla Torre, Jose Pedro Consumption in the Community in Russian Pharmacies in the City of Alexandria, Egypt Guerreiro, Maria João Lima, Ana Azevedo, Federation (RF) [252] [263] Suzete Costa, Nuno Lunet. (Portugal) Ivan Zaharenkov, Polina Antoshkina, Svetlana Omnia AbdelRahman, Aida Reda, Nessrin Rachina, Julia Belkova. (Russian Federation) Elnimr, Adel Abou-Ali. (Egypt) 195. Patients’ Awareness of Bioequivalence Study Methods Supporting Generic 174. Use of Antidepressives and the Economic 185. Trends in the Medical Consumption of Venlafaxine Extended Release (ER) Tablet Crisis in Portugal [253] Strong Opioid Analgesics in Taiwan During Approval [274] Claudia Furtado. (Spain) Years 2007 To 2011 [264] Bilal Khokhar, Yujin Park, Francoise Pradel, Li-Fen Kuo, Wen-Ing Tsay. (Taiwan) Francis Palumbo, Zippora Kiptanui, Sarah 175. Trends in Use of Erythropoiesis-Stimulating Dutcher, Wenlei Jiang, Ilene Zuckerman. Agents and Blood Transfusions in US 186. The Burden of Cardiovascular Disease and (United States) Hemodialysis Patients With Cancer [254] the Impact of Anti-Diabetic Medication on Anne M Butler, Abhijit V Kshirsagar, Andrew Incident Cardiovascular Disease in Patients 196. Prescribing Pattern of Anti-Epileptic and F Olshan, Matthew E Nielsen, Stephanie B With Type 2 Diabetes: Findings from U.S. Concomitant Drugs in Children With Wheeler, M Alan Brookhart. (United States) National Surveys [265] Epilepsy in India [275] Longjian Liu, Hui Liu. (United States) Anil Dasari, Dipika Bhansal, Chandrika Azad. 176. Drug Utilization in Rheumatoid Arthritis (India) from a Large Japanese Hospital 187. Antipsychotic (AP) Use in Older Adults Administrative Database [255] With Dementia: Results from a Post- 197. Socio-Demographic and Geographic Bruce Crawford, Joseph Kim. (Japan) Authorisation Safety Study (PASS) [266] Variations in the Utilization of Hormone Deborah Layton, Miranda Davies, Vicki Therapy in Older Breast Cancer Women 177. New Oral Anticoagulants in Clinical Osborne, Saad AW Shakir. (United Kingdom) With Medicare Part-D Coverage [276] Practice: Trends in Prescribing Patterns Xin Wang, Xianglin Du. (United States) and Health Spending [256] 188. Preadmission Prescriptions of Claudia Furtado. (Spain) Antidepressants and Prognosis After 198. Polypharmacy and Multiple Indications Colorectal Cancer Surgery [267] Among Adults Prescribed Antidepressants 178. Urban-Rural Differences in the Uptake of Kathrine D Lycke, Christian F Christiansen, [277] New Formulations of Osteoporosis Drugs Mette Nørgaard. (Denmark) Jenna Wong, Aude Motulsky, Robyn Tamblyn. [257] (Canada) Racquel Jandoc, Muhammad Mamdani, Linda 189. Survey on Management of Severe Intensive E Lévesque, Suzanne M Cadarette. (Canada) Care Unit (ICU) Infections: Clinical 199. Role of Residential Segregation in Disparity Experience With Colistin Methane Sulfonate Research: A Case Example of ADHD (CMS) [268] Diagnosis and Treatment [278] 68 Chetan Mehndiratta, Pradip Gore, Mayuresh Dinci Pennap, Mehmet Burcu, Julie M Zito. 2015 ICPE Fegade. (India) (United States) POSTER SES- SION A

POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

200. Socioeconomic Differential in One-Year 209. Drug Utilization: Pattern and Influence on 219. Physicians’ Acceptance of Pharmacists’ Survival After Hospitalization for Ischemic the Quality of Life of Patients Under Care at Interventions in a Dutch University Hospital Stroke: The Effect of Acute and Post-Acute Public Health Centers in Brazil [288] [298] Care-Pathways [279] Katia Rodrigues Silva, Micheline Rosa Silveira, Rianne J Zaal, Edwin W den Haak, Arnold Valeria Belleudi, Paolo Sciattella, Nera Agabiti, Celline Cardoso Almeida-Brasil, Luana G Vulto, Patricia MLA van den Bemt. Mirko Di Martino, Riccardo Di Domenicantonio, Faria Cruz, Lais Lessa Pantuzza, Mariana (Netherlands) Marina Davoli, Danilo Fusco. (Italy) Guimarães Lima, Maria das Graças Braga Ceccato. (Brazil) 220. Mind the Gap: Why Closing the Doughnut 201. Drug Utilization Study of Asthma Hole Is Insufficient for Medicare Specialty Medications in the U.S. Medicare 210. Health Literacy Skills and Correct Use of Drug Users [299] Beneficiaries [280] Medicines in the Netherlands: A Study in Stacie B Dusetzina, Nancy L Keating. Ayad K Ali. (United States) Community Pharmacies [289] (United States) Ellen S Koster, Daphne Philbert, Marcel L 202. Misclassification of Indication When Bouvy. (Netherlands) 221. Treatment Patterns and Outcomes of Measuring Indacaterol Use in a US Patients Diagnosed With Ovarian Cancer in Administrative Claims Database [281] 211. An Educational Intervention To the Netherlands: A Registry Study [300] Scott C Quinlan, Rajeev K Amar, Raymond Improve the Knowledge and Practice of Eline Houben, Heleen GM van Haalen, Schlienger, Stephan Lanes, Crystal N Holick. Pharmacovigilance Among Healthcare Wouter Sparreboom, Jetty A Overbeek, Nicole (United States) Professionals in Private Hospitals in Lagos Ezendam, Hannie JMA Pijnenborg, Myrthe PP State Nigeria [290] van Herk-Sukel. (Netherlands) 203. Prescribed Opioid Use and Potential Chioma S Ejekam, Vivian O Chuka-Ebene, Misuse in Australia (2006 To 2013) [282] Ibrahim A Oreagba, SO Olayemi, AJ Adewumi. 222. Predictors of Gastrointestinal Bleeding Bianca Blanch, Nicholas Buckley, Preeyaporn (Nigeria) Among Patients With Atrial Fibrillation Srasuebkul, Melisa Litchfield and Sallie-Anne Initiating Dabigatran and Subsequent Pearson. (Australia) 212. Clinical Manifestations and Treatment Patterns of Use [301] Patterns of Systemic Lupus Erythematosus Julie C Lauffenburger, Denise H Rhoney, Joel 204. Quality of Community Pharmacy Care in [291] F Farley, Anil K Gehi, Gang Fang. the Netherlands: Changes in Dispensing Sreedharan Nair, Sowmya Annavarapu, (United States) Outcome Scores Across Five Years [283] Vijayanarayana Kunhikatta, Girish Thunga. Martina Teichert, Tim Scheonmakers, Nico (India) 223. Monitoring of Mortality Associated To New Kijlstra, Berend Mosk, Marcel Bouvy, Frans Oral Anticoagulants vs Warfarin in Atrial van de Vaart, Peter de Smet, Michel Wensing. 213. Prevalence and Predictors of Medication Fibrillation [302] (Netherlands) Non-Adherence in Patients With Mental Flavia Mayer, Ursula Kirchmayer, Nera Agabiti, Disorders: A Cross-Sectional Study [292] Giovanna Cappai, Danilo Fusco, Marina 205. Effect of a Certified Quality Management Gurumurthy Parthasarathi, Jisha Jojo, Madhan Davoli. (Italy) System on Dispensing Outcome Quality Ramesh, Krishna Undela, Dushad Ram. Indicators in Community Pharmacies [284] (India) 224. The Risk of Urinary Tract Infections With Martina Teichert, Tim Schoenmakers, Nico the Use of Dextromethorphan in Different Kijlstra, Berend Mosk, Marcel Bouvy, Frans 214. Baseline Antidiabetic Drug Patterns in Indications. Results from a Systematic van de Vaart, Peter de Smet, Michel Wensing. Patients Initiating Treatment for Diabetes Review and Meta-Analysis of Randomised (Netherlands) [293] Clinical Trials [303] Donnie P Funch, Li Zhou, Atheline Major- Luis G Velez-Nandayapa, Laura M DeVore. 206. Translation and Cross-Cultural Pedersen, Helge Gydesen, David D Dore. (Switzerland) Adaptation of the Brief Illness Perception (United States) Questionnaire, the Beliefs About Medicines 225. Ocular Beta-Blockers in People With Questionnaire and the Morisky Medication 215. Multiple Imputation (MI) for Missing Asthma and Glaucoma [304] Adherence Scale Into Vietnamese [285] Outcome Data in a Medical Chart Review Daniel R Morales, Brian J Lipworth, Cathy Thang Nguyen, Thao H Nguyen, Suol T Pham, Study [294] Jackson, Bruce Guthrie. (United Kingdom) Hoang TK Cao, Khanh K Le, Hoa TK Pham, Xiaojuan Li, Violeta Hennessey, Fei Xue. Phong T Pham, Dung N Quach, Dao TT Tran, (United States) 226. Can Reporters of a Medicines Incident Tam T Pham, Katja Taxis. (Viet Nam) Accurately Reflect the Clinical Risk? [305] 216. Applying the Ready Reckoner (RRec) Alice V Gilbert, Michael Roberts, Des Williams, 207. Access To Drug Benefit Plans Among Tool for Assessing Antipsychotic (AP) Andrew L Gilbert. (Australia) Canadian Cancer Survivors [286] Prescribing Within Post-Authorisation Lawson Eng, Devon Alton, Tom Yoannidis, Safety Studies (PASS) [295] 227. Pharmacovigilance Practices for Better Robin Milne, Samantha Sarabia, Zahra Merali, Deborah Layton. (United Kingdom) Healthcare Services: Knowledge, Liam Murphy, M Catherine Brown, Ashlee Awareness and Practices of Healthcare Vennettilli, Meredith E Giuliani, Wei Xu, 217. Drug Utilization Study (DUS) Methodology: Professionals (HCPs) Toward Geoffrey Liu. (Canada) Applications and Challenges [296] Pharmacovigilance in Malaysia [306] Dara Stein, Kristin A Hanson. (Canada) Muhammad Shahid Iqbal, Mohd Baidi Bahari, 208. Affordability of Medicines in Armenia [287] Muhammad Zahid Iqbal, Muhammad Waseem Irina Kazaryan, Anahit Sevikyan, Margarit 218. Automated Extraction of VTE Events from Iqbal. (Malaysia) Melikyan, Anahit Amirkhanyan. (Armenia) Narrative Radiology Reports in Electronic Health Records: A Validation Study [297] Zhe Tian, Simon Sun, Tewodros Eguale, Christian Rochefort. (Canada) 69 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

228. Adverse Drug Reactions (ADRs) Reporting 236. Incidence of Outcomes Relevant To 246. Factors Predicting Human Papillomavirus Among Community Health Extension Vaccine Safety Monitoring in a Large Vaccination Intention and Uptake: A Meta- Workers (CHEWs) in Oyo State, Nigeria: An Commercially Insured Population [315] Analysis and Systematic Review [325] Assessment of Attitude and Practice [307] Daina B Esposito, Lina Titievsky, Jennifer Andrew R Wilson, Mia Hashibe, Lisa H Gren, Waheed A Adedeji, Fatai A Fehintola. (Nigeria) CL Hawes, Rosalind C Hollingsworth, Daniel Chang-Chung Chou, Anna T Gardener, A Scott, Crystal N Holick, Stephan Lanes. Jessica Greenwood, Brian R Jackson, Spotlight Session-Vaccines (United States) Rosemary She, Deanna Kepka, Nicole Bailey, Marlene J Egger. (United States) 229. New Methodology for Enhanced Safety Vaccines Surveillance of Nasal Quadrivalent Live 247. Validation of Current Procedural Attenuated Influenza Vaccine (QLAIV) 237. Use of the High-Dose Influenza Vaccine Terminology Codes for Rotavirus Using Participant Questionnaire Feedback: Among Commercially Insured Patients in Vaccination in Two Commercially-Insured Interim Results [308] the United States, 2010-2012 [316] US Populations [326] Rhian McNaughton, Elizabeth Lynn, Vicki Leah J McGrath, M Alan Brookhart. Veena Hoffman, Nicholas J Everage, Scott Osborne, Saad Shakir, Abigail Coughtrie. (United States) Quinlan, Kathleen Skerry, Daina Esposito, (United Kingdom) Nicolas Praet, Dominique Rosillon, Crystal N 238. Effectiveness of Influenza Vaccination for Holick, David D Dore. (United States) 230. What Explains the Different Rates of Children in Japan [317] Human Papillomavirus Vaccination Among Natsumi Shibata, Hisashi Urushihara. (Japan) 248. Intussuception After Rotarix Vaccien Adolescent Males and Females in the Adverse Event Reporting System(VAERS0, United States? [309] 239. Active Monitoring of Local Inflammations 04/2008-12/2014 [327] Yoonyoung Choi, Efe Eworuke, Richard Segal. Within a Cohort of Patients Vaccinated With Penina Haber, Umesh D Parashar, Eric S (United States) Influenza Vaccine [318] Weintraub, Michael J Haber, Frank DeStefano. Leontine HW van Balveren, Agnes C Kant, (United States) 231. Safety of a Novel Meningococcal Group Linda VDH Härmark. (Netherlands) B Vaccine Used in Response To Two 249. Clinical and Demographic Characteristics Outbreaks in the US [310] 240. Effectiveness of Seasonal Influenza of an Expanded Target Population for Jonathan Duffy, Peter Johnsen, Mary Ferris, Vaccines Against Influenza A (H1N1) 13-Valent Pneumococcal Conjugate Mary Miller, Kevin Leighton, Mark McGilvray, Infection in Post-Pandemic Seasons: A Vaccine (Prevnar 13®, PCV13) [328] Lucy McNamara, Lucy Breakwell, Yon Yu, Systematic Review [319] Lina Titievsky, Daina B Esposito, Jennifer Tina Bhavsar, Elizabeth Briere, Manisha Patel. Songul Bozat-Emre, Natalie Casaclang, CL Hawes, Robert Maroko, Rosalind C (United States) Hasantha C Sinnock, Xibiao Ye, Salaheddin M Hollingsworth, Crystal N Holick, Stephan Mahmud. (Canada) Lanes. (United States) 232. Immunocompromising Medications and Conditions Among Patients With Severe 241. Influenza Vaccine Utilization: A Comparison 250. Knowledge, Attitude, and Practice of Streptococcus pneumoniae Infections [311] Between Urban and Rural Counties in Healthcare Professionals Toward Hepatitis Jacob B Morton, Haley J Morrill, Aisling R Florida [320] B Vaccine and Disease [329] Caffrey, Kerry L LaPlante. (United States) Abdullah Abdulaziz Alalwan, Xiaohui Xu, Hisham Alshammari, Metab Alenazi, Abraham Hartzema. (United States) Mohammad Almuslim, Mohamad Aljofan, 233. Near “Real-Time” Vaccine Safety Thamir Alshammari. (Saudi Arabia) Surveillance Using Electronic Health 242. Reduction of Influenza Disease Cost With Records – A Systematic Review of Suboptimal Vaccination [321] 251. Current Practices and Regulations in Statistical Methods [312] Nicole M Bailey, Andrew Wilson, Yongmei Li, European Countries for Data Privacy and Andreia H Leite, Nick J Andrews, Sara L Aaron Kamauu. (United States) Ethics for the Use of Secondary Data: An Thomas. (United Kingdom) ADVANCE Initiative [330] 243. Post-Licensure Surveillance of Helene Denis, Alena Khromava, Harshana 234. Key Features of Vaccine Reports in Quadrivalent Live Attenuated Influenza Liyanage, Jorgen Bauwens, Lieke Van der VigiBase [313] Vaccine United States, Vaccine Adverse Aa, Patrick Mahy, Filipa Ferreira, Alessandro Lovisa Sandberg, Jonas Fransson, Kristina Event Reporting System (VAERS), July Spina, Germano Ferreira, Miia Artama, Kari Juhlin, Kristina Star, Rebecca Chandler 2013-June 2014 [322] Natunen, Nynke Rots, Klara Berencsi, Miriam (Sweden) Penina Haber, Pedro L Moro, Maria Sturkenboom, Simon de Lusignan. (Canada) Cano, Paige Lewis, Brock Stweart, Tom T 235. Risk of Anaphylaxis Following Vaccination Shimabukuro. (United States) 252. The ADVANCE Code of Conduct: A Tool for in Children and Adults [314] Vaccine Benefit-Risk Monitoring in Europe Michael M McNeil, Eric Weintraub, Jonathan 244. Safety of Seasonal Influenza Vaccines in [331] Duffy, Lakshmi Sukumaran, Steven J Pregnancy in the Vaccine Adverse Event Xavier Kurz, Vincent Bauchau, Jorgen Jacobsen, Nicola P Klein, Simon J Hambidge, Reporting System, 2010 - 2014 [323] Bauwens, Phillip Bryan, Stephen Glismann, Grace M Lee, Lisa A Jackson, Stephanie A Pedro L Moro, Paige Lewis, Janet Cragan, Mirna Robert-Du Ry van Beest Holle, Irving, Jennifer P King, Elyse O Kharbanda, Naomi Tepper. (United States) Raphaele Roten, Miriam Sturkenboom, Lieke Robert A Bednarczyk, Frank DeStefano. van der Aa, Jane Whelan. (United Kingdom) (United States) 245. Pattern of Quadrivalent Human Papillomavirus Vaccine (HPV4) Use Among 253. Assessment of Sex-Specific Differences Insured Males in the United States: 2009 - in Adverse Event Following Immunization 2013 [324] Reporting in Ontario, Canada [332] Kandace L Amend, Bruce Turnbull, Michael Tara M Harris, Kenny Wong, Jill Fediurek, Doherty, Mark Marsico, Christine Velicer, Shelley L Deeks. (Canada) 70 Patricia Saddier, John Seeger. (United States) 2015 ICPE POSTER SESSION A Monday, August 24, 2015 | 8:00am – 6:00pm

254. The Assessment of Characteristics of Spotlight Session Adverse Events Following Immunization in Japanese Adverse Drug Event Report Molecular Epidemiology Database and Vaccine Adverse Event Biomarkers/ Reporting System for Signal Detection Pharmacogenetics [333] Makoto Miyazaki, Akihito Shito, Minoru 263. Tumor Subtypes Among Breast Cancer Shimodera. (Japan) Patients With Diabetes [342] Heleen K Bronsveld, Vibeke Jensen, Pernille 255. Is the Case-Population Approach Useful for Vahl, Marieke L de Bruin, Sten Cornelissen, Vaccine Safety Surveillance? [334] Joyce Sanders, Peter Vestergaard, Marjanka K Hélène Théophile, Antoine Pariente, Nicholas Schmidt. (Netherlands) Moore, Bernard Bégaud. (France) 264. Preliminary Results on the Impact of 256. The Development of an In-House Signal Genetic Factors on Gastrointestinal Mining and Management Tool for GSK Bleeding in a Prospective Cohort of New Vaccine Spontaneous Reports [335] Warfarin Users [343] Lionel Van Holle, Pascale Schrauben. Stephanie Dumas, Sylvie Perreault, Robert (Belgium) Côté, Payman Shahabi, Ian Mongrain, Marie- Josée Gaulin, Sylvie Provost, Jean-Claude 257. Screening Vaccine Spontaneous Reports Tardif, Marie-Pierre Dubé. (Canada) Linked With Hierarchical Manufacturing Data: A Proof-Of-Concept of Manufacturing 265. Decision Analysis Model for Genetic Safety Signal Detection [336] Testing Prior To Antidepressant Treatment Olivia J Mahaux, Lionel F Van Holle. (Belgium) [344] Jacob T Painter, Bradley C Martin, Chenghui 258. The Incidence of Childhood and Adolescent Li, Amit Bodhani, Jeffrey M Pyne. Seizures in the UK from 1999 To 2011; (United States) a Retrospective Cohort Study Using the Clinical Practice Research Datalink [337] 266. Association Between Genetic Cormac J Sammon, Rachel A Charlton, Julia Polymorphisms of Drug-Metabolizing Snowball, John G Weil. (United Kingdom) Enzymes and Transporters and Anti- Tuberculosis Drug-Induced Liver Injury in a 259. Pharmacoepidemiology in the Vaccine Chinese Population [345] Industry: GSK Vaccines’ Example of Ru Chen, Jing Wang, Shaowen Tang, Yuan a Multidisciplinary Response To the Zhang, Xiaozhen Lv, Siyan Zhan. (China) Changing Regulatory Environment [338] Catherine Cohet, Corinne Willame, François 267. Prevalence and Characteristics of Non- Haguinet, Dominique Luyts, Vincent Bauchau, Small Cell Lung Cancer (NSCLC) Patients Germano LC Ferreira, Dominique Rosillon, Harboring Oncogenic Drivers [346] Laurence Baril. (Belgium) Dixa B Thakrar, Ceri Hirst. (United Kingdom)

260. Landscape Analysis of Existing Models 268. A National Survey of Pharmacists’ Roles in of Public-Private Interactions in a Public Clinical Pharmacogenomics: Assessment Health Environment: An ADVANCE of Predictors [347] Initiative [339] Emily Schwartz, Amalia M Issa. (United States) Laurence Torcel-Pagnon, Tin Tin Myint Htar, Lisen Arnheim Dahlström, François Simondon, Vincent Bauchau, Xavier Kurz. (France) z END SESSION A

261. Safety and Tolerability Evaluation of the Use of Montanide ISATM 51 as Vaccine Adjuvant: A Systematic Review [340] Eva van Doorn, Heng Liu, Anke Huckriede, Eelko Hak. (Netherlands)

262. Assessing Bias in Administrative Database Studies of Vaccine Completion Due To Exclusion of Subjects With Incomplete Follow-Up [341] Scott C Quinlan, T Christopher Mast, Sander Greenland, Crystal N Holick, Stephan Lanes. (United States)

71 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

Spotlight Session-Medicines Medicines in Pregnancy 16. HAART Use During Pregnancy and the Risk of Major Congenital Malformations [443] in Pregnancy 9. Insulin Analogues in Pregnancy and Anick Bérard, Odile Sheehy, Sasha Bernatsky, 1. Association Between Exposure To Acid- Specific Congenital Anomalies; a Literature Marc Boucher. (Canada) Suppressing Drugs During Pregnancy and Review [436] Asthma in Childhood [428] Josta de Jong, Ester Garne, Ewa Wender- 17. Quality of Reporting of Malaria Trials Lucia Cea Soriano, Sonia Hernández-Díaz, Ozegowska, Margery Morgan, Lolkje TW de During Pregnancy and Its Impact on the Saga Johansson, Péter Nagy, Luis A García- Jong-van den Berg, Hao Wang. (Netherlands) Effectiveness of Antimalarial Drug [444] Rodríguez. (Spain) Flory Tsobo Muanda, Anick Bérard. (Canada) 10. Use of Insulin Analogs in Pregestational 2. Oral Fluconazole in Pregnancy and Risk of Diabetes and Risk of Congenital Anomalies 18. Women’s Values and Preferences: Fetal Death [429] [437] Decisions Making About Ditte Mølgaard-Nielsen, Henrik Svanström, Hao Wang, Ewa Wender-Ozegowska, Ester Thromboprophylaxis in Pregnancy [445] Mads Melbye, Anders Hviid, Björn Pasternak. Garne, Margery Morgan, Maria Loane, Anna Luciane C Lopes, Shannon M Bates, Pablo (Denmark) Materna-Kiryluk, Awi Wiesel, Sue Jordan, Alonso-Coello, Mark Eckman,, Ignacio Miriam Gatt, Guy Thys, Vera Nelen, Marian Neumann, Elie A Akl, Amparo Santamaria, 3. Maternal Use of Specific Selective Serotonin- Bakker, Hermien de Walle, Lolkje de Jong-van Anne F Jacobsen, Yuqing Zhang, Kari A Reuptake Inhibitors in Early Pregnancy and den Berg. (Netherlands) Tikkinen, Shanil Ebrahim, Sarah D McDonald, the Risk of Birth Defects [430] Gordon H Guyatt. (Brazil) Jennifer N Lind, Jennita Reefhuis, Jan 11. Patterns of Antidiabetic Agent Use During M Friedman, Carol Louik, Tiffany Riehle- Pregnancy Among Women Delivering 19. Use of Antihypertensive Drugs in Colarusso, Margaret A Honein. (United States) a Liveborn Infant in the Mini-Sentinel Pregnancy. A Cross-Sectional Study in the Database (MSDD) [438] Lazio Region, Italy [446] 4. Maternal Use of Varenicline and Risk of Katrina Mott, Marsha E Reichman, Darren Martina Ventura, Ursula Kirchmayer, Serena Congenital Malformations [431] Toh, Monika Houstoun, Marilyn Pitts, Donati, Alice Maraschini, Alessandra Marani, Morten Olsen, Kenneth R Petronis, Trine Caren Kieswetter, Carrie Ceresa, Katherine Marta Buoncristiano, Sabrina Senatore, Flavia Frøslev, Lars Pedersen, Vera Ehrenstein, Haffenreffer, Susan E Andrade. (United States) Mayer, Marina Davoli. (Italy) Jingping Mo, Fredrik Granath, Helle Kieler, Henrik T Sørensen. (Denmark) 12. Risk of Preterm Delivery Among Live Births 20. Pregnancies and Pregnancy Outcomes Exposed To Anti-Diabetic Agents During During Isotretinoin Treatment in Four 5. The Teratogenic Risk of Antiepileptic Drugs the First Trimester of Pregnancy [439 Canadian Provinces [447] in Pregnancy [432] Caitlin A Knox, Christian Hampp, Babette David Henry, Colin Dormuth, Brandy Winquist, Shuk-Li Collings, Irwin Nazareth, Mary Brumback, Xiaohui Xu, Richard Segal, Almut G Shawn Bugden, Robert Platt. (Canada) Thompson, Irene Petersen. (United Kingdom) Winterstein. (United States) 21. Intranasal Triamcinolone Use During 6. Patterns of Anti-Epileptic Drug (AED) Use 13. Risk of Preeclampsia Among Live Births Pregnancy and the Risk of Adverse During Pregnancy in the Mini-Sentinel Exposed To Anti-Diabetic Agents During Pregnancy Outcomes [448] Database (MSDD) Among Women the First Trimester of Pregnancy [440] Anick Bérard, Odile Sheehy, Marie-Laure Delivering a Liveborn Infant [433] Caitlin A Knox, Christian Hampp, Babette Kurzinger, Juhaeri Juhaeri. (Canada) Marilyn R Pitts, Katrina Mott, Marsha E Brumback, Xiaohui Xu, Richard Segal, Almut G Reichman, Carrie Ceresa, Susan E Andrade, Winterstein. (United States) 22. Calcium Channel Blockers To Prevent Caren Kieswetter, Sengwee Toh, Monika Preterm Labor: A Drug Utilization Study in Houstoun, Katherine Haffenreffer. 14. Risk of Cesarean Section Delivery Among Two French Databases [449] (United States) Live Births Exposed To Anti-Diabetic Justine Benevent, Anna-belle Beau, Béatrice Agents During the First Trimester of Guyard-Boileau, Caroline Delarue-Hurault, 7. Antidepressant, Especially SSRI Use, Pregnancy [441] Isabelle Lacroix, Jean-Louis Montastruc, During Pregnancy and the Risk of Autism Caitlin A Knox, Christian Hampp, Babette Christine Damase-Michel. (France) Spectrum Disorder: A Meta-Analysis [434] Brumback, Xiaohui Xu, Richard Segal, Almut G Takoua Boukhris, Flory Muanda-Tsobo, Anick Winterstein. (United States) 23. Risk Factors Associated With Early Bérard. (Canada) Intrauterine Device Insertion After Delivery 15. Sulfonamide Use During the First Trimester [450] 8. Asthma Medicine Prescribing Before, of Pregnancy and Risk of Selected Efe Eworuke, David G Moeny. (United States) During and After Pregnancy: A Study in 7 Congenital Anomalies Among Live Births European Regions [435] [442] 24. Periconceptional Benzodiazepine Use and Rachel Charlton, Anna Pierini, Kari Klungsøyr, Craig Hansen, Susan E Andrade, Heather the Risk for Birth Defects: Data from the Amanda Neville, Sue Jordan, Lolkje de Jong- Freiman, Sascha Dublin, Katie Haffenreffer, National Birth Defects Prevention Study van den Berg, Daniel Thayer, H Jens Bos, William O Cooper, T Craig Cheetham, Darren [451] Aurora Puccini, Anna Hansen, Rosa Gini, Toh, De-Kun Li, Marsha A Raebel, Jennifer Sarah Tinker, Jennita Reefhuis, Cheryl Anders Engeland, Anne-Marie Nybo Andersen, L Kuntz, Nancy Perrin, A Gabriela Rosales, Broussard, Suzanne Gilboa, Rebecca Bitsko, Helen Dolk, Ester Garne. (United Kingdom) Shelley Carter, Pamala A Pawloski, Elizabeth Martha Werler, Allen Mitchell. (United States) M Maloney, David J Graham, Leyla Sahin, Pamela E Scott, John Yap, Robert Davis. 25. Psychotropic Medications in Combination (United States) Prior To Pregnancy: A UK Population Based Study [452] Rachel L McCrea, Irwin Nazareth, David PJ Osborn, Stephen JW Evans, Irene Petersen. 72 (United Kingdom) 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

26. Use of Folic Acid and Antidepressants 34. Exposure To Prescription Opioid 44. Direct-To-Patient Research: The Future of During Pregnancy and Child Language Analgesics In-Utero and the Risk of Pharmacovigilance? [471] Development [453] Neonatal Abstinence Syndrome: A Nancy A Dreyer, Shahrul Mt. Isa, Jonathan L Marte Handal, Svetlana Skurtveit, Christine Population-Based Cohort Study [461] Richardson, Maja Laursen, A Priscilla Zetstra- Roth, Sonia Hernandez-Diaz, Randi Selmer. Rishi J Desai, Krista F Huybrechts, Sonia van der Woude, Anna Jamry-Dziurla, Valerie (Norway) Hernandez-Diaz, Elisabetta Patorno, Brian T Hliva, Alison Bourke, Stella Blackburn. Bateman. (United States) (United States) 27. Selective Serotonin Reuptake Inhibitor Use in First Trimester Pregnancy and Risk of 35. SNRI, Bupropion and Mirtazapine Use During 45. The Epidemiology of Ebstein’s Anomaly Congenital Anomalies: A EUROmediCAT Pregnancy and the Risk of PPHN [462] in Europe: A Registry-Based Study With Case-Malformed Control Study in 12 Anick Bérard, Odile Sheehy, Sasha Bernatsky, Special Emphasis on Medication Exposure Countries [454] Michal Abrahamowitz. (Canada) [472] B Boyle, M Loane, M Bakker, MC Addor, Breidge Boyle, Ester Garne, Maria Loane, L Arriola, E Garne, M Gatt, S Jordan, B 36. Detection Bias in the Prenatal Diagnosis Marie-Claude Addor, Larraitz Arriola, Clara Khoshnood, K Klungsoyr, V Nelen, A Neville, M of Malformations Among SSRI Exposed Cavero-Carbonell, Hermien EK deWall, Miriam O’Mahoney, A Pierini, A Rissman, D Tucker, A Women [463] Gatt, Nathalie Lelong, Catherine Lynch, Vera Wiesel, H Dolk. (United Kingdom) Anna M Modest, Marth M Werler, Carla Van Nelen, Amanda J Neville, Mary O’Mahony, Bennekom, Allen A Mitchell. (United States) Anna Pierini, Anke Rissmann, David Tucker, 28. 5-Year Experience With the Cymbalta Natalia Zymak-Zakutnia, Helen Dolk. Pregnancy Registry: A Prospective 37. Neonatal Drug Withdrawal Syndrome: Cross- (United Kingdom) Observational Study To Assess Duloxetine Country Comparison of Recorded Hospital Exposure During Pregnancy [455] Admissions in England, USA, Western 46. Medication Use Among Pregnant Women Hu Li, Mark Bangs, Jennifer Zimmer, Dawn Australia and Ontario, Canada [464] Enrolled in the United States Medicaid Dyer, Sheila Miller. (United States) Hilary R Davies, Ruth Gilbert, Irene Petersen, Program [473] Irwin Nazareth, Arturo Gonzalez-Izquierdo. Kristin Palmsten, Sonia Hernández-Díaz, 29. Antipsychotics in Pregnancy: Comparative (United Kingdom) Christina D Chambers, Helen Mogun, Sophia Cohort Studies of Women Treated Before Lai, Todd P Gilmer, Krista F Huybrechts. and During Pregnancy [456] 38. The Impact of Different Case Ascertainment (United States) Irene Petersen, Rachel L McCrea, Cormac J Definitions on the Prevalence of Major Sammon, Stephen JW Evans, David Osborn, Congenital Malformations and Their 47. Medications Prescription in Pregnancy: Phil J Cowen, Irwin Nazareth. Association With Asthma During Is There an Association With (United Kingdom) Pregnancy [465] Sociodemographic Features? [474 Sherif Eltonsy, Amelie Forget, Lucie Blais. Francesca Sammartano, Silvia Ussai, Liza 30. Use of Topiramate in Relation To the Risk (Canada) Vecchi Brumatti, Anica Casetta, Federica E of Orofacial Clefts [457] Pisa, Fabio Barbone. (Italy) Hao Wang, Maria Loane, Joan Morris, Ester 39. Asthma Medication During Pregnancy: A Garne, Vera Nelen, Babak Khoshnood, Anke Cohort Study in EFEMERIS Database [466] 48. Systematic Review of Pregnancy Exposure Rißmann, Awi Wiesel, Mary O’Mahony, Anna Anna-belle Beau, Alain Didier, Isabelle Registries: Fetal/Infant Outcomes, Target Pierini, Amanda Neville, Miriam Gatt, Hermien Lacroix, Caroline Delarue-Hurault, Jean- Sample Size, and Comparators [475] de Walle, Marie-Claude Addor, David Tucker, Louis Montastruc, Christine Damase-Michel. Kate Gelperin, Hoda Hammad, Steven Bird, Kari Klungsoyr, Anna Latos-Bielenska, Jan (France) Christian Hampp, Kira Leishear, Leyla Sahin, Mejnartowicz, Christine Verellen-Dumoulin, Lockwood Taylor. (United States) Bérénice Doray, Larraitz Arriola, Ingeborg 40. The Use of Antiasthmatic Medications Barisic, Elisa Calzolari, Diana Wellesley, Helen During Pregnancy and the Risk of 49. A Multidisciplinary Structured Approach Dolk, Lolkje de Jong-van den Berg. Gestational Diabetes [467] for Interpreting and Integrating Medication (The Netherlands) Veronique Baribeau, Marie-France Exposure and Pregnancy Outcomes Beauchesne, Evelyne Rey, Amelie Forget, Information [476] 31. Prenatal Triptan Exposure and Lucie Blais. (Canada) Keele E Wurst, Sara A Ephross, Patrick Wier, Psychomotor Changes in 18 and 36 Month Greta A Bushnell, Alice D White. (United States) Old Norwegian Children [458] 41. Association Between Folic Acid Mollie Wood, Kate Lapane, Jean Frazier, Supplementation and Neural Tube Defects 50. Performance of an Algorithm for Identifying Nordeng Hedvig. (United States) Among High Risk Pregnancies [468] Pregnancy Outcomes in Commercial Health Corey M Benedum, Samantha E Parker, Allen Plan Claims Data [477] 32. Is Exposure To Benzodiazepine A Mitchell, Martha M Werler. (United States) Wendy J Carman, Neil A Accortt, Li Zhou, During Pregnancy Increase the Risk of Lauren Sanders, Mary S Anthony, Cheryl Spontaneous Abortion? [459] 42. Factors Associated With Achieving Enger. (United States) Odile Sheehy, Anick Bérard. (Canada) Success for Pregnancy Registries [469] Deborah Covington, Kristin Veley, Ann Mallard. 51. Performance of an Algorithm for 33. Prenatal Acetaminophen Exposure and (United States) Determining Dates of Conception and Cortical Thickness in Typically-Developing Pregnancy Termination Dates Using Children [460] 43. First Data on Participation Rates of a Commercial Health Plan Claims Data [478] Mollie Wood, David Kennedy, Steven Hodge, National Pregnancy Drug Register in the Wendy J Carman, Neil A Accortt, Li Zhou, Jean Frazier. (United States) Netherlands [470]Saskia Vorstenbosch, Lauren A Sanders, Mary S Anthony, Cheryl Agnes Kant (Netherlands) Enger. (United States)

73 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

52. Prevalence and Associated Factors With 61. Psychiatric Healthcare Utilization and 70. Psychotropic Medication Use Prior To Use of Medication During Pregnancy By Related Costs in Newly Diagnosed Initiation of Antipsychotics in Foster Care Risk Class [479] Individuals With Autism Spectrum Disorder Youth: Are All New Users Equal? [497] Djanilson Barbosa Santos, Bruna Cunha (ASD) in Quebec (Canada) [488] Wendy Camelo Castillo, Ming-Hui Tai, James F Girardi, Lais Alves de Lima Prisco, Wilanne Caroline Croteau, Laurent Mottron, Jean- Gardner, Susan dosReis. (United States) Pinheiro de Oliveira Alves, Michele de Jesus Eric Tarride, Marc Dorais, Sylvie Perreault. Cavalcante. (Brazil) (Canada) 71. The Use of Psychotropic Medications in Autism Sprectrum Disorder: The Parents’ 53. Optimizing the Value of Pregnancy Reports 62. Stratification, Hypothesis Testing, and Perspective [498] in a Drug Safety Database [480] Clinical Trial Simulation in Pediatric Drug Danielle Boucher, Hubert Gascon, Caroline Amanda Golembesky, Dirk De Cuyper, Laura Development [489] Sirois, Maude Garant. (Canada) Shaughnessy, Maureen Cooney, Kristel Ann W McMahon, M Dianne Murphy. Luijtens, Marie Teil. (United States) (United States) 72. Modeling the Complexity and Continuity of Psychotropic Use Among Youth as an 54. Obstetric Complications Following Fertility Pediatrics Indicator of Illness Severity [499] Treatment – Disentangling the Role of Susan dosReis, Wendy Camelo Castillo, Multiple Gestation [481] 63. Cardiovascular Medication Use and James Gardner, Ming-Hui Tai. (United States) Anna S Oberg, Tyler J VanderWeele, Catarina Cardiovascular Disease in Children and Almqvist, Sonia Hernandez-Diaz. Adolescents With Type 1 Diabetes [490] 73. The Association Between Atopic (United States) Fariba Ahmadizar, Soulmaz Fazeli Farsani, Diseases and Childhood Attention-Deficit/ Patrick Souverein, Anthonius de Boer, Anke Hyperactivity Disorder: A Retrospective Spotlight Session-Pediatrics Hilse Maitland-van der Zee. (Netherlands) Matched Case-Control Study [500] Jurjen van der Schans, Janine C Pleiter, 55. Asthma Medication Use Before and After 64. Increased Use of Oral Anti-Diabetic Tjalling W de Vries, Catherina CM Schuiling- the Onset of Type 1 Diabetes in Children Medications in Dutch Children Mainly Veninga, Jens HJ Bos, Pieter J Hoekstra, and Adolescents: A Population-Based Driven By (Off-Label) Metformin Use [491] Eelko Hak. (Netherlands) Cohort Study [482] Soulmaz Fazeli Farsani, Patrick C Souverein, Fariba Ahmadizar, Anke-Hilse Maitland-van Jetty A Overbeek, Marja M van der Vorst, 74. High Incidence of Oral Corticosteroids der Zee, Anthonius de Boer, Patrick Souverein, Catherijne A Knibbe, Ron M Herings, Prescriptions in Young Children With Hubertus Arets. (The Netherlands) Anthonius de Boer, Aukje K Mantel-Teeuwisse. Asthma [501] (Netherlands) Ali Arabkhazaeli, Susanne JH Vijverberg, 56. Antibiotic Exposure and the Development Cornelis K van der Ent, Jan Raaijmakers, of Pediatric Psoriasis: A Population-Based 65. Metformin Prescriptions as a Proxy for Anke-Hilse Maitland-van der Zee. Case-Control Study [483] Pediatric Type 2 Diabetes Burden [492] (Netherlands) Daniel B Horton, Frank I Scott, Kevin Haynes, Ann M McNeill, Tongtong Wang, Yong Chen, Mary E Putt, Carlos D Rose, James D Lewis, Ravi R Shankar, Michael Sanderak. 75. Comparative Safety of Antimuscarinics Brian L Strom. (United States) (United States) in the United States Pediatric Population, 2000-2012 [502] 57. The Impact of Antibiotic Exposures Early in 66. Antibiotic Prescribing for Children in Alan C Kinlaw, Jennifer M Wu, Mitchell M Life on Childhood Obesity [484] General Practice and Adherence To Conover, Michele Jonsson Funk. Frank I Scott, Daniel B Horton, Ronac Treatment Guidelines [493] (United States) Mamtani, Dale Y Lee, Kevin Haynes, James D Verica Ivanovska, Karin Hek, Aukje Mantel Lewis. (United States) Teeuwisse, Bert Leufkens, Liset van Dijk. 76. Parental Exposure To Folic Acid (Macedonia, The Former Yugoslav Republic of) Antagonists Are Associated With 58. The Extent of Off-Label Use of Childhood Cancer [503] Psychotropic Drugs for Danish Children 67. Adherence To Index Therapy as a Predictor Yu-Hsuan Joni Shao, Ming-Tsang Chuang, and Adolescents: A Nationwide Study [485] of Treatment Augmentation in Children and Kitaw Demissie. (Taiwan) Eva Skovslund Nielsen, Maja Hellfritzsch, Adolescents Newly Initialized on Metformin Mette Nørgaard, Torben Laursen. (Denmark) Monotherapy [494] 77. Access To Oral Paediatric Medicines in Mona Cai, Til Stuermer, Cynthia J Girman, Ghana: An Unmet Need [504] 59. State-Level Variation of Psychotropic Drug Michael Kappelman, Nina Jain, Alan Brookhart. Daniel Ankrah, Joseph Turkson, Edith Utilization in Children With ADHD in the (United States) Boateng, Frank Amegavie, Elizabeth Bruce. United States Using Multiple Disparity (Ghana) Measures [486] 68. Association Between Antipsychotics and Xinyue Liu, Paul Kubilis, Regina Bussing, Risk of Epilepsy in Patients With Autism 78. Use of Epidemiology Data To Inform Almut G Winterstein. (United States) Spectrum Disorder in Taiwan [495] Pediatric Clinical Trials [505] Chien-Chou Su, Ching-Lan Cheng, Yen-Kuang Laura E Wallace, Stacy Baldridge. 60. Medication Errors Among Paediatric Yang, Yea-Huei Kao Yang. (Taiwan) (United States) In-Patients at a Rural Referral Hospital in Kenya [487] 69. Initial Prescription Medication for Children 79. The Risk of Malignancy Among Biologic- Christabel N Khaemba, Christabel N With Anxiety: Concordance With Evidence Naïve Pediatric Psoriasis Patients: A Khaemba, Eric M Guantai, Margaret O Oluka, [496] Retrospective Cohort Study in a US Claims Kipruto A Sinei. (Kenya) Greta A Bushnell, Stacie B Dusetzina, Bradley Database [506] N Gaynes, Scott N Compton, Alice D White, Til Yun Gu, Beth L Nordstrom. (United States) Stürmer. (United States)

74 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

80. Factors Associated With Hospital 88. Comparison of Open, Laparoscopic, and 97. The Effect of Age on Re-Intervention Admissions Through the Emergency Robotic Colectomy in a National Database: for Sling Implants in Stress Urinary Department for Pediatric Patients With Outcomes and Trends Related To Hospital Incontinence [524] Acute Asthma [507] Volume [515] Bilal Chughtai, Jessica Buck, Jialin Mao, Wei Wang, Haesuk Park. (United States) Heather Yeo, Abby Isaacs, Jeffrey Milsom, Art Richard Lee, Alexis Te, Steven Kaplan, Art Sedrakyan. (United States) Sedrakyan. (United States) 81. Drug Utilization Study in Neonates of a Public Hospital in Brazil: Off-Label, 89. Relationships Between Total Hip 98. Spontaneous Reports for Toothbrushes: Unlicensed, Potentially Harmful Drugs and Replacement Characteristics and Its An Exemplar of Postmarket Vigilance for Harmful Excipients [508] Survivorship at Three Years in 100 191 Low-Risk Devices [525] Djanilson Barbosa Ssntos, Alcidésio Sales de Patients: A Population-Based Study [516] Mary E Ritchey, Lisa Dunlap, Kelly Solinsky, Souza Júnior, Helena Lutéscia Luna Coelho. Sandrine Colas, Cédric Collin, Philippe Piriou, Michael Steinbuch. (United States) (Brazil) Mahmoud Zureik. (France) 99. A Quality Weighted Pooled Analysis of 82. Performance of Signal Detection 90. How Risky Is Morcellation? Population- Single Proportions: A Case Study of Algorithms in the Paediatric Dataset of the Based Estimates of Prevalence of Uterine Infections in Modular Endoprosthesis Publicly-Available US FDA Adverse Event Sarcoma Among Leiomyomata Patients Implant [526] Reporting System (FAERS) [509] Undergoing Surgical Treatment [517] Grace Wangge, Siti RF Saldi, Meutia Osemeke Osokogu, Caitlin Dodd, Daniel Jialin Mao, Samantha Pfeifer, Xi E Zheng, A Kumaheri, Yogi Prabowo, Sudigdo Weibel, Erik van Mulligen, Florentia Peter Schlegel, Art Sedrakyan. (United States) Sastroasmoro, Achmad F Kamal. (Indonesia) Kaguelidou, Miriam Sturkenboom. (Netherlands) Medical Devices 100. Increased Sensitivity and Negative Predictive Value With the Sysmex UF- Spotlight Session- 91. Effect of Femoral Head Size on the Rate of 1000i™ Urine Particle Analyzer Reduces Revision Surgeries Among Metal-On-Metal the Need for Empirical Antibiotic Therapy Medical Devices Total Hip Replacements: A Propensity [527] 83. Characterization of Patients With End-Stage Score Matched Cohort Study from the Meghan Riley, Patrick Erdman, Keri Heart Failure Secondary To Anthracycline Veterans Health Administration [518] Donaldson. (United States) Cardiac Toxicity [510] Katherine Etter, Art Sedrakyan, Lee E Rubin, Garry R Thomas, Michael A McDonald, Linda Resnik, Ira Wilson, David D Dore. 101. Accuracy of Optional ICD-9-CM Bearing Heather J Ross, Diego H Delgado, Billia Filio, (United States) Surface Codes for Total Hip Replacement in Thavendiranathan Paaladinesh. (Canada) the Veterans Health Administration [528] 92. Opioid Use as an Early Indication of Total Katherine Etter, David D Dore. (United States) 84. NIS/AHRQ-Derived Epidemiologic Evidence Knee Arthroplasty Failure [519] on Modifying Effects of Sex and Race on Maria CS Inacio, Robert S Namba, Nicole Safety End Point Studies Arthroplasty-Related Outcomes [511] L Pratt, Stephen E Graves, Elizabeth E 102. Cardiovascular Risks Associated With Yelizaveta Torosyan, Tigran Karapetyan, Nilsa Roughead, Craig T Cheetham, Elizabeth W Dipeptidyl–Peptidase 4 Inhibitors: A Cohort Loyo-Berrios, Danica Marinac-Dabic. Paxton. (Australia) Study [529] (United States) 93. Effect of Femoral Head Size in Non-Metal- Maki Komamine, Chieko Ishiguro, Yoshiaki 85. Predictors of Early (6-Month) Revision On-Metal Devices on Surgical Revision Uyama, Emiko Kondo. (Japan) and All-Cause Mortality Following Hip Rates in Total Hip Replacements: A 103. Domperidone, Cytochrome P450 3A4 Arthroplasty: A Population-Based Cohort Propensity Score Matched Cohort from the Isoenzyme Inhibitors and Ventricular Study [512] Veterans Health Administration [520] Arrhythmia: A Nationwide Case-Crossover Albert Roso, Cristian Tebé, Mireia Katherine Etter, Art Sedrakyan, Lee E Rubin, Study [530] Espallargues, Daniel Prieto-Alhambra, Linda Resnik, Ira Wilson, David D Dore. Hung-Lin Chen, Pi-Hui Chao, Jia-Jhen Chen, PRESS-UP Study Investigators. (United States) Fei-Yuan Hsiao. (Taiwan) (United Kingdom) 94. Effect of Bearing Surface Material on 104. Systematic Review With Meta-Analysis: The 86. National Trends and Cost Related To Surgical Revision Rates in Total Hip Association Between the Use of Calcium the Use of Minimally Invasive Device Replacements: A Propensity Score Channel Blockers and Gastrointestinal Technology in Urology [513] Matched Cohort from the Veterans Health Bleeding [531] Bilal Chughtai, Jialin Mao, Abby Isaacs, Administration [521] Ying He, Esther W Chan, Wai K Leung, Richard Lee, Alexis Te, Steven Kaplan, Peter Katherine Etter, Art Sedrakyan, Lee E Rubin, Shweta Anand, Ian CK Wong. (China) Schlegel, Art Sedrakyan. (United States) Linda Resnik, Ira Wilson, David D Dore. (United States) 105. Metformin Exposure in Head and Neck 87. National Trends in Utilization and In- Cancer Patients: Is There an Association Hospital Outcomes of Mechanical vs. 95. Clipping and Coiling of Unruptured With Improved Surival? [532] Bioprosthetic Aortic Valve Replacements Intracranial Aneurysms (UIA) Among Matthew Alcusky, Scott Keith, Tom [514] Medicare Beneficiaries, 2000-2010 [522] Karagiannis, Carol Rabinowitz, Daniel Louis, Abby Isaacs, Jeffrey Shuhaiber, Arash Salemi, Jessica J Jalbert, Abby J Isaacs, Hooman Vittorio Maio. (United States) O Wayne Isom, Art Sedrakyan. (United States) Kamel, Art Sedrakyan. (United States) 96. Extracorporeal Membrane Oxygenation (ECMO) Use Among Children and Adults in the United States, 2009-2012 [523] Sarah R Hoffman, Erika Avila Tang, John C 75 Laschinger. (United States) 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

106. The Role of Differential Work-Up in the 115. Androgen Deprivation Therapy and the 124. Lipophilic Statins and the Risk of Suicide: Association Between Pioglitazone and Incidence of Autoimmune Diseases in A Population Based Study [551] Bladder Cancer [533] Patients With Prostate Cancer [542] Jessica LS Leen, Erin M MacDonald, Simon Elizabeth M Garry, John B Buse, Virginia Pate, Adi J Klil-Drori, Koray Tascilar, Hui Yin, Armen Hollands, Muhammad M Mamdani, J Michael Til Stürmer. (United States) Aprikian, Laurent Azoulay. (Canada) Paterson, David N Juurlink. (Canada)

107. Thiazolidinediones and Parkinson’s 116. Effectiveness and Safety of Cetuximab 125. Use of Nicorandil Is Associated With Disease: A Cohort Study [534] as 1st-Line Treatment in the Elderly With Increased Risk for Gastrointestinal John G Connolly, Katsiaryna Bykov, Joshua J Metastatic Colorectal Cancer from the Ulceration and Perforation- A Nationally Gagne. (United States) EREBUS Cohort [543] Representative Population-Based Study Annie Fourrier-Réglat, Pernelle Noize, Magali [552] 108. Comparative Risk of Acute Liver Injury Rouyer, Denis Smith, Eric François, Alain Meng-tse Gabriel Lee, Shih-Hao Lee, Yueh- Associated With Oral Azole Antifungal Monnereau, Aurélie Balestra, Jérémy Jové, Sheng Chen, Xia-Dong Xia, Shy-Shin Chang, Drugs [535] Régis Lassalle, Nicholas Moore. (France) Chien-Chang Lee. (Taiwan) Vincent Lo Re III, Dena M Carbonari, James D Lewis, Kimberly A Forde, David S Goldberg, 117. Risk of Venous Thromboembolism in 126. Use of Dipeptidyl Peptidase-4 (DPP-4) Rajender Reddy, Kevin Haynes, Jason Roy, Cancer Patients Treated With Epoetins or Inhibitors and Risk of Ileus Among a Type Daohang Sha, Amy R Marks, Jennifer L Blood Transfusions [544] 2 Diabetes Mellitus (T2DM) Population: A Schneider, Brian L Strom, Douglas A Corley. Antonios Douros, Kathrin Jobski, Bianca Retrospective Cohort Study in Japan [553] (United States) Kollhorst, Tania Schink, Edeltraut Garbe. Dimitri Bennett, Shreya Davé, Motonobu (Germany) Sakaguchi, Chia-Hsien Chang, Paul Dolin. 109. Fluoroquinolones Use and Development of (United States) Retinal Detachment: A Systematic Review 118. Safety of Low Molecular Weight Heparin and Meta-Analysis [536] Compared To Unfractionated Heparin in 127. Safety Experience in New Oral Carlos Alves, Ana Penedones, Diogo Mendes, Hemodialysis: A Systematic Review and Anticoagulant Use in Patients With Non- Francisco Batel Marques. (Portugal) Meta-Analysis [545] Valvular Atrial Fibrillation - Data from One- Hind Harrak, Émilie René, Naoual Elftouh, Year Post Launch [554] 110. Use of Fluoroquinolones Is Associated Jean-Philippe Lafrance. (Canada) Han-Yao Huang, Hugh Kawabata. With Increased Risk for Nontraumatic (United States) Spontaneous Pneumothorax- A Population- 119. Drug Associated Angioedema: Effect Based Study in a National Representative Modification By Race [546] 128. Statin-Related Muscle Problems: Cohort [537] Marsha E Reichman, Michael Wernecke, Prevalence and Therapeutic Response Chien-Chang Lee, Meng-tse Gabriel Lee, John Yap, Yoganand Chillarige, Jiemin Liao, [555] Tse-Chih Chou, Yi-Hsien Lin, Shyr-Chyr Chen. Stephine Keeton, Margie Goulding, Katrina Donald R Miller, Kyung Lee, Adam Rose, (Taiwan) Mott, Jeffrey A Kelman, David J Graham. Varsha Vimalananda, Cindy L Christiansen. (United States) (United States) 111. Rates of Anaphylaxis With Moxifloxacin: Verification of Case Status [538] 120. Long-Term Use of Calcium Channel 129. Preadmission Diuretic Use Is Associated Najat J Ziyadeh, Kiliana Suzart-Woischnik, Blockers, Beta-Blockers, Angiotensin- With 30-Day and 1-Year Mortality in Patients Frank Kruesmann, Pierre Arvis, N Franklin Receptor Blockade and Risk of Breast With Hyponatremia [556] Adkinson, Jr, Werner J Pichler, Gillian M Cancer in Women Aged 55 Years or Older: Louise Holland-Bill, Christian F Christiansen, Shepherd, John D Seeger. (United States) A Nation-Wide Study [547] Sinna P Ulrichsen, Troels Ring, Jens Otto L Chia-Hsuin Chang, Li-Chiu Wu, Chien-Hsieh Jørgensen, Henrik T Sørensen. (Denmark) 112. Clinical Outcomes Among Patients Who Chiang, Jou-Wei Lin, Mei-Shu Lai. (Taiwan) Are Prescribed Antibiotics With Vs. Without 130. Cataract Risk After Exposure To Point-Of-Care Testing for Infection: A 121. Bleeding Risks Are High in Elderly Persons Angiotensin-Converting-Enzyme Inhibitors: Danish Nationwide Population-Based Who Use Vitamin K Antagonists Combined A Case-Control Analysis [557] Cohort Study [539] With Platelet Aggregation Inhibitors [548] Claudia Becker, Susan S Jick, Christoph R Mette Søgaard, Johnny Kahlert, Reimar W Nienke van Rein, Uffe Heide-Jørgensen, Meier. (Switzerland) Thomsen, Flemming Bro, Henrik T Sørensen. Willem M Lijfering, Lars Pedersen, Olaf M (Denmark) Dekkers, Henrik T Sørensen, Suzanne C 131. Cardiovascular Drugs and Erectile Cannegieter. (Netherlands) Dysfunction – A Symmetry Analysis [558] 113. The Safety of Pegylated Interferon α-2a and Lotte Rasmussen, Jesper Hallas, Kenneth α-2b Combined With Ribavirin in Patients 122. Assessing Clinical Outcome of Aspirin Grønkjær Madsen, Anton Pottegård. (Denmark) With Chronic Hepatitis C Based on the Containing Magnesium Stearate for Acute Japanese Interferon Database [540] Coronary Syndrome [549] 132. Pattern of Risks of Systemic Lupus Izumi Sato, Yohei Kawasaki, Takumi Imai, Kelly Huang, Chin-lan Cheng, Jinding Huang, Erythematosus Among Statin Users: A Sachiko Tanaka, Hiroshi Yamada, Koji Yea-Huei Kao Yang. (Taiwan) Population-Based Retrospective Cohort Kawakami, Naohiko Masaki. (Japan) Study [559] 123. Epidemiologic Study on the Risk of Hilda J De Jong, Tjeerd P Van Staa, Arief 114. Androgen Deprivation Therapy Use and the Developing Depression in Association Lalmohamed, Rob J Vandebriel, Henk Van Risk of Venous Thromboembolism [541] With use of Beta-Blockers or Other Loveren, Frank De Vries, Olaf H Klungel, Jan Adi J Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Cardiovascular Drugs [550] Willem Cohen Tervaert. (Canada) Aprikian, Laurent Azoulay. (Canada) Delia C Bornand, Susan S Jick, Christoph R Meier. (Switzerland)

76 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

133. Risk of Skin Ulcerations Associated With 143. Antidepressant Medication Use and Its 153. Use of Antipsychotics and the Risk of Oral Nicorandil Therapy- A Population- Association With Cardiovascular Disease Pneumonia: A Systematic Review and Based Study [560] [570] Meta-Analysis of Observational Studies Chien-Chang Lee, Hsin-Yi Lin, Meng-tse Richard A Hansen, Yulia Khodneva, Stephen [580] Gabriel Lee, Shih-Hao Lee, Sie-Huei Lee, Glasser, Jingjing Qian, Nicole Redmond, Chien-Chang Lee, Wan-Ting Hsu, John W Shy-Shin Chang, Hsiung-Wen Vennia Chang, Monika M Safford. (United States) Jackson, Jason Wang, Albert Yuh-Chyuan Shyr-Chyr Chen. (Taiwan) Shan, Wei Kian Chua. (Taiwan) 144. Transient Risk of Breakthrough Seizures 134. Effect of Non-Technological Interventions Associated With Phenytoin Refilling [571 154. Comparative Safety of Typical and Atypical on Medication Errors in Cardiology [561] Mengdong He, Jodi Segal. (United States) Antipsychotics After Cardiac Surgery [581] Mariana Molina, Carolina Lobos, Pia Cárcamo, Dae Kim, Elisabetta Patorno, Yoonyoung Marcela Jirón. (Chile) 145. Benzodiazepine Use Is Not Associated With Park, Krista Huybrechts, Raisa Levin, Brian an Increased Risk of Alzheimer’s Disease Bateman. (United States) 135. Safety of Aspirin for Cardiovascular or Vascular Dementia [572] Disease in China: A Systematic Review and Patrick Imfeld, Michael Bodmer, Susan S Jick, 155. Observational Assessment of Safety in Meta-Analysis [562] Christoph R Meier. (Switzerland) Seroquel (OASIS) – Rates & Patterns of Lin Zhuo, Yinchu Cheng, Yang Zhang. (China) Common Events Observed in Users of 146. Association of Antipsychotic Use With Quetiapine Extended-Release (Seroquel 136. The Effect of Antiarrhythmics on QT Extrapyramidal Symptoms: Data Mining of XL©) and Immediate Release (IR) [582] Variability in a Population-Based Cohort of the Japanese National Receipt Database Deborah Layton, Sarah Clarke, Ian Ratcliffe, Middle-Aged and Elderly Persons [563] [573] Saad AW Shakir, Tony Hale. (United Kingdom) Marten E van den Berg, Maartje N Niemeijer, Kouichi Hosomi. (Japan) Bruno H Stricker, Mark Eijgelsheim, Jan A 156. Suicide Risk and Side Effects from Kors, Peter R Rijnbeek. (Netherlands) 147. Risk Evaluation of Drug-Induced Antipsychotics in Schizophrenia: A Nested Parkinsonism Associated With Case–Control Study [583] 137. Epidemiological Evidence on Associations Antipsychotics Based on Two Different Johan Reutfors, Shahram Bahmanyar, Lena Between Statin Use and Lymphoid Study Designs [574] Brandt, Eric Clapham, Erik G Jönsson, Robert Malignancy Incidence Risk and Survival Chieko Ishiguro, Kazuhiro Kajiyama, Yoshiaki Bodén, Anders Ekbom, Urban Ösby. (Sweden) [564] Uyama, Emiko Kondo. (Japan) Xibiao Ye, Ayat Mneina, James Johnston, 157. The Potential Risk of Upper Salaheddin Mahmud. (Canada) 148. Risk of Seizures Associated With Gastrointestinal Bleeding Associated Antipsychotic Drug Use - A Nested Case- With Use of Selective Serotonin Reuptake 138. The Association of Hormone Therapy and Control Analysis [575] Inhibitors in Older Adults [584] Incident Gout: Population-Based Case- Marlene Bloechliger, Stephan Rueegg, Susan Eunsun Noh, Brian J Quilliam. (United States) Control Study [565] S Jick, Christoph R Meier, Michael Bodmer. Saskia G Bruderer, Michael Bodmer, Susan S (Switzerland) 158. Anticholinergic Medication Use and Risk of Jick, Christoph R Meier. (Switzerland) Community-Acquired Pneumonia in Older 149. Comparative Risk of Death Among Elderly Adults [585] 139. Cardiovascular Disease Risk and Androgen Users of Antipsychotic Drugs [576] Kathleen J Paul, Rod L Walker, Sascha Dublin. Deprivation Therapy in Patients With Niklas Schmedt, Bianca Kollhorst, Kathrin (United States) Localized Prostate Cancer [566] Jobski, Tania Schink, Edeltraut Garbe. Reina Haque, Xiaoqing Xu, Marianne Ulcickas (Germany) 159. Effects of Second-Generation Yood, Andrea E Cassidy-Bushrow, Stephen Antidepressants on Cognitive Function: A K Van Den Eeden, Arnold L Potosky. (United 150. All-Cause Mortality Among Elderly Users of Systematic Review and Meta-Analysis [586] States) Antidepressant Drugs in Germany [577] Shalak Gunjal, Satabdi Chatterjee, Helena Bianca Kollhorst, Kathrin Jobski, Niklas VonVille, Patricia Dolan Mullen, Hua Chen, 140. Risk of Fracture Following Bisphosphonate Schmedt, Tania Schink, Edeltraut Garbe. Rajender Aparasu. (United States) Drug Holiday [567] (Germany) Jennifer L Kuntz, John L Adams, Marsha A 160. The Impact of Intravitreal Drugs on Rates Raebel, Beth T Tang, Vinutha Vijayadeva, 151. Use of Antipsychotics and the Risk of of Post-Injection Endophthalmitis [587] Elizabeth A McGlynn, Wendolyn S Gozansky, Fracture: A Systematic Review and Meta- Brian L VanderBeek, Sarah Bonaffini, Liyuan Ma. Annette L Adams. (United States) Analysis of Observational Studies [578] (United States) Wan-Ting Hsu, Jason Wang, Yi-Han Sheu, 141. Type II Diabetes Mellitus, Antidiabetic Che-Wei Su, Sheng-Chi Tung, Chien-Chang 161. Low Dose Aspirin, Non-Steroidal Anti- Drugs, and Statins and the Risk of Lee. (Taiwan) Inflammatory Drugs, Selective COX-2 Developing Osteoarthritis in Non-Weight Inhibitor Prescriptions & Breast Cancer Bearing Joints [568] 152. Risk of Medication Use for Heat-Related Recurrence: A Danish Population-Based Noel Frey, Julia Spoendlin, Thomas Huegle, Hospital Admissions - A Matched Case Cohort Study [588] Susan S Jick, Christoph R Meier. (Switzerland) Control Study [579] Deirdre Cronin-Fenton, Uffe Heide-Jørgensen, Ying Zhang, Monika Nitschke, Antoinette Thomas P Ahern, Timothy L Lash, Peer 142. Comparative Risk of Venous Krackowizer, Peng Bi. (Australia) Christiansen, Bent Ejlertsen, Henrik T Thromboembolism Among Elderly Users of Sørensen. (Denmark) Antipsychotic Drugs [569] Niklas Schmedt, Bianca Kollhorst, Kathrin Jobski, Tania Schink, Edeltraut Garbe. (Germany) 77 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

162. Ethnic and Regional Differences in 170. Effect of Antimalaria Prophylaxis With 179. Short Term Effect on Hemoglobinemia in Neutrophil Counts and Neutropenia Sulfadpxine-Pyrimethamine on Pregnancy Epoetin Users: No Difference Between Reporting in Two International Clinical Outcomes [597] Biosimilar and Originator [606] Trials of Rifapentine and Rifampicin for Nneka U Igboeli, Chibunna J Mbaeri, Cletus N Ylenia Ingrasciotta, Francesco Giorgianni, Tuberculosis Treatment [589] Aguwa. (Nigeria) Andrea Fontana, Jenny Bolcato, Roberta Ruth N Moro, John L Johnson, Chi-Chiu Pirolo, Alessandro Chinellato, Achille Patrizio Leung, Kwok-Chiu Chang, Neil Martinson, 171. Outcomes of Facility-Level Use of Caputi, Gianluca Trifirò. (Italy) Andrey Borisov, Stefan V Goldberg. Ferumoxytol Versus Other Intravenous (United States) Iron Formulations in Incident Hemodialysis 180. Comparative Effects of Antihypertensive Patients [598] Medications on Colorectal Cancer Risk 163. The Role of Allopurinol and Febuxostat Medha Airy, Sreedhar Mandayam, Aya A [607] in Stevens-Johnson Syndrome and Toxic Mitani, Tara I Chang, M Alan Brookhart, Phyo T Htoo, Til Stürmer, Michele J Funk, Epidermal Necrolysis [590] Benjamin A Goldstein, Wolfgang C Virginia Pate, Jennifer L Lund. (United States) Maja Mockenhaupt, Peggy Sekula, Jean- Winkelmayer. (United States) Claude Roujeau. (Germany) 181. Effectiveness of Aldosterone Antagonist 172. Comparative Effectiveness and Safety Therapy Among Survivors of Acute 164. Drugs and Ventricular Repolarization in a of SSRI Treatment With or Without ST-Elevation Myocardial Infarction - A General Population: The Rotterdam Study Concomitant Use of Statins: A Population- Nationwide Nested Case-Control Study [591] Based Study [599] [608] Maartje N Niemeijer, Marten E van den Berg, Ole Köhler, Christiane Gasse, Ole Mors, Hsu-Wen Chou, Chao-Lun Lai, Kin-Wei Arnold Oscar H Franco, Albert Hofman, Jan A Kors, Andrew Nierenberg, Liselotte Petersen, Søren Chan, Mei-Shu Lai. (Taiwan) Bruno H Stricker, Mark Eijgelsheim, Peter R Dinesen Østergaard. (Denmark) Rijnbeek. (Netherlands) 182. Association of Treatment With Carvedilol, 173. Effectiveness of Medication in Preventing Bisoprolol and Metoprolol on the Risk of 165. Risk of Hospital Admission for Liver Injury Psychiatric Hospitalization in Bipolar Mortality and Hospital Admission Among in Users of NSAIDs and Non-Overdose Disorder - A Swedish Register Based Study Older Adults With Heart Failure [609] Paracetamol (EPIHAM) [592] [600] Perreault Sylvie, De Denus Simon, White Ezgi Gulmez, Régis Lassalle, Jérémy Jové, Erik Joas, Alina Karanti, Paul Lichtenstein, Michel, Guay-White Brian, Bouvier Michel, Guillaume Caridade, Adeline Grolleau, Mikael Landén. (Sweden) Dorais Marc, Dubé Marie-Pierre. (Canada) Nicholas Moore. (France) 174. Effects of Reformulating OxyContin on 183. Comparison of Methods To Estimate 166. Heterogeneity on Case Definition and Opioid Abuse in 6 National US Abuse Cardiovascular Event Rates Over Time in a Diagnostic Method of Lipodystrophy Surveillance Systems [601] Diabetic Population on High Intensity Statin Among HIV-Infected Patients on Paul M Coplan, Howard D Chilcoat. Therapy [610] Antiretroviral Therapy [593] (United States) Mark Danese, Benjamin Taylor, Villa Guillermo, Lorena GC Lana, Daniela RG Junqueira, Lothgren Mickael. (United States) Edson Perini, Cristiane A Menezes de Padua, 175. Metformin Plus Insulin Versus Metformin Letícia Penna Braga. (Brazil) Plus Sulfonylurea and the Associated Risk 184. Impact of Fibrates on the Cardiovascular of Hypoglycemia [602] Events in Patients With Acute Coronary 167. Initiative To Improve Recruitment To a Christianne L Roumie, JeaYoung Min, Robert A Syndrome Underwent Percutaneous Streamlined Safety Study By Providing Greevy, Carlos Grijalva, Adriana M Hung, Xulei Transluminal Coronary Angioplasty: A Study Information in a More Accessible Liu, Marie R Griffin. (United States) Population-Based Cohort Study in Taiwan Format [594] [611] Robert Flynn, Claudine Jennings, Wendy 176. Associations Between Lithium and Suicide Jui Wang, Zhen-Fang Lin. (Taiwan) Saywood, Isla Mackenzie, Evelyn Findlay, and Nonsuicide Death Among Veterans Kay Walker, George Nuki, Ian Ford, Thomas Health Administration Patients [603] 185. Comparative Effectiveness of Carotid MacDonald. (United Kingdom) Eric G Smith, Karen L Austin, Hyungjin M Kim, Artery Stenting (CAS) and Carotid Susan V Eisen, Amy M Kilbourne, Donald R Endarterectomy (CEA) Among Medicare 168. Observations of Progressive Multifocal Miller, Kara Zivin, Claire Hannemann, Brian Beneficiaries Treated in Routine Clinical Leukoencephalopathy (PML) in Patients Sauer, Marcia Valenstein. (United States) Practice [612] With Systemic Lupus Erythematosus (SLE): Jessica J Jalbert, Louis L Nguyen, Marie D Systematic Literature Review [595] Comparative Effectiveness Gerhard-Herman, Hiraku Kumamaru, Lauren Amanda Eudy, Cassidy Henegar, Vineetkumar A Williams, Chih-Ying Chen, Jun Liu, Andrew Kumar, Dimitri Bennett, Barbara Haight, Eric Research (CER) T Rothman, Michael R Jaff, John D Seeger, Lewis, Deanna Hill. (United States) 177. Differential Postpartum Surveillance for Herbert D Aronow, Joseph A Johnston, Type 2 Diabetes in Women Treated With Thomas G Brott, Christopher J White, Soko Spotlight Session Glyburide Versus Insulin for Gestational Setoguchi. (United States) Comparative Effectiveness Diabetes [604] Suzanne N Landi, Wendy Camelo Castillo, 186. Unintended Pregnancies in Users of Different Research (CER) Kim Boggess, Mitchell M Conover, Michele Combined Oral Contraceptives – Final Jonsson Funk. (United States) Results from the INAS-SCORE Study [613] 169. Risk of Hypoglycemia Associated With Kristina Bardenheuer, Juergen Dinger, Sulfonylurea and Insulin or Insulin 178. Long-Term Effectiveness of Entecavir Christian Franke, Christine Hagemann, Sabine Monotherapy [596] Among Hepatitis B Patients in Taiwan [605] Möhner. (Germany) Jea Young Min, Marie R Griffin, Carlos G Yi-Chun Yeh, Chun-Jen Liu, Pei-Jer Chen, Grijalva, Robert A Greevy, Adriana M Hung, Mei-Shu Lai. (Taiwan) 78 Xulei Liu, Christianne L Roumie. (United States) 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

187. Withdrawn By Author 198. Protective Effects of Statins in Burden of Disease Staphylococcus aureus Bacteremia [624 Epidemiology of Illness 188. Similarities Regarding Diagnostic Workup Eunsun Noh, Aisling R Caffrey, Kerry L Utilization in Two Data Systems [614] LaPlante. (United States) 207. Epidemiology of Lactic Acidosis in Type 2 Xiaojuan Li, Yong Chen, Julie Chandler, Diabetes Patients Treated With Metformin Cynthia J Girman, Til Stürmer. (United States) 199. Comparing Patient-Centered Outcomes in Japan [633] After Uterus-Conserving Procedures for Chia-Hsien Chang, Motonobu Sakaguchi. 189. Impact of Urate Level on Cardiovascular Uterine Fibroids Using a Linked Electronic (Japan) Risk in Allopurinol Treated Patients. A Medical Record (EMR)-Claims Database Nested Case Control Study [615] [625] 208. Change in Prevalence and Distribution of Kasper Søltoft Larsen, Anton Pottegård, Hanne Kristina M Franke, Aaron B Mendelsohn, Emma Diabetes Mellitus Type I and Type II Over M Lindegaard, Jesper Hallas. (Denmark) Brinkley, Priscilla Velentgas, Tongsheng Wang, Time in the Netherlands [634] Evan R Myers, Kathy Lang. (United States) Jetty A Overbeek, Fernie JA Penning-van 190. Efficacy of Osteoporosis Beest, Eric CJ van Dongen, Ron MC Herings. Pharmacotherapies in Preventing Fractures 200. Diabetes Treatment Intensification and (Netherlands) Among Chronic Oral Glucocorticoids Associated Changes in HbA1c and Body Users: A Network Meta-Analysis [616] Mass Index [626] 209. Time To Onset and Duration of Induction M Amine Amiche, Jordan M Albaum, Mina Christianne L Roumie, Robert A Greevy, Carlos Therapy and Associated Factors Among Tadrous, Petros Pechlivanoglou, Jonathan G Grijalva, Adriana M Hung, Xulei Liu, Marie R Newly Diagnosed Multiple Myeloma D Adachi, Linda E Lévesque, Suzanne M Griffin. (United States) Patients [635] Cadarette. (Canada) Akeem A Yusuf, Tanya Bovitz, Tom Matlon, 201. The Use of Low Molecular Weight Heparin Winifred Werther, Diana Felici, Maya Mahue, 191. Selective Serotonin Reuptake Inhibitors and Pneumatic Compression Devises for Kenneth Bridges, Yi Peng. (United States) (SSRIs) and Colorectal Cancer (CRC) [617] Deep Vein Thrombosis Prophylaxis in Monica E D’Arcy, Til Sturmer, Michele Major Trauma Patients: A Comparative 210. Prevalence and Characteristics of Patients Jonsson-Funk, John Baron, Robert S Sandler, Effectiveness Analysis [627] With Low Level of Low-Density Lipoprotein Virginia Pate, Anne Marie Meyer, Melissa A Abdullah Alahmari, Ziyad Almalki, Guo Jeff. Cholesterol in Denmark [636] Troester, Jennifer L Lund. (United States) (United States) Sigrún AJ Schmidt, Uffe Heide-Jørgensen, Angelika D Manthripragada, Vera Ehrenstein. 192. Antidepressants (AD) and Colorectal 202. Comparing Inverse Probability Weighting, (Denmark) Cancer (CRC) [618] Stabilized IPW and Entropy Balance Monica E D’Arcy, Til Sturmer, Michele Jonsson Methods To Generalize Observational 211. Comparison of Diagnostic Accuracy Funk, Robert S Sandler, John A Baron, Pate Cohorts To a Population [628] of IASP Grading System and ID Pain Virginia, Anne Marie Meyer, Melissa A Troester, Raymond A Harvey, Jennifer D Hayden, Pravin Questionnaire in Patients With Confirmed Jennifer L Lund. (United States) S Kamble, Joanna C Huang, Jonathan R Neuropathic Component and Chronic Low Bouchard. (United States) Back Pain [637] 193. Use of Different Formulations Rivastigmine Kapil Gudala, Dipika Bansal, Babita Ghai. and Risk of Cardiovascular Adverse Events 203. Improving Utility of Electronic Health (India) [619] Data for Clinical Research: The Need for Edward Chia-Cheng Lai, Monera B Wong, Isao Harmonization [629] 212. Cross-Cultural Adaptation and Validation Iwata, Yinghong Zhang, Cheng-Yang Hsieh, Michelle Leavy, Michael Barboza, Estefania of the Hindi Version of the Pain Yea-Huei Kao Yang, Soko Setoguchi. (Taiwan) Rodriguez, Sarah Rosenblum, Lisa Green. Catastrophizing Scale [638] (United States) Sreenu Lavudiya, Kapil Gudala, Dipika Bansal, 194. Comparison of Short-Term Versus Babita Ghai. (India) Long-Term Outcomes of West Syndrome 204. In Balance You Say? How We Assess Treatment [620] Baseline Comparability in Comparative 213. Trends and Outcome of Acute Poisoning in Marina E Farnosova, Tatiana F Zharikova, Effectiveness Research [630] a Tertiary Care Hospital of Eastern India: A Rimma G Gamirova. (Russian Federation) Jin-Liern Hong, Richard Wyss, Til Stürmer, Prospective Observational Study [639] Cynthia J Girman. (United States) Suparna Chatterjee, Vivek Verma, Avijit Hazra. 195. Stimulant Treatment and Risk of Traffic (India) Accidents Requiring Acute Care in Adults 205. Best Methods To Get Your Comparative With Attention Deficit Hyperactivity Effectiveness Paper Cited: How GRACE 214. A Multi-State Model for Investigating the Disorder [621] Helps [631] Effects of Multiple Medication Use and Drug Daina B Esposito, Gaurav Deshpande, Crystal Nancy A Dreyer, Allison Bryant, Priscilla Burden Index on Transitions in Cognitive N Holick, Stephan Lanes. (United States) Velentgas, Zhaohui Su. (United States) Function and Death in Community-Dwelling Older Men: The CHAMP Cohort [640] 196. Comparative Risk of Glaucoma in Patients 206. Registry of Patient Registries (RoPR): Kris M Jamsen, Danijela Gnjidic, Sarah N With Epilepsy Receiving Antiepileptic Pilot Results and Lessons Learned for Hilmer, Jenni Ilomaki, David Le Couteur, Drugs [622] Registering Observational Studies [632] Fiona M Blyth, Vasi Naganathan, Robert G Wan-Ju Annabelle Lee, Chia-Cheng Edward Michelle Leavy, Daniel Campion, Thomas Cumming, J Simon Bell. (Australia) Lai, Yea-Huei Kao Yang. (Taiwan) Taylor, Jannette Karl. (United States) 215. Age of Initiation of Opioid Abuse Overall 197. Prescription Opioid Use and Mortality Risk and By Route of Administration Among in Hemodialysis Patients [623] Opioid Abusers in Rural Kentucky [641] Maurice A Brookhart, Diane Reams, Anne Angela DeVeaugh-Geiss, Jennifer Havens, Butler, Magdalene Assimon, Jennifer Flythe, Carl Leukefeld, Paul Coplan, Howard Chilcoat. Abhijit Kshirsagar. (United States) (United States) 79 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

216. Clinical Outcomes and Predictors in 225. The Prevalence of Sjögren’s Syndrome in 235. Non-Medical Use of Benzodiazepines and Patients With Biofilm Producing Methicillin- United States Health Insurance Claims [651] Opioids: An Online National Survey in the Resistant Staphylococcus aureus (MRSA) Susan A Hall, Maneesh Juneja, Lisa Vinikoor, United Kingdom [661] [642] Cristina Musselli, Nathalie Franchimont. Jody L Green, Andrea C Besharat, Erin M Diane M Gomes, Aisling R Caffrey, Megan K (United States) Goodman, Becki Bucher-Bartelson, David M Luther, Kerry L LaPlante. (United States) Wood, Paul I Dargan. (United States) 226. Factors Associated With Primary and 217. The Association of Thyroid Disorders and Secondary Diagnosis of Clostridium 236. Primary Sclerosing Cholangitis in the UK Incident Gout: Population-Based Case- Difficile Infection [652] Clinical Practice Research Datalink (CPRD Control Study [643] Robert McConeghy, Cynthia Willey, Aisling GOLD) [662] Saskia G Bruderer, Susan S Jick, Christoph R Caffrey. (United States) Huifang Liang, Jennifer H Lin, Jesse Shick, Meier, Michael Bodmer. (Switzerland) Sudhakar Manne, Punam Bharania, Paul 227. Incidence of Pulmonary Embolism Among Dolin. (United States) 218. Incidence and Prevalence of COPD Postmenopausal (PM) Women With ER+/ By GOLD 2013 Classification in the HER2- Breast Cancer [653] 237. Mitigating the Paucity-of-Data Problem Netherlands [644] Xiaofeng Zhou, Cynthia de Luise, Rongjun for Target Population Sizing: Exploring Jetty A Overbeek, Elsa J van den Berg, Fernie Shen, Andrew Bate, Nicolle Gatto. a Model-Based Approach for Advanced JA Penning-van Beest, Mona Khalid, Richard (United States) Gastroenteropancreatic Neuroendocrine Dekhuijzen, Ron MC Herings. (Netherlands) Tumors [663] 228. Minimally Important Differences for Alia Yousif, Aurore Bergamasco, Caroline 219. Characteristics of Patients Enrolled in a Patient-Reported Outcomes Measurement Tremblay, Anne-Marie Castilloux, Jérôme Dinet, Cancer Care Quality Program: A Linked Information System (Promis) Fatigue and Gabrielle Nayroles, Sylvie Gabriel, Yola Moride. Pharmacoepidemiology Resource in the Pain Interference Scores [654] (Canada) HealthCore Research Environment [645] Jennifer Beaumont, James F Fries, Jeffrey R Kevin Haynes, Crystal Hollick, Nandini Curtis, David Cella, Huifeng Yun. 238. Prevalence of Attention Deficit Hyperactivity Selvam, Vincent J Willey, Ralph Quimbo, (United States) Disorder in Publically Insured Adults [664] Ozgur Tunceli, Michael R Mack, Jennifer Yanmin Zhu, Wei Liu, Yan Li, Almut G Malin. (United States) 229. Attention Deficit Hyperactivity Disorder Winterstein. (United States) (ADHD) and Socioeconomic Status in 220. Iron Deficiency, Anemia and Colorectal Children and Adolescents in the UK [655] 239. Association Between Lifestyle and Quality Cancer [646] Adrian J Hire, Darren M Ashcroft, David A of Life in Healthy Postgraduate Students of Cornelia Schneider, Michael Bodmer, Susan S Springate, Doug Steinke. (United Kingdom) India [665] Jick, Christoph R Meier. (Switzerland) Shallu Sharma, Deepika Bansal. (India) 230. Does FEV1 Change Predict Hospital 221. Outcomes in Patients With Stable Coronary Admission and All-Cause Mortality Spotlight Session-AsPEN Artery Disease Post Myocardial Infarction: in Patients With Chronic Obstructive the HORUS Cohort Study in the French Pulmonary Disease (COPD)? [656] 240. Suboptimal Management of Patients With Health Insurance and Hospital-Discharge Robert W Flynn, Thomas M MacDonald, Non-Valvular Atrial Fibrillation: Real-World Database [647] Adrian Hapca, Isla S Mackenzie, Li Wei, Steve Clinical Setting [666] Patrick Blin, Caroline Dureau-Pournin, Régis V Morant, Stuart Schembri. (United Kingdom) Wallis CY Lau, Esther W Chan, Ian CK Wong. Lassalle, Jérémy Jové, Florence Thomas- (China) Delecourt, Cécile Droz-Perroteau, Nicolas 231. Correlates of Patient Delay in the Initiation Danchin, Nicholas Moore. (France) of Treatment Among New-Smear Positive 241. Effect of Antiplatelet Agents Combined TB Patients in Rural Health Settings in the With Cilostazol on Cardio–Cerebrovascular 222. Risk of Myocardial Infarction in Patients Philippines [657] Events and Bleeding Risk in Acute Coronary With Increased Level of Lipoprotein (A) - Imelda G Pena. (Philippines) Syndrome Patients [667] Retrospective Analysis of an Us Insurance Xue-Mei Jin, Ye-Jee Kim, Bo Ram Yang, Claims Database and NHANES III [648] 232. Breast Cancer Subtype and Survival in a Nam-Kyong Choi, Joongyub Lee, Mi-Sook Kim, Tzuyung D Kou, Anura Deshmukh, Andres Population-Based Cohort of Patients from Ju-Young Shin, Jong-Mi Seong, Yoosoo Chang, Gomez. (United States) California [658] Byung-Joo Park. (Republic of Korea) Christina A Clarke, Scarlett Lin-Gomez, Li Tao, 223. Subgroups of Depression in the Sequenced Lisa Moy, Juan Yang, Lisa I Wang, Mary S 242. Persistence To Oral Anticoagulant Therapy Treatment Alternatives To Relieve Beattie, Jennifer Eng-Wong, Melissa Brammer, in Japanese Atrial Fibrillation Patients [668] Depression (STAR*D) Study: A Latent Class Laura Chu. (United States) Hiraku Kumamaru, Chisa Matsumoto, Soko Analysis [649] Setoguchi. (United States) Christine M Ulbricht, Anthony J Rothschild, 233. Cardiovascular and Renal Morbidity in Kate L Lapane. (United States) Gout Patients in Germany, United Kingdom, 243. Persistence of Dabigatran Versus Warfarin United States, and France [659] Therapy in Patients With Non-Valvular Atrial 224. Body Mass Index and Risk of Dementia in Fredrik Nyberg, Javier Nuevo, Laura Horne, Fibrillation in the Real-World Clinical Practice a Cohort Study of Two Million People in UK Robert Morlock, Chris Storgard, Lalitha Aiyer, [669] Primary Care Database [650] Dionne M Hines, Xavier Ansalobehere, Pierre Wallis CY Lau, Esther W Chan, Ian CK Wong. Nawab Qizilbash, John Gregson, Michelle Chevalier. (Sweden) (China) E Johnson, Neil Pearce, Ian Douglas, Kevin Wing, Stephen JW Evans, Stuart J Pocock. 234. Trends in Healthcare Utilization and Cost of (United Kingdom) Epilepsy Across Ages 0-90 [660] Chintan Dave, Abraham Hartzema. 80 (United States) 2015 ICPE POSTER SESSION B Tuesday, August 25, 2015 | 8:00am – 6:00pm

244. Increasing Atomoxetine and Decreasing 253. A Survey on Self-Medication With Methylphenidate Use for Pediatric Patients Antibiotics and Over the Counter Drugs With Attention Deficit Hyperactivity Disorder Among Undergraduate Medical Students in (ADHD) in Korea [670] Yogyakarta, Indonesia [679] Ju-Young Shin, Sun Mi Shin, Shin Haeng Lee, Sharonjit Sandhu. (Indonesia) Han Na Shin. (Republic of Korea) 254. Survey on Self-Medication of Vitamin and 245. Validity of a Claims-Based Stroke Severity Supplement Among Medical Undergraduate Index for Hospitalized Acute Ischemic Stroke Students in Yogyakarta, Indonesia [680] Patients [671] Yana Suryani. (Indonesia) Cheng-Yang Hsieh, Sheng-Feng Sung, Huey- Juan Lin, Yu-Wei Chen, Chih-Hung Chen, Yea- 255. Myocardial Infarction and Cardiac Huei Kao Yang, Ya-Han Hu. (Taiwan) Death Associated With Current Use of Clarithromycin: Cohort Study [681] 246. Myocardial Infarction Associated With Angel YS Wong, Adrian Root, Ian Douglas, Celine Current Use of Helicobacter Pylori Eradication Chui, Esther W Chan, Liam Smeeth, Ian CK Regimen Containing Clarithromycin: Self- Wong. (China) Controlled Case Series [672] Angel YS Wong, Adrian Root, Ian Douglas, 256. Association Between an Excess Risk of Celine Chui, Esther W Chan, Yonas Anaphylaxis and Concomitant Use of Ghebremichael-Weldeselassie, Liam Smeeth, Ian Benzylpenicillin and Herba Houttuyniae CK Wong. (China) Injection, Retrospective Analysis of a Spontaneous Reporting System [682] 247. Withdrawn By Author Haona Li, Jianxiong Deng, Yiexiang Zhang, He Sun. (China) AsPEN 257. The Association Between Oral 248. The Gender Differences in the Short-Term Fluoroquinolones and Seizures: A Hong Kong and Long-Term Treatment Outcomes in and United Kingdom Population-Based Self- Taiwan Rheumatiod Arthritis Patients [674] Controlled Case Series Study [683] Tzu-Chieh Lin, Yea-Huei Kao Yang, Swu-Jane Celine SL Chui, Esther W Chan, Angel YS Wong, Lin. (Taiwan) Adrian Root, Ian J Douglas, Ian CK Wong. (China)

249. Comparison of High-Potency Statin 258. Cardiotoxicity of Adjuvant Trastuzumab in Monotherapy and Statin Plus Ezetimibe Taiwan Breast Cancer Patients: A Population- Combination Therapy for Reducing Cardio- Based Study [684] Cerebrovascular Disease Risk [675] Hsu-Chih Chien, Yea-Huei Kao Yang, Jane PF Bo Ram Yang, Joongyub Lee, Nam-Kyong Choi, Bai. (Taiwan) Ju-Young Shin, Yoosoo Chang, Hong-Ji Song, KyungEun Youn, Xue-Mei Jin, Mi-Sook Kim, 259. Withdrawn By Author Ye-Jee Kim, Jong-Mi Seong, Byung-Joo Park. (Republic of Korea) 260. An Indian Study on Assessment of the Suitability of Pharmacotherapy in Elderly 250. Risk of Peptic Ulcer Among Antidepressants Patients and Its Enhancement [686] Users With or Without Concurrent Use of Mandavi Kashyap, Mangu Rohit, Vinay Kapur, Non-Steroidal Anti-Inflammatory Drugs: Sanjay D’Cruz, Atul Sachdev, Pramil Tiwari. Nationwide Propensity Score Matched Study (Malaysia) [676] Ju-Young Shin, Mi-Ju Park, Shin Haeng Lee, So- 261. Type 2 Diabetes Among Adults in Hyun Choi, Byung-Joo Park. (Republic of Korea) Bangladesh: A Population Based Study [687] Muhammad AB Chowdhury, Md Jamal Uddin, 251. Prescribing Patterns of Antidepressants for Hafiz MRU Khan, Md Rabiul Haque. the Elderly Depressive Patients in Korea [677] (United States) Kyoung-eun Kwon, Ju-Young Shin, Ye-Jee Kim, Nam-Kyong Choi, Joongyub Lee, Byung-Joo 262. Risk Factors of Hypertension Among Adults Park. (Republic of Korea) in Bangladesh: Evidence from a National Cross Sectional Survey [688] 252. Geographic Variation and Type of Medical Muhammad A.B. Chowdhury, Md. Jamal Service in the Prescribing Pattern of Zolpidem Uddin, Boubakari Ibrahimou, Md. Rabiul Use in Korea [678] Haque, Oren Dale Williams. (United States) Hyo-Ju Park, Ju-Young Shin, Han-Na Shin. (Republic of Korea) z END SESSION B

81 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

Pharmacovigilance 10. Utility of Social Listening in 18. Studying Cancer as an Adverse Outcome Pharmacovigilance for Groups of Special from Nononcological Therapies: Review 1. Pharmacovigilance Knowledge and Interest: Product Complaints, Pregnancy, of the Food and Drug Administration’s Practices Amongst Health Care Pediatric, and the Elderly [777] Postmarketing Commitment Database [785] Professionals; a Regional Survey [768] Heidi G Bell, Laurie S Anderson, Nancy A Kirk D Midkiff, David H Harris, Alicia W Maria Rizvi, Mehreen Abbas. (Pakistan) Yuen, Bridget Ruane, Harry Seifert, Gregory E Gilsenan, Elizabeth B Andrews. Powell. (United States) (United States) 2. Prospective Evaluation of vigiRank for First-Pass Screening in Real-World Signal 11. A Statistical Method for Estimating the 19. Pharmacovigilance of Psychotropic Detection [769] Prevalence of Adverse Drug Reactions in Medicines in a Developing Country—A Ola Caster, Lovisa Sandberg, Kristina Juhlin, Hospitalized Patients Using Laboratory Prospective Surveillance [786] Sarah Watson, G Niklas Norén. (Sweden) Results from Electronic Health Records Ramesh Madhan, Jisha Lucca, Parthasarathi [778] Gurumurthy. (India) 3. Evaluation of EU Post-Authorization Safety Dukyong Yoon, Man Young Park, Eun Kyoung Studies Using EU-RMP / European Public Ahn, Soo Yeon Cho, Dahye Shin, Jihyun Kim, 20. Impact of Adverse Drug Reactions on Assessment Reports: Analysis, Trends, Hojun Park, George Hripcsak, Rae Woong Daily Living of Patients on Anti-Psychotic and Implications [770] Park. (Republic of Korea) Medications [787] David Neasham, Sarah Baradaran, Corina Ramesh Madhan, Jisha Lucca, Parthasarathi Chalkiadaki, Ravi Sadasivan, Beth L 12. Active Surveillance of Adverse Drug Gurumurthy, Himanshu Patel. (India) Nordstrom, Matthew W Reynolds. Reactions Using Administrative Databases (United Kingdom) [779] 21. Prospective Safety Monitoring of Drug-Drug Ella T Nkhoma, Kyna Gooden, Jennifer Wood, Interactions: A Case Study of Warfarin and 4. Comparison of Events in Spontaneous Brian Dreyfus, Heather Mazakas, Andres Selective Serotonin-Reuptake Inhibitors Adverse Event Reports To Events Gomez. (United States) [788] Discussed Within Context of Drug Use on Krista F Huybrechts, Macarius M Donneyong, Facebook and Twitter [771] 13. The Impact of the New Pharmacovigilance Moa Park, Joshua J Gagne, Sebastian Gregory Powell, Heidi Bell, Harold Rodriguez, Legislation on the Applications and Files Schneeweiss, Shirley Wang. (United States) Michele Thomas, Jeffery Painter, Cath Harvey, Submitted To the Department of Adverse James Blowers, Nabarun Dasgupta. Drug Reactions of the National Organisation 22. Rhabdomyolysis Could Be a Consequence (United States) for Medicines in Greece (EOF) [780] of the Interaction Between Clonazepam Eirini Apostolidou, George Aislaitner, Leonidas and Other Antiepileptic Medications: A 5. Bias in Spontaneous Reporting of Adverse Klironomos, Agni Kapou, Dimitrios Kouvelas. Pharmacovigilance Assessment [789] Drug Reactions in Japan [772] (Greece) Ayad K Ali, Mahyar Etminan. (United States) Shinichi Matsuda, Kotonari Aoki, Takuya Kawamata, Tetsuji Kimotsuki, Takumi 14. Comparison of Safety Signal Detection 23. Inverse Association Between Antiepileptic Kobayashi, Hiroshi Kuriki, Terumi Nakayama, Algorithms Used in Data Mining With Drugs and Cancers; Data Mining of Large Seigo Okugawa, Yoshihiko Sugimura, Minami Regard To Masking Bias [781] Medical Databases [790] Tomita, Yoichiro Takahashi. (Japan) David J Nimke, Vaishali K Patadia. Mitsutaka Takada, Mai Fujimoto, Migiwa (United States) Kanou, Kouichi Hosomi. (Japan) 6. Experiences With a Computer-Assisted Database Screening Tool at the Netherlands 15. Consumption Adjusted Reporting Rates of 24. 397 Patterns in Spontaneous Adverse Pharmacovigilance Centre Lareb [773] Adverse Drug Reactions in Norway [782] Event Reporting Among Branded and Florence van Hunsel, Corine Ekhart. Kristian Svendsen. (Norway) Generic Antiepileptic Drugs [791] (Netherlands) Justin Bohn, Cindy Kortepeter, Monica Muñoz, 16. Sentinel Site Active Surveillance for First- Kelley Simms, Susan Montenegro, Gerald Dal 7. The Role of Registries in European Post- Line Antiretroviral Medicines in Namibia Pan. (United States) Marketing Surveillance: A Retrospective [783] Analysis of Centrally Approved Products Marita Mann, Assegid Mengistu, Johannes 25. Psychotropic Drug-Drug Interactions During 2005-2013 [774] Gaeseb, Evans Sagwa, Greatjoy Mazibuko, in Three Most Commonly Used Drug Jacoline Bouvy, Xavier Kurz, Kevin Blake, Andy Stergachis. (United States) Information Databases [792] Giampiero Mazzaglia, Jim Slattery, Corinne de Xinyue Liu, Marie Barnicoat, Regina Bussing, Vries, Marie L De Bruin, Peter Arlett. 17. Pharmacovigilance Data from Systematic Almut G Winterstein. (United States) (United Kingdom) Patient Reported Outcome (PRO) Tools Versus Usual Clinician Interactions: Are 26. Polypharmacy in Spontaneous Reports 8. Framework for Impact Assessment of Cancer Patients Reporting Toxicity Data To of Over-the-Counter (OTC) Products: Skin Regulatory Science: Application To the Their Health Care Providers? [784] Care [793] PROTECT Project [775] Joseph N Samuel, Tian Qi Wang, Andrea Mary E Ritchey, Leslie Rylander, Michael Xavier Kurz, Peter Arlett, Jim Slattery, Kevin Perez-Cosio, M Catherine Brown, Ashlee Steinbuch. (United States) Blake, Corinne de Vries. (United Kingdom) Vennettilli, Nicholas Cheng, Gusharan Gill, Mindy Liang, Doris Howell, Wei Xu, Jack Seki, 27. Comparison of Inhibitors of 9. Impact of Scheduled Post-Marketing Safety Geoffrey Liu. (Canada) Dipeptidylpeptidase 4 (DDP-4 Inhibitors or Summary Analyses on Regulatory Actions Gliptins) Marketed By Indian Companies [776] With the Original SmPC from Innovator Shohko Sekine, Ellen E Pinnow, Rebecca Companies [794] Kurtzig, Eileen Wu, Hall Marni, Gerald Dal Nilima P Justice, Pipasha N Biswas. Pan. (Japan) (United States) 82 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

28. Allergic Reactions Associated With 36. Patient Knowledge of Safe Use of 44. Preferences of Diabetes Patients for Lipid- Herbal Remedies in the WHO-UMC ER/LA Opioid Analgesics Following Lowering Treatment: A Discrete Choice Pharmacovigilance Database [795] Implementation of the Class-Wide REMS Experiment [811] Jitka Pokladnikova, Ricarda Meincke, Ronald [803] Dianna de Vries, Sieta T de Vries, Petra Denig. Meyboom, Stefan Russmann. (Switzerland) Daina B Esposito, Judith J Stephenson, M (Netherlands) Soledad Cepeda, Paul M Coplan, Jennifer CL 29. Withdrawn By Author Hawes, Crystal N Holick, Jean-Yves Maziere, 45. Development of a Shared Decision-Making Gregory P Wedin, Stephan F Lanes. Tool To Assist Patients and Clinicians With 30. Development of a Research Network and an (United States) Assessing the Individualized Risks and Infrastructure for the Nationwide Registry Benefits of Oral Anti-Coagulation Therpay Study in Palliative Care in Japan [797] 37. Impact of Risk Minimisation Measures on for Atrial Fibrillation [812] Keisuke Ariyoshi, Tempei Miyaji, Isseki Maeda, Citalopram Use in Two European Countries Karen Kaiser, Wendy Cheng, Sally Jensen, Satoru Iwase, Takuhiro Yamaguchi. (Japan) [804] Marla Clayman, Frances Schwiep, Andrew Inge Zomerdijk, Gianluca Trifirò, Sabine Thappa, Anita Chawla, Jeffrey J Goldberger, 31. Using the Earliest Available Claims Data Straus, Miriam Sturkenboom. (Nepal) Nananda Col, Jeff Schein. (United States) for Influenza Vaccine Safety Surveillance in Mini-Sentinel [798] 38. Diabetes Testing for Adults Taking 46. Benefit-Risk Assessment of W Katherine Yih, Lauren Zichittella, Antipsychotic Drugs: Where To Target Risk Nonprescription Diclofenac [813] Sukhminder K Sandhu, Michael Nguyen, Minimization Interventions [805] Eric P Brass, Jessica Swanson, Steven M Martin Kulldorff, David V Cole, Robert Jin, Elaine H Morrato, Elizabeth Campagna, Sarah Weisman. (United States) Alison T Kawai, Cheryl N McMahill-Walraven, Brewer, Miriam Dickinson, Deborah Thomas, Nandini Selvam, Mano S Selvan, Grace M Richard C Lindrooth. (United States) 47. Defining Risk Profiles in Special Lee. (United States) Populations -Results from a Post 39. Primary Care Physicians and Prescription Authorisation Safety Study (PASS) of 32. Long-Acting Bronchodilators and Risk of Opioid Abuse: A National Survey [806] Seroquel XL© Conducted in Primary Care Adverse Cardiovascular Events in Chronic Catherine S Hwang, Lydia W Turner, Stefan in England [814] Obstructive Pulmonary Disease: A Focused P Kruszewski, Andrew Kolodny, G Caleb Deborah Layton, Vicki Osborne, Miranda Critical Review [799] Alexander. (United States) Davies, Saad Shakir. (United Kingdom) Sunning Tao, Erika Kirsch, Karen Yeomans, Catherine Sigler. (Canada) 40. The Combination Tenofovir/Lamivudine 48. U.S. Women Who Could Benefit from (Emtricitabine) /Efavirenz (Nevirapine) Tamoxifen or Raloxifene for Breast Cancer Spotlight Session-Benefit Better Tolerated Than Zidovudine/ Chemoprevention in 2010 [815] Lamivudine/Nevirapine in a Prospective Andrew N Freedman, Donna R Rivera, Mitchell Risk Assessment, Observational Study of Adverse Effects in H Gail, Barry I Graubard. (United States) Communication and Newly Treated Individuals in Burkina Faso [807] 49. Qualitative Research With Primary Care Evaluation (BRACE) Frank ER Zongo, Emile Ouedraogo, Clinicians and Neurologists Regarding 33. Comparison of Benefit-Risk Assessment Souleymane Fofana, Arsène Zongo, Arsène Drug Safety Communications [816] Methods for Prospective Monitoring of Ouedraogo, Moussa Ouedraogo. (Canada) Suzanne L West, Craig Lefebvre, Lauren A Newly Marketed Drugs: A Simulation Study McCormack, Olivia Taylor, Paula Rausch. [800] Benefit Risk Assessment, (United States) Joshua J Gagne, Mehdi Najafzadeh, Niteesh Communication and K Choudhry, Katsiaryna Bykov, Kristijan 50. Disproportionality Analysis of Cardiac H Kahler, Diane Martin, James R Rogers, Evaluation (BRACE) Arrhythmia Events in the FDA Adverse Sebastian Schneeweiss. (United States) Event Reporting System for Buprenorphine 41. ECG Monitoring of Hospitalised Patients Patch [817] Using Domperidone, Before and After 34. Benefit-Risk Analysis and Management Nelson E Sessler, Ekaterina Walker, Paul M Media Attention Regarding Sudden Cardiac Plan for Rare Serious Adverse Events Coplan. (United States) Death [808] (SAEs): Progressive Multifocal Selma Saaid, Matthijs L Becker, Teun Leukoencephalopathy (PML) Case Example 51. What Can Social Media Networks van Gelder, Patricia MLA van den Bemt. [801] Contribute To Medicines Safety (Netherlands) Deanna Hill, Amanda Eudy, Dimitri Bennett, Surveillance? [818] Preciosa M Coloma, Benedikt Becker, Miriam Jonathon Haddad, Barbara Haight, Sarah 42. Application of Quantitative Methodologies Kavanagh, Christi Kleoudis, Eric Lewis, Susan CJM Sturkenboom, Erik M van Mulligen, Jan A for Benefit-Risk Assessment: Case Study Kors. (Netherlands) Duke. (United States) With Rosiglitazone and Pioglitazone [809] Diogo Mendes, Carlos Alves, Francisco Batel 35. Direct-To-Consumer Advertising of 52. The Use Off-Label of Thalidomide in Brazil Marques. (Portugal) Medicines in Singapore: Understanding from 2010 To 2014 [819] Awareness, Perception and Behavior Nair R Souza, Francisco JR Paumgartten. 43. Benefit-Risk Assessment of Statins: A (Brazil) Among the General Public [802] Multiple Criteria Decision Analysis [810] Cheong Hian Goh, Mui-Ling Tan, Terence Tze- Hsing-Chun Hsieh, Jason C Hsu, Yea-Huei Yin Fong, Wai-Ping Yau. (Singapore) Kao Yang, Christine Y Lu. (Taiwan)

83 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

53. Can Online Data Lead To the Earlier 61. Bone Pain, Skeletal-Related Events and Pharmacoeconomics Detection of Drug-Related Adverse Events? Opioid Analgesic Use in Prostate Cancer [820] Patients With Bone Metastases [828] Outcomes Research Mei S Duh, Pierre Cremieux, Marc Van Adriana Valderrama, Sara Eapen, Kelly 70. Assessing Cost-Effectiveness of HPV Audenrode, Francis Vekeman, Paul Karner, A Hennessey, Casey Jones, Lonnie Wen, Vaccines with Decision Analytic Models: Haimin Zhang, Paul Greenberg. (United States) Joseph Germino, Mei S Duh. (United States) What Are the Distinct Challenges of Low and Middle Income Countries? A Protocol 54. Reasons for and Time To Antipsychotic 62. Evaluating the Effectiveness of the Soliris for a Systematic Review [837] (AP) Treatment Discontinuation: Results REMS Program [829] Obinna I Ekwunife, Andreas Gerber Grote, from a Post-Authorisation Safety Study Alexander Cole, Camille Bedrosian, Arshadul Christoph Mosch, James F O’Mahony, Stefan [821] Haque, Arshad Mujeebuddin, Amanda Wilson, K Lhachimi. (Germany) Deborah Layton, Vicki Osborne, Miranda Jenifer Wogen, John Price. (United States) Davies, Saad AW Shakir. (United Kingdom) 71. Costs, Resource Utilization, and Treatment 63. Association Between Renin-Angiotensin Patterns for Patients With Metastatic 55. Direct Healthcare Professional System Inhibitors and Cancer Risk; Data Melanoma [838] Communications – Can Their Effectiveness Mining of a Spontaneous Reporting Edmond L Toy, Michael C Lewis, Alan K Be Measured? [822] Database and a Claims Database [830] Oglesby, Mei S Duh, Francis Vekeman Taco Monster, Liana Martirosyan, Peter Mol. Mai Fujimoto, Tomoya Higuchi, Kouichi (Canada) (Netherlands) Hosomi, Mitsutaka Takada. (Japan) 72. Clinical and Economic Benefits of Extended 56. Adverse Events in Patients With Advanced 64. Instructions for Clinical and Biomarker Treatment With Apixaban for the Treatment Non-Small Cell Lung Cancer – Findings from Monitoring in the Summary of Product and Prevention of Recurrent Venous IMS Oncology, a US Oncology Electronic Characteristics (SmPC) of Psychotropic Thromboembolism in Canada [839] Medical Record (EMR) System [823] Drugs: Overview and Applicability in Peter Quon, Hoa H Le, Vincent Raymond, Lei Chen, Belen San Antonio, Jonathan Lucas Clinical Practice [831] Mondher Mtibaa, Andriy Moshyk. Swain, Lucy Mitchell, William J John, Hafida Mariette Nederlof, Lennart J Stoker, Toine CG (United States) Arkoub, James A Michael, Dale Quentin Egberts, Eibert R Heerdink. (Netherlands) Marmaduke, Yuer Yan. (United States) 73. The QUA-VKA Study To Identify New Risk 65. Assessment of Metabolic Monitoring Factors for Bleeding During Treatment With 57. Pattern of Postmarket Requirements and By Physicians of Patients Treated With Vitamin K Antagonists: Objectives and Commitments and Fda Approval of Novel Quetiapine in Selected European Countries Design [840] Therapeutic Agents from 2003 To 2013 [824] [832] Nienke van Rein, Mettine HA Bos, Willem Anura Deshmukh, Andres Gomez, Tzuyung D Robert S Brody, Charlie L Liss, Heather Wray, M Lijfering, Felix JM van der Meer, Pieter H Kou. (United States) Ramon Iovin, Carmen Michaylira, Catherine Reitsma. (Netherlands) Datto, Leigh Jefferies, Anneli Thuresson. Risk Management (United States) 74. Rivaroxaban Versus Warfarin: Effect on Risk Minimization Healthcare Resource Utilization and Costs 66. Objective Assessment of Metabolic in Nonvalvular Atrial Fibrillation Patients Communication Monitoring in Patients Treated With Seroquel [841] IR/XR in the UK and Germany Using François Laliberté, Concetta Crivera, Winnie 58. An Evaluation of Clinical Practices Among Electronic Medical Records (EMR) [833] UK General Practitioners in Managing W Nelson, William H Olson, Jeffrey Schein, Robert S Brody, Charlie L Liss, Heather Wray, Guillaume Germain, Patrick Lefebvre. (Canada) Individuals Attempting To Quit Smoking Anushini Muthutantri, Catherine Datto, Leigh With Varenicline [825] Jefferies. (United States) 75. Health Utilities Associated With Muhammad Younus, Kenneth R Petronis, Bleeding Control and Adverse Events Xiaofeng Zhou, Harshvinder Bhullar, Michelle 67. Risk Minimization and Assessment of in Premenopausal Women With Uterine Johnson, Shobhna Koria, Jingping Mo. Olanzapine Long-Acting Injection in 21 Fibroids [842] (United States) Countries in Europe [834] Seung-Mi Lee, Insun Choi, Soyun Kim, Sung- Meghan E Jones, Holland C Detke, Rashna Jin Park, Dong-churl Suh. (Republic of Korea) 59. Identifying Patients for Clinical Trials Chhabra-Khanna. (United States) By Risk Stratification: The Case of an 76. A Cost-Effectiveness Analysis of Opioid Intervention To Reduce Post-Operative 68. National Trends in Treatment With Substitution Therapy Upon Release in Opioid Use in Total Joint Replacement [826] Prescription Medications With Risk Reducing Mortality Among Prisoners With Jennifer L Kuntz, Eric S Johnson, Amanda F Evaluation and Mitigation Strategies in the a History of Opioid Dependence [843] Petrik, Xiuhai Yang, David H Smith. United States, 2003-2010 [835] Natasa Gisev, Marian Shanahan, Don J (United States) Rachel Harrington, Dima M Qato. Weatherburn, Richard P Mattick, Sarah Larney, (United States) 60. Decrease in Diagnosed Abuse, Addiction, Lucy Burns, Louisa Degenhardt. (Australia) and Opioid Poisoning Among Patients 69. Trends in the Safety of New Molecular 77. A Cost Comparison of Split-Dose Reduced- Prescribed Opioids After Introduction Entities and Therapeutic Biologics Volume Oral Sulfate Solution (OSS) and of OxyContin With Abuse-Deterrent Approved By the FDA (1980-2014) [836] Polyethylene Glycol With Electrolytes Characteristics [827] Enrique Seoane-Vazquez, Rosa Rodriguez- Solution (PEG-ELS) [844] Aditi Kadakia, Paul Coplan. (United States) Monguio. (United States) Mark Cleveland, Sander Yermakov, Matthew Davis, Romaine Campbell, Lynn Huynh, Francis A Farraye, Mihran Yenikomshian. (United States) 84 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

78. Impact of Intensive and Maintenance 87. The Adherence To Inhaled Drugs in COPD 96. Determinants of Patient Adherence To Treatment of Pulmonary Tuberculosis on Patients: Effect on Survival [854] Imatinib – A Retrospective Study in a Respiration-Quality of Life in Indonesia [845] Valeria Belleudi, Nera Agabiti, Mirko Di Malaysian Teaching Hospital [863] J Atthobari, H Firmansyah, UA Mulyani, D Martino, Silvia Cascini, Ursula Kirchmayer, Sharmini Balashanker, Li-Chia Chen, Chelsea Perwitasari. (Indonesia) Riccardo Pistelli, Danilo Fusco, Marina Davoli. AM Taylor, Siew Siang Chua, Izam EM (Italy) Zakaria. (Malaysia) 79. Cost Effectiveness of Melanoma Therapies [846] 88. Comparative Adherence of ICS/LABA 97. Development of a New Methotrexate (MTX)- Karissa M Johnston, Emily McPherson, Products in Elderly Asthma Patients [855] Specific Adherence Tool for Use in the Katherine Osenenko, Joanna Vergidis, Adrian Mina Tadrous, Diana Martins, Zhan Yao, Management of Patients With Rheumatoid Levy. (Canada) Matthew Stanbrook, Samantha Singh, David Arthritis (RA) [864] N Juurlink, Muhammad M Mamdani, Tara Jeffrey R Curtis, Maher Aassi, Carla Dias 80. Predictors of High Healthcare Resource Gomes. (Canada) Barbosa, Corrado Bernasconi, Michel Utilization and Liver Disease Progression Brethous, Benoit Arnould. (United States) Among Patients With Chronic Hepatitis C 89. E-Monitoring of Asthma Therapy To [847] Improve Compliance in Children (E-MATIC) 98. Medication Adherence in Chronic Joyce LaMori, Neeta Tandon, François [856] Myeloid Leukemia and Patients’ Need for Laliberté, Guillaume Germain, Dominic Pilon, Erwin C Vasbinder, Lucas MA Goossens, Information [865] Patrick Lefebvre, Avinash Prabhakar. (Canada) Hettie Janssens, Brenda CM De Winter, Christel Boons, Lonneke Timmers, Jeroen Liset Van Dijk, Arnold G Vulto, Maureen Janssen, Jan de Jong, Eleonora Swart, 81. Outcomes and Patterns of Health Care PMH Rutten, Patricia MLA Van den Bemt. Jacqueline Hugtenburg. (The Netherlands) Usage Among Acute Ischemic Stroke (Netherlands) Patients in Canada [848] 99. 470 Trajectories of Adherence To qaAnne-Marie Castilloux, K. Tore Jørgensen, 90. Effects of Breast Cancer on Chronic Thienopyridines After Coronary Stenting in F. Coste, Yola Moride. (Canada) Disease Medication Adherence in Elderly Patients on Dialysis [866] Women [857] Jenny I Shen, Tara I Chang, Maria E Montez- 82. Patterns of Health Care Utilization Among Melissa L Santorelli, Hirshfield M Kim, Michael Rath, Wolfgang C Winkelmayer. (United Patients Hospitalized for Acute Ischemic B Steinberg, Kitaw Demissie. (United States) States) Stroke (AIS) in Canada [849] Anne-Marie Castilloux, K. Tore, F. Coste, Yola 91. Primary Non-Adherence To Antidepressants: 100. Preliminary Analyses of Primary Adherence Moride. (Canada) Differences By Class [858] and Persistence To Antihypertensive Heather D Anderson, Gerald E Pulver, Sam L Therapy in Portuguese Primary Care Units 83. A Descriptive Analysis of a Real-World Ellis, Mykel G Walsh, John T Lynch, Robert J [867] Population With Chronic Hepatitis C (CHC) Valuck. (United States) André F Coelho, Pedro A Caetano. (Portugal) Treated With Simeprevir (SMV)- And/ Or Sofosbuvir (SOF)-Based Regimens: 92. Validity of Pharmacy-Based Adherence 101. Use of the Guideline-Recommended Drugs Findings from a US Payer Database [850] Measures in Individuals With Type 2 After a First Acute Myocardial Infarction Jamie B Forlenza, Jonathan Fortier, François Diabetes [859] in the Province of Québec in the Elderly: Laliberté, Patrick Lefebvre, Neeta Tandon. Arsène Zongo, Jocelyne Moisan, Jean-Pierre Effect of Deprivation and Sex [868] (Canada) Grégoire, Line Guénette. (Canada) Adjo E Akator, Claudia Blais, Phillipe Gamache, Guénette Line. (Canada) 84. Pulmonologist Involvement and Overall Adherence Survival in Newly-Diagnosed Extensive 102. Patterns of Statin Use Following Initiation Stage Small Cell Lung Cancer Patients 93. Persistence of Proton Pump Inhibitor of Lipid Lowering Therapy in a Commercial [851] Refills in Community Pharmacies [860] Insurer’s Administrative Database [869] Xinyi Ng, Janaki A Deepak, Josephine Emre Yucel, Aylin Yucel, Latif Ozbay. Florence T Wang, Ling Li, Laura Yochum, Ben Feliciano, Amy J Davidoff. (United States) (United States) Taylor, Robin Clifford, John D Seeger. (United States) Spotlight Session-Adherence 94. Liver Outcomes and Mortality Among Patients Newly-Diagnosed With Hepatitis C 103. Factors Influencing Adherence 85. Impact of Persistence and Adherence on Virus Infection in Israel During the Period and Persistence To Cardiovascular Mortality in Women Treated With Hormonal 2006-2011 [861] Medications: A Systematic Review [870] Breast Cancer Therapy: A Nested Case Clara Weil, David R Walker, Varda Shalev, Danielle M van der Laan, Petra JM Elders, Control Study in a French Nationwide Mira Friedman, Gabriel Chodick. Christel CLM Boons, Giel Nijpels, Jacqueline Database [852] (United States) G Hugtenburg. (The Netherlands) Pauline Bosco-Levy, Annie Fourrier-Reglat, Simone Mathoulin-Pelissier, Nicholas Moore, 95. Adherence To Interferon-Based Treatment 104. Factors Associated With Non-Adherence To Julien Bezin. (France) Among Patients Newly-Diagnosed With Cardiovascular Medication: A Comparison Hepatitis C Virus in Israel During the Period Between Pharmacy Refill and Self-Report 86. Persistence and Compliance With Lipid- 2006-2011 [862] Methods [871] Lowering Drugs in Patients With Chronic Clara Weil, David R Walker, Varda Shalev, Danielle M van der Laan, Petra JM Elders, Kidney Disease [853] Mira Friedman, Gabriel Chodick. Christel CLM Boons, Giel Nijpels, Jacqueline Viet Thanh Truong, Jocelyne Moisan, Edeltraut (United States) G Hugtenburg. (The Netherlands) Kroger, Serge Langlois, Jean-Pierre Gregoire. (Canada)

85 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

105. Primary Non-Adherence Associated With 114. Adherence To Inhaled Corticosteroids in 123. Switching Antihypertensive Drug Class in Rosuvastatin from Electronic Health Asthmatic Children in Dutch Primary Care Primary Healthcare: The Swedish Primary Record (EHR) Prescribing Data in the [881] Care Cardiovascular Database (SPCCD) United States [872] Marjolein Engelkes, Hettie M Janssens, Johan [890] Christopher G Rowan, Nikita Stempniewicz, C de Jongste, Miriam CJM Sturkenboom, Katia Miriam Qvarnström, Thomas Kahan, Helle James Flory, Tobias Gerhard, James D Lewis, MC Verhamme. (Netherlands) Kieler, Lena Brandt, Jan Hasselström, Kristina John Cuddeback, Sean Hennessy. Bengtsson Boström, Karin Manhem, Per (United States) 115. Longitudinal Inhaled Corticosteroid Hjerpe, Björn Wettermark. (Sweden) Adherence Using Multiple Methods To 106. Medication Possession Ratio Associated Calculate Medication Possession Ratios 124. Health Professionals’ Perceptions About With Rosuvastatin from Electronic Health [882] Oral Anticancer Drugs Adherence and Record (EHR) Prescribing Data in the Patrick C Souverein, Ellen S Koster, Alexandra Shared Decision Making in Belgium and the United States [873] L Dima, Gene Colice. (Netherlands) Netherlands [891] Christopher G Rowan, Nikita Stempniewicz, Mathieu Verbrugghe, Lonneke Timmers, James Flory, Tobias Gerhard, James D Lewis, 116. Multi-Dose Drug Dispensing as a Tool Christel CLM Boons, Bart FJ Van den Bemt, John Cuddeback, Sean Hennessy. To Improve Medication Adherence: A Jacqueline G Hugtenburg, Ann Van Hecke. (United States) Crossover Study [883] (Netherlands) Nienke van Rein, Kristel S de Geus, Suzanne 107. Patterns of Testosterone Persistence and C Cannegieter, Pieter H Reitsma, Felix JM van 125. “I Just Forget To Take It”- New Media for Switching Among Commercially-Insured der Meer, Willem M Lijfering. (Netherlands) Asthma Self Management: Assessment of Men in the United States [874] Teenagers’ Preferences [892] J Bradley Layton, Dongmei Li, Julie L 117. The Impact of Adherence To Antidiabetic Ellen S Koster, Daphne Philbert, Tjalling W de Sharpless, Til Stürmer, M Alan Brookhart. Medications on Glycaemic Control in Type Vries, Liset van Dijk, Marcel L Bouvy, Patrick (United States) 2 Diabetes Patients [884] Souverein. (Netherlands) Alison K Wright, Darren M Ashcroft, Martin K 108. Gout Control Among Hypertensive Patients Rutter, Richard Emsley, Douglas T Steinke. Spotlight Session-Databases With Gout and the Relationship To Onset of (United Kingdom) End-Stage Renal Disease [875] 126. Use of Electronic Health Records To Sylvie Perreault, Javier Nuevo, Scott 118. Improving Adherence Measurement Evaluate Drug Safety: Example for the Baumgartner, Rob Morlock. (Canada) for Applied Pharmacoepidemiology: Incidence of Non-Melanoma Skin Cancer in Estimating the Association Between Patients With Myelofibrosis [893] 109. Adherence and Persistence To Allopurinol Endocrine Therapy Adherence and Alex Allepuz, Iulian Alecu, Andreas Brueckner, Among Hypertensive Patients With Gout Mortality Among Women With Breast Norbert Hollaender, Katarina Sablinska. (Spain) [876] Cancer [885] Sylvie Perreault, Javier Nuevo, Scott Aaron N Winn, Stacie B Dusetzina. 127. Incidence of Multiple Sclerosis in Germany Baumgartner, Rob Morlock. (Canada) (United States) [894] Lasse Pachaly, Edeltraut Garbe, Dunya 110. Patient and Policy-Level Determinants 119. Adherence and Persistence To Bentama, Laura Khil, Klaus Berger, Niklas of Long-Acting Injectable Antipsychotic Anticoagulants and Its Effect on Risk of Schmedt. (Germany) Use After Relapse: A Nationwide Study of Recurrence of Venous Thromboembolism – Schizophrenia Patients in the United States A Systematic Review [886] 128. Validation of Claims Algorithms for [877] Pareen Vora, Gunnar Brobert, Kiliana Progression To Metastatic Cancer in John W Jackson, Lisa Fulchino, James Suzart-Woischnik, Montse Soriano-Gabarró. Patients With Breast, Non-Small Cell Lung, Rogers, Jennifer Polinski, David C Henderson, (Germany) and Colorectal Cancer [895] Sebastian Schneeweiss, Michael A Fischer. Jason C Simeone, Beth L Nordstrom, Karen (United States) 120. Single Versus Multi-Tablet Fixed Dose G Malley, Kathy H Fraeman, Zandra Klippel, Combination (FDC) HIV Treatment Mark Durst, John H Page, Hairong Xu. 111. Persistence of Stimulants in Children Regimens: A Systematic Literature Review (United States) and Adolescents With Attention-Deficit/ and Meta-Analysis [887] Hyperactivity Disorder: A Longitudinal Siva Narayanan, Soma Nag, Camelia M 129. On the Accuracy of Using Natural Study [878] Graham, Patrick G Clay. (United States) Language Processing Techniques for Sneha Sura, Satabdi Chatterjee, Pravin the Surveillance of Hospital-Acquired Kamble, Rajender Aparasu. (United States) 121. The Impact of Pharmacist-Led Educational Pneumonia [896] Interventions on Medication Adherence Christian M Rochefort, Aman D Verma, 112. Utilization and Adherence Pattern of and Polypharmacy in Geriatric Patients in Tewodros Eguale, David L Buckeridge. Generic and Brand-Name Drugs in the Malaysia [888] (Canada) Treatment of Epilepsy [879] Muhammad Shahid Iqbal, Muhammad Zahid Chao Chen, Ramon E Bautista, Abraham G Iqbal, Muhammad Waseem Iqbal, Mohd Baidi 130. Impact of Case Definition on Disease Hartzema. (United States) Bahari. (Malaysia) Incidence Rates Estimated from Administrative Claims Databases [897] 113. Drug Utilization and Adherence in Multiple 122. Impact of Out-Of-Pocket Expenses on Daina B Esposito, Lina Titievsky, Jennifer Sclerosis Patients – A Nationwide Medication Adherence in Patients Covered CL Hawes, Crystal N Holick, Stephan Lanes. Observational Study in Taiwan [880] By Private Drug Insurance Plans [889] (United States) Chih-Ho Chou, Tzu-Chieh Lin, Ching-lan François Després, Amélie Forget, Fatima- Cheng, Yea-Huei Kao Yang. (Taiwan) Zohra Kettani, Lucie Blais. (Canada)

86 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

131. Getting the Right Cohort: Effect of 141. Anesthesia Exposure and Risk of Dementia 152. Feasibility Analysis of Myopic Chroidal Inclusion Criteria in Studies Using EMR and and Alzheimer’s Disease: A Prospective Neovascularization (mCNV) Recording Claims [898] Study [908] Using the THIN Database [919] Emma Brinkley, Christina Mack, Tongsheng Erin JA Bowles, Eric B Larson, Ryan P Pong, Zdravko P Vassilev, María E Sáez, Antonio Wang, Kathy Lang. (United States) Rod L Walker, Melissa Anderson, Onchee Yu, González-Pérez, Luis A García-Rodríguez. Shelly Gray, Paul K Crane, Sascha Dublin. (United States) 132. Validity of Cancer Diagnoses in General (United States) Practitioner Medical Records [899] 153. Contrasting Adverse Event Rates Joan Fortuny, James A Kaye, Andrea V 142. Susceptibility To Infection Before Among Medicare Beneficiaries With High Margulis, Estel Plana, Brian Calingaert, Diagnosis of Primary Chronic Immune Cardiovascular Disease Risk Taking Statins Susana Perez-Gutthann, Alejandro Arana. Thrombocytopenia [909] [920] (Spain) Charlotta Ekstrand, Marie Linder, Honar Cherif, Paul Muntner, Shia T Kent, Robert S Helle Kieler, Shahram Bahmanyar. (Sweden) Rosenson, Keri L Monda, Meredith Kilgore, 133. Development of a Risk Model for Drug- Hong Zhao, Angelika D Manthripragada. Associated Inpatient Falls [900] 143. Non-Infectious Wound Complications After (United States) Yoonyoung Choi, Benjamin Staley, Carl Mastectomy Result in Additional Surgical Henriksen, Paul Kubilis, Gigi Lipori, Babette Procedures and Early Breast Implant Loss 154. Suicide Incidence in Post-Menopausal Brumback, Almut G Winterstein. (United States) [910] Women With Breast Cancer [921] Katelin B Nickel, Ida K Fox, Julie A Alex Allepuz, Katarina Sablinska. (Spain) Databases Margenthaler, Anna E Wallace, Victoria J Fraser, Margaret A Olsen. (United States) 155. The Burden of Gout in a Primary Care 134. Detection and Validation of Ototoxicity Canadian Population With Uncontrolled Associated With Anticancer Platinum 144. Withdrawn By Author Urate Levels [922] Drugs Using a Hospital Database [901] Dawn M Williams, Cory Cowan, Alain Gendron, Katsuhito Hori, Ayami Kato, Junichi Kawakami. 145. Withdrawn By Author Jason Goodfield, Driss Oraichi, Aren Fischer, (Japan) Richard Borrelli, Neil Liu, Alison Dziarmaga. 146. Incidence and Predictors for Hospitalization (Canada) 135. Impact of the Sharp Changes in the Use Among Patients With Heart Failure in of Contraception in 2013 on the Risk of the UK Using Linked Primary Care and 156. Effects of Methotrexate on the Risk of Pulmonary Embolism in France [902] Hospitalization Data [913] Myocardial Infarction Among Canadian Aurore Tricotel, Cédric Collin, Mahmoud Ana Ruigómez, Alexander Michel, Mar Martín- Patients With Psoriasis and Psoriatic Zureik. (France) Perez, Luis-Alberto García-Rodríguez. (Spain) Arthritis [923] Marie-Christyne Cyr, Robert Bissonnette, Jean 136. Risk of Fractures in Patients With Diabetes 147. Risk for Cardiovascular Disease in Lachaine. (Canada) Mellitus Type 2 – Results of a Database Japanese Patients With Rheumatoid Analysis in the Primary Care Setting in Arthritis: A Large-Scale Epidemiological 157. Development of an Approach To Identify Germany [903] Study Using a Healthcare Database [914] and Quantify Statin Intolerance Using Karel Kostev, Birgit Ehlken, Franz-Werner Kunihiko Tanaka, Kenji Hamada, Terumi Claims Data [924] Dippel, Wolfgang Rathmann. (Germany) Nakayama, Akihide Atsumi, Shinichi Matsuda, Paul Muntner, Shia T Kent, Robert S Tomomi Shimura, Masatomi Nemoto. (Japan) Rosenson, Keri L Monda, Lei Huang, Hong 137. Hormonal Therapy for Breast Cancer Zhao, Jeffrey R Curtis, Meredith Kilgore, and Diabetes Incidence Among 148. Demographic, Co-Morbid Conditions, Angelika D Manthripragada. (United States) Postmenopausal Women [904] and Drug Utilization of Stroke Patients Melissa L Santorelli, Tobias Gerhard, Kitaw in a Large US Health Insurance Claims 158. Usage Patterns of Paracetamol in France Demissie. (United States) Database [915] [925] Nicholas J Everage, Sarah Gheuens, Sandra Mai TT Duong, Abdelilah Abouelfath, Regis 138. Does Aspirin Use in Myocardial Infarction Richman, Anne Dilley, Maneesh Juneja, Madé Lassalle, Cecile Droz, Nicholas Moore. Patients Increase the Risk of Neovascular Wenten. (United States) (France) Age-Related Macular Degeneration [905] Wan-Ju Annabelle Lee, Ching-Lan Cheng, 149. Incidence of Depression in Patients With 159. Comparison of Claims for Sickle Cell Yea-Huei Kao Yang. (Taiwan) Diabetes in Quebec: A Population-Based Disease Patients Across 3 US Health Cohort Study [916] Insurance Databases [926] 139. The Incremental Impact of Cardiovascular Carlotta Lunghi, Jocelyne Moisan, Jean-Pierre Nancy N Maserejian, Li Li, Maneesh Juneja, (CV) Disease on the Health-Related Quality Grégoire, Line Guénette. (Canada) William Hobbs. (United States) of Life (HRQoL) of Canadians With and Without Diabetes Mellitus (DM) [906] 150. Challenges of Identifying Relapses Among 160. Effects of a Reimbursement Restriction Shelagh M Szabo, Karissa M Johnston, Hugh MS Patients in a Health Plan Database [917] of Proton Pump Inhibitors Among D Tildesley, Adrian R Levy. (Canada) Florence T Wang, Nan Liu, Eva Ng, Audrey Patients With an increased Risk of Gastric Muller, Daniele D’Ambrosio, Ewa Lindenstrøm, Complications [927] 140. Comorbid Diagnostic Categories in Cheryl Enger. (United States) Linda E Flinterman, Karin Hek, Joke Korevaar, Myotonic Dystrophy [907] Liset van Dijk. (Netherlands) Cynthia Jones, Maneesh Juneja, Anne Dilley. 151. NFL Injury Surveillance and Analytics: (United States) Improving Data Collection Through Use of 161. The Swedish Prescribed Drug Register Electronic Health Records (EHR) [918] in the Scientific Literature 2005-2013 – A Christina D Mack, Kristina Franke, Owen Literature Review [928] McCarron, Allison Bryant, Rachel Jablonski, Mikael Hoffmann, Susanna Wallerstedt, Björn Michael Barboza, Nancy A Dreyer. Wettermark. (Sweden) 87 (United States) 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

162. Applying the Common Data Model To 171. Identification of Device Attributes of Total 178. Identifying Chronic Conditions from Data Analyze Multiple Claims Databases in Hip Replacements Via Linkage To the Sources With Incomplete Diagnostic a Study of Lymphoma Among Treated Veterans Health Administration’s National Information: The Case of Italian Rheumatoid Arthritis Patients [929] Prosthetic Patient Database [938] Administrative Databases [945] Nicole Baker, Hugh Kawabata, Vidya Moorthy, Katherine Etter, Art Sedrakyan, David D Dore. Rosa Gini, Martijn Schuemie, Alessandro Samy Suissa, Teresa A Simon. (United States) (United States) Pasqua, Patrizio Dazzi, Emanuele Carlini, Massimo Coppola, Iacopo Cricelli, Valentina 163. Application of Marginal Structural Models 172. Opportunities and Challenges of Using Real Barletta, Paolo Francesconi, Francesco Profili, To Unbalanced Longitudinal Health Data World Data in Oncology: Demonstrations Francesco Lapi, Andrea Donatini, Mario [930] of Truven MarketScan and IMS Oncology Saugo, Giulia Dal Co, Mariadonata Bellentani, Edmore Chamapiwa, David Reeves, Darren Electronic Medical Records Databases Niek Klazinga, Miriam Sturkenboom. (Italy) Ashcroft, Evangelos Kontopantelis, David [939] Springate. (United Kingdom) Lei Chen, Cinira Lefèvre, James A Michael, 179. Evaluating CPRD GOLD Recording Sensitivity Dale Quentin Marmaduke, Jonathan Lucas of Selected Chronic Conditions Recorded in 164. Assessing the Agreement of Hospitalization Swain, Lucy Mitchell, Yu Yan. (United States) HES Hospital Data [946] Estimates Between Three Nationally Amy Matcho, Patrick Ryan. (United States) Representative US Hospital Discharge 173. Identifying Cases of Type 2 Diabetes from Databases, the Nationwide Inpatient Heterogeneous Data Sources: Strategy 180. An Audit of Patients Transferred Out of the Sample (NIS), the National Hospital from the EMIF Project [940] Health Improvement Network (THIN) – A UK Discharge Survey (NHDS) and the Kid’s Giuseppe Roberto, Ingrid Leal, Naveed Sattar, Primary Care Database [947] Inpatient Database (KID) [931] Katrina Loomis, Paul Avillach, Peter Egger, Melissa Myland, David Ansell, Ahmed Nasser, Abigail Doucette, Elizabeth Hedgeman, Jon Rients van Wijngaarden, David Ansell, Sulev Fiona Hill, Caroline J O’Leary. (United Kingdom) Fryzek. (United States) Reisberg, Alessandro Pasqua, Lars Pedersen, James Cunningham, Lara Tramontan, Miguel 181. The Incidence of Solid Tumors in a 165. Standardizing Event Rates in Non- Angel Mayer, Ron Herings, Preciosa Coloma, Healthcare Database Compared To SEER Representative Data: An Applied Example Francesco Lapi, Miriam Sturkenboom, Johan [948] [932] van der Lei, Martijn Schuemie, Peter Rijnbeek, Chintan Dave, Jinghua He, Almut Winterstein, Mitchell M Conover, Suzanne Landi, Michele Rosa Gini. (Italy) Abraham Hartzema. (United States) Jonsson Funk. (United States) 174. Refinement of a Generalized Natural 182. Development of Common Data Model Using 166. Leveraging Real-Time Pharmacy Data from Language Processing Algorithm for the Clinformatics Datamart Database and Its a Managed Care Organization To Collect Identification of Clinical Terms from Free- Application in a Descriptive Analysis of Patient Reported Outcomes in a Real World Text Clinical Notes [941] Diabetes Population [949] Setting [933] Anthony P Nunes, Kathleen M Mortimer, Ling Zhang, Lili Wang, Jusmanda Wu, Juhaeri Suvapun Bunniran, Brandon Suehs, Cralen Jeanne Loughlin, Florence T Wang, David D Juhaeri, Yunxun Wang, Ali Pasha. Davis, Claudia Uribe, Daniel Ng, Thomas Dore. (United States) (United States) Yuran, Maria Vassilakis, Matt Zajack, Hugh Lee. (United States) 175. Validation of Treatment Codes in the 183. Comparison of Beta Coefficient Versus Danish National Patient Register [942] Risk Ratio Based Scoring System To 167. Relevant Automated Healthcare Databases Uffe Heide-Jørgensen, Maja Hellfritzsch, Assign Weights To Comorbidity Score [950] To Perform Studies in Oncology: Easy To Henriette Kristoffersen, Vera Ehrenstein Hemalkumar B Mehta, Vinay Mehta, Cynthia Find? [934] (Denmark) Girman, Michael L Johnson. (United States) Stephan Linden, Fatemeh Asadzadeh Vostakolaei, Dorothee B Bartels, Patrice 176. The Use of Heatmaps for the Visualisation 184. The Apparent Effect of Oral Contraceptives Verpillat. (Germany) of Secular Trends of Data Completeness for on the Risk of Venous Thromboembolism Individual Variables: A Study Using the R Depends on the Length of the Look-Back 168. Validity of Cancer Diagnosis in UK Primary Shiny Package [943] Period [951] Care Databases: Comparison of Observed Eduardo Hermosilla, Josep Maria Elorza, Anders H Riis, Martin B Johansen, M Alan and Expected Cancer Incidence Rates [935] Manuel Medina-Peralta, Daniel Prieto- Brookhart, Til Stürmer, Henrik Støvring. Michael Rañopa, Ian Douglas, Tjeerd van Alhambra. (United Kingdom) (Denmark) Staa, Liam Smeeth, Krishnan Bhaskaran. (United Kingdom) 177. Automatic Identification of Stages of Type 185. Addressing Confounding Through Extreme 2 Diabetes, Hypertension, Ischaemic Heart Cohort Restriction in Large Datasets: 169. A Study on Treatment and Characteristics Disease and Heart Failure from Italian CNODES Analysis of PPIs and Pneumonia of Prostate Cancer Patients Using Real- General Practioners’ Electronic Medical [952] World Data [936] Records: A Validation Study [944] Dan Chateau, Kristian B Filion, Laura E Jamilette Miranda, Birgitta Lilja, Björn Rosa Gini, Martijn Schuemie, Giampiero Targownik, Matthew Dahl. (Canada) Wettermark, Gunnar Ljunggren, Roger Mazzaglia, Francesco Lapi, Paolo Henriksson. (Sweden) Francesconi, Alessandro Pasqua, Carmelo 186. Impact of the Start of Follow-Up Montalbano, Valentina Barletta, Iacopo Cricelli, on Estimates of Incidence Rates of 170. Validation of Laboratory Values in a Claudio Cricelli, Mariadonata Bellentani, Prespecified Outcomes Following Heterogeneous Healthcare System: The US Miriam Sturkenboom, Niek Klazinga. (Italy) Administration of 23-Valent Pneumococcal Veterans Affairs Experience [937] Polysaccharide Vaccine (PPSV23) [953] Sanjay P Raju, Yuk-Lam Ho, Andrew Zimolzak, Lina Titievsky, Daina B Esposito, Jennifer Beth Katcher, Valmeek Kudesia, Kelly Cho, CL Hawes, Crystal N Holick, Robert Maroko, David R Gagnon. (United States) Rosalind C Hollingsworth, Stephan Lanes. 88 (United States) 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

187. Exploring Methods To Measure the 196. Minimizing Competition Bias in Signal 204. Fracture Healing Complication (FHC) Prevalence of Ménière’s Disease (MD) in Detection from Spontaneous Reporting in Women With Postmenopausal the US Clinformatics™ Database, 2009- Databases [963] Osteoporosis (PMO) Exposed To 2012 [954] Mickael Arnaud, Francesco Salvo, Moore Bisphosphonate (BP) Versus Other or No Kristen Ricchetti-Masterson, Molly L Aldridge, Nicholas, Bégaud Bernard, Pariente Antoine. Osteoporosis Medication (OPM) [971] Nittaya Suppapanya, John Logie, Suzanne F (France) Fei Xue, Yessenia Bartley, Victor Gastanaga, Cook. (United States) Chuck Wentworth. (United States) 197. A Review of Databases Used for 188. Hybrid Prospective Studies: Combining Pharmacoepidemiology in China [964] 205. Antidepressants and the Risk of Hip Existing and New Data Sources To Achieve Yang Zhang, Zhi Qu, Yuji Feng, Kui Huang, Fractures [972] Research Goals [955] Xiaofeng Zhou, Siyan Zhan, Yu Yang. (China) Tania Schink, Kathrin Jobski, Niklas Schmedt, Christina D Mack, Ann Marie McNeil, Louise Bianca Kollhorst, Edeltraut Garbe. (Germany) Parmenter, Kourtney Davis, Nancy A Dreyer. 198. Detecting Early Drug Safety Signals (United States) Utilizing Data from Individual Case Safety 206. Antipsychotics and the Risk of Hip Reports and Electronic Medical Records Fractures [973] 189. The Risk of Cardiovascular Events [965] Tania Schink, Niklas Schmedt, Kathrin Jobski, With Clarithromycin: A Comparison of Kristina Juhlin, Alex Asiimwe, Daniel Soeria- Bianca Kollhorst, Edeltraut Garbe. (Germany) Self-Controlled and Propensity Score Atmadja, Susanna Cederholm, David Ansell, I Methodologies [956] Ralph Edwards, Andrew Bate, Kristina Star, G 207. Risk of Major Cardiovascular Events During Adrian A Root, Angel YS Wong, Yonas Niklas Norén. (Sweden) Second-Line Antidiabetic Treatments: A Ghebremichael-Weldeselassie, Liam Smeeth, Population-Based Cohort Study [974] Krishnan Bhaskaran, Stephen Evans, Ruth 199. Evaluation of Internet Social Networks Salwa S Zghebi, Douglas T Steinke, Martin K Brauer, Ian CK Wong, Vidya Navaratnam, Ian Using Net Scoring Tool: A Case Study in Rutter, Richard A Emsley, Darren M Ashcroft. Douglas. (United Kingdom) Adverse Drug Reaction Mining [966] (United Kingdom) Sandrine Katsahian, Agnès Lillo Le Louet, 190. Comparing Incidence of Serious Adverse Redhouane Abdellaoui, Nathalie Texier, Cédric 208. 30-year Mortality Following Coronary Events Between Laninamivir and Non-User Bousquet, Abdelali Boussadi, Carole Faviez, Artery Bypass Graft Surgery: A Nationwide of Neuraminidase Inhibitor in Influenza ADR Prism Study Goup. (France) Population-Based Cohort Study [975] Patients [957] Kasper Adelborg, Erzsébet Horváth-Puhó, Shimpei Niwa, Masato Fukushima, Kazuhito 200. Cardiovascular Risk of Over-The-Counter Morten Schmidt, Troels Munch, Lars Pedersen, Shiosakai, Yasushi Hasebe. (Japan) Non-Steroidal Anti-Inflammatory Drugs in Henrik Toft Sørensen. (Denmark) the French National Claims Database [967] 191. Standardised Classification Not Suitable for Mai TT Duong, Abdelilah Abouelfath, Regis 209. What Is the Optimal Second-Line Spontaneous Reporting: The Example of Lassalle, Cecile Droz, Nicholas Moore. Antidiabetic Regimen To Delay the Onset of Osteonecrosis of the Jaw [958] (France) Microvascular Complications? Application Paul de Boissieu, Brahim Azzouz, Caroline of a Marginal Structural Model [976] Saint Martin, Thierry Trenque. (France) 201. Multidimensional Indicators for Mortality Alison K Wright, Darren M Ashcroft, Martin K Prediction in Community-Dwelling Older Rutter, Richard Emsley, Douglas T Steinke. 192. Consequences of Drugs Withdrawal: People in a UK Nationwide Healthcare (United Kingdom) The Examples of Pioglitazone and Database: Data from the EU-Funded MPI_ Dextropropoxyphene in France [959] AGE Project [968] 210. Validation of Endocrine Therapy Cecile Pageot, Julien Bezin, Theo Larrousse, Janet Sultana, Andrea Fontana, Francesco Indication To Identify Breast Cancer Francesco Salvo, Mickael Arnaud, Francoise Giorgianni, Alberto Pilotto, Miriam Chemoprevention: A Feasibility Study [977] Haramburu, Antoine Pariente. (France) Sturkenboom, Gianluca Trifiro’. (Italy) Hazel B Nichols, Kala Visvanathan, Valerie S Lee, Janise M Roh, Jean X Lee, Till Stürmer, 193. Long-Term Cancer Surveillance: Five-Year 202. Breast Cancer Risk With Long-Term Use of Lawrence H Kushi. (United States) Update for the Forteo Patient Registry Calcium Channel Blockers or Angiotensin Surveillance Study [960] Converting Enzyme Inhibitors Among 211. Toward Optimizing Data Structure in David Harris, Alicia Gilsenan, Abenah Harding, Postmenopausal Women [969] Cancer Registries [978] Elizabeth Andrews, Nicole Kellier, Daniel Marsha A Raebel, Chan Zeng, Heather Anokhi J Kapasi, Varinder Singh, Sharmila A Masica. (United States) Spencer Feigelson, Susan Shetterly, Nikki M Kamani, Judith K Jones. (United States) Carroll, Kristin Goddard, Denise M Boudreau, 194. Safety Assessment and Selection Bias: David H Smith, T Craig Cheetham, Heather 212. Validity of Inhospital Mortality Records in Who Uses Social Media To Communicate Tavel, Stanley Xu. (United States) the National Health Insurance Research About Medications? [961] Database Among Patients With Acute Rachael L DiSantostefano, Jeffery L Painter, 203. Risk of Acute Myocardial Infarction During Myocardial Infarction and Stroke Cases in Michele Thomas, Greg Powell. (United States) Use of Individual NSAIDs: A Nested Case- Taiwan [979] Control Study in the SOS Project [970] Ching-Lan Cheng, Cheng-Han Lee, Swu-Jane 195. A Rapid Reporting and Active Surveillance Gwen MC Masclee, Huub Straatman, Ron Lin, Yea-Huei Kao Yang. (Taiwan) System for Adverse Drug Events Based Herings, Edeltraut Garbe, Tania Schink, on Electronic Medical Records: Status and Bianca Kollhorst, Andrea Arfe, Silvia Lucchi, 213. Development and Validation of the RxDx- Perspective [962] Marco Villa, Jordi Castellsague, Susana Perez- Dementia Risk Index To Predict Dementia Ying Liu, Yexiang Zhang, Yu Yang, Shengfeng Gutthann, Cristina Varas-Lorenzo, Silvana in Patients With Type 2 Diabetes and Wang, Renfei Fang, Siyan Zhan, Jianxiong Romio, Rene Schade, Martijn J Schuemie, Hypertension [980] Deng. (China) Vera E Valkhoff, Miriam CJM Sturkenboom. Hemalkumar B Mehta, Vinay Mehta, Chu-Lin (Netherlands) Tsai, Hua Chen, Rajender R Aparasu, Michael L Johnson. (United States) 89 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

214. Publication of Clinical Drug Trials: An 223. A Simulation Study To Explore Bias 233. Concordance of Hospitalizations Within the Inception Cohort Study in the Netherlands Generated When Conditioning on an Clinical Practice Research Datalink (CPRD) [981] Intermediate Variable That Is Also a Time- and Hospital Episode Statistics (HES) Cornelis A van den Bogert, Patrick C Varying Confounder [990] Among Type 2 Diabetes Mellitus Patients Souverein, Cecile TM Brekelmans, Susan Yan Cheng, Marlene Egger, Wei Chen, Joanne [1000] WJ Janssen, Manon van Hunnik, Gerard H LaFleur, Brian Sauer. (United States) M Elle Saine, Dena M Carbonari, Craig W Koëter, Hubertus GM Leufkens, Lex M Bouter. Newcomb, Jason A Roy, Kevin Haynes, (Netherlands) 224. Parametric Time-To-Onset (TTO) Modelling Jennifer Wood, Arlene M Gallagher, Serena of Common ADRs in Patients Using Cardillo, Sean Hennessy, Brian L Strom, 215. Presence of Type 2 Diabetes Mellitus Antidiabetic Drugs [991] Vincent Lo Re III. (United States) Diagnoses in Different Types of Healthcare Joep HG Scholl, Peter M van de Ven, Eugène Databases--Empirical Evidence from EHR P van Puijenbroek. (The Netherlands) 234. Differential Use of Screening and Claims [982] Mammography in Older Women Initiating Zhiwen Liu, Yong Chen, Michael Senderak, 225. Dynamic Channeling Among Initiators of a Metformin or Sulfonylureas [1001] Edward A Bortnichak. (United States) Recently Marketed Medication for Type 2 Jin-Liern Hong, Louise M Henderson, Michele Diabetes Mellitus (T2DM) [992] Jonsson Funk, Jennifer L Lund, Virginia Pate, 216. Treatment-Related Adverse Events Elisabetta Patorno, Chandrasekar Til Stürmer. (United States) Recorded in Administrative Claims Gopalakrishnan, Olesya I Zorina, Sebastian Compared To Electronic Medical Records Schneeweiss, Dorothee B Bartels, Jun Liu, 235. Determination of Proxies for Obesity Status [983] John D Seeger. (United States) in the Clinical Practice Research Database Debra E Irwin, Helen Varker. (United States) (CPRD) [1002] 226. An Evaluation of the Multinomial Mona Cai, Vinay Mehta, Kimberly Brodovicz, Methods Propensity Score in a Simulated Drug-Drug Cynthia Girman. (United States) Interaction Study [993] 217. Improving Control for Confounding By Christopher G Rowan, Warren B Bilker, Jason 236. Application of the International Society Frailty When Estimating Influenza Vaccine Roy, Sean Hennessy, James Lewis, Daniel on Thrombosis and Haemostasis (ISTH) Effectiveness in Older Adults [984] Mines, Brian L Strom. (United States) Definition of Major Bleeds To Bleeding Henry T Zhang, Leah J McGrath, Richard Events Within a Post Authorization Safety Wyss, Alan R Ellis, Til Sturmer. (United States) 227. Comparison of Calipers for Matching on the Study [1003] Disease Risk Score [994] Miranda Davies, Vicki Osborne, Deborah 218. Simulation Study of Analysis of an John G Connolly, Joshua J Gagne. Layton, Saad Shakir. (United Kingdom) Open-Label Trial With Time-Dependent (United States) Confounders/Mediators [985] 237. Validity Assessment of Rosuvastatin Heidi Moseson, Khaled Sarsour, Neil 228. Non-Collapsibility and Selection Bias of Prescribing Data from Electronic Health Collinson, Katie Tuckwell, Micki Klearman, Eric Hazard Ratio [995] Records (EHR) in the United States [1004] Vittinghoff. (United States) Menglan Pang, Michal Abrahamowicz, Robert Christopher G Rowan, Nikita Stempniewicz, W Platt. (Canada) James Flory, Tobias Gerhard, James D Lewis, 219. Using Area Over the Curve of Absolute John Cuddeback, Sean Hennessy. Neutrophil Count To Estimate Severity 229. Historical Data for Augmenting High (United States) and Duration of Chemotherapy Induced Dimensional Covariate Selection [996] Neutropenia and Relationship With Hiraku Kumamaru, Joshua J Gagne, 238. Validation of Colorectal Cancer Diagnoses Infection Risk [986] Robert J Glynn, Soko Setoguchi, Sebastian in the Health Improvement Network in the Yanli Li, Zandra Klippel, Xiaolong Shih, Hong Schneeweiss. (United States) United Kingdom [1005] Wang, Maureen Reiner, John H Page. Montse Soriano-Gabarró, Lucía Cea Soriano, (United States) 230. Comparison of Zero-Cell Correction Factors Luis A García Rodríguez. (Germany) for the High-Dimensional Propensity Score 220. Reducing and Quantifying Over-Fitting in Algorithm in Studies With Few Outcomes 239. Withdrawn By Author Regression Models [987] [997] John Rigg, Matthew Hankins. Hiraku Kumamaru, Joshua J Gagne, Robert 240. Medical Record Validation of Algorithms for (United Kingdom) J Glynn, Wesley Eddings, Soko Setoguchi, Acute Myocardial Infarction (AMI) Within a Sebastian Schneeweiss. (United States) United States (US) Administrative Claims 221. A Novel Multi-Modal Approach To Stroke Database [1007] Care Quality Improvement and the 231. The ACCE Method for Estimating Kathleen M Mortimer, Stephen M Ezzy, Jillian Development of High-Performing Stroke Unmeasured Confounding [998] T Jessup, Robert V Gately, John D Seeger. Care Teams [988] Eric G Smith. (United States) (United States) Aaron Kamauu, Mark Loveless. (United States) 232. A Method To Identify Patients Included 241. Validation of Diagnosis and Treatment 222. The Importance of Competing Risks Within Both the Clinical Practice Codes for Patients With Acute in Predictive Modelling of Hip Implant Research Datalink (CPRD) and the Health Lymphoblastic Leukemia (ALL) in Denmark Survival: A Cohort Study Using Improvement Network (THIN) [999] [1008] Computerised Records and Registry Data M Elle Saine, Dena M Carbonari, Craig W Victoria M Chia, Alma B Pedersen, Thomas B [989] Newcomb, Betina Blak, Jason Roy, Kevin Rasmussen, Aaron J Katz, Michael A Kelsh, Albert Roso, Cristian Tebe, Gary Collins, Haynes, Jennifer Wood, Arlene M Gallagher, Sally Wetten, Mette Norgaard. (United States) Andrew Judge, M Kassim Javaid, Montse Rué, Harshvinder Bhullar, Serena Cardillo, Sean Mireia Espallargues, Daniel Prieto-Alhambra, Hennessy, Brian L Strom, Vincent Lo Re III. PRESS-UP Study Investigators. (Spain) (United States) 90 2015 ICPE POSTER SESSION C Wednesday, August 26, 2015 | 8:00am – 6:00pm

242. Revisions To Published Algorithms 251. The Impact of Time-Window Bias on 261. Use of Natural Language Processing (NLP) for Stroke Within a United States (US) the Assessment of Long-Term Effect To Identify Patients With Binge Eating Administrative Claims Database [1009] of Medication Adherence: The Case of Disorder (BED) in Optum’s Humedica Kathleen M Mortimer, Stephen M Ezzy, Jillian Secondary Prevention After Myocardial Research Database [1028] T Jessup, Robert V Gately, John D Seeger. Infarction [1018] Kathleen M Mortimer, Baevin S Carbery, (United States) Mirko Di Martino, Ursula Kirchmayer, Nera Robert V Gately, Dave D Dore. (United States) Agabiti, Lisa Bauleo, Danilo Fusco, Carlo 243. Sensitivity of Diagnosis and Treatment Alberto Perucci, Marina Davoli. (Italy) 262. Withdrawn By Author Codes in the Identification of Adults With Acute Lymphoblastic Leukemia in SEER- 252. Does the Length of the “Pre-Exposure” 263. Utility of Linked Data in Controlling for Medicare [1010] Window Affect the Relative Risk Estimate? Confounding By Indication: A Case of Aaron J Katz, Victoria M Chia, Mark D Danese, A Self-Controlled Case Series Study [1019] Cardiovascular CER Using Propensity Jennifer Duryea, Michael A Kelsh, Deborah P Gema Requena, Francisco J De Abajo, Score Adjustment [1030] Lubeck. (United States) Consuelo Huerta, Stephen J Evans, Ian J Soko Setoguchi, Hiraku Kumamaru, Lauren Douglas. (United Kingdom) Williams, Jalbert J Jessica. (United States) 244. Small Differences Among Approaches in the Estimated Prevalence of a Very Rare 253. The Critical Impact of Complex Cases 264. Completeness of Key Variables in the Clinical Disease [1011] Behavior on the Performance of Self- Practice Research Datalink (CPRD) [1031] Dana Y Teltsch, Richard Scott Swain, Don Controlled Case Series Method [1020] Emily Herrett, Arlene Gallagher, Krishnan Robinson Jr., Matthew W Reynolds. Ling Zhang, Jasmanda Wu, Juhaeri Juhaeri. Bhaskaran, Harriet Forbes, Rohini Mathur, (United States) (United States) Tjeerd van Staa, Liam Smeeth. (United Kingdom) 245. Implications for Signal Detection of 254. Diffusion of Methodological Innovation in Duplicated Case Reports of Stress Pharmacoepidemiology: Self-Controlled 265. Utilizing Electronic Medical Record Cardiomyopathy [1012] Study Designs [1021] Networks and Advanced Analytics for Manfred Hauben, Maribel Salas, Peter Huber, Giulia P Consiglio, Malcolm Maclure, Lisa Identifying Patients for Clinical Trial Eric Hung. (United States) McCarthy, Suzanne M Cadarette. (Canada) Recruitment [1032] Spencer Justin, Andrew Wilson, Nicole Bailey, 246. Differential Racial and Regional Effects of 255. Does One-Size Fit All in Accounting for Matthew Longson, Aaron Kamauu. Baseline Timeframe on Potential Bias in Risk Immortal Time? [1022] (United States) Factor Assessment Using EHR Data [1013] Evelyn M Flahvan, Hu Li, Claudia A Salinas, Anne Yuk-Lam Ho, Jason L Vassy, David Stephen P Motsko. (United States) R Gagnon, J Michael Gaziano, Jacqueline z END SESSION C Honerlaw, Sanjay Raju, Peter WF Wilson, 256. Impact of Eligibility Length on Prevalence Kelly Cho. (United States) Estimates Using Automated Healthcare Claims Data [1023] 247. Developing a Stroke Severity Index Based Yanmin Zhu, Wei Liu, Yan Li, Almut G on Administrative Data Was Feasible Using Winterstein. (United States) Data Mining Techniques [1014] Cheng-Yang Hsieh, Sheng-Feng Sung, Yea- 257. Systematic Review of Adaptive Design Huei Kao Yang, Huey-Juan Lin, Chih-Hung Clinical Trials [1024] Chen, Yu-Wei Chen, Ya-Han Hu. (Taiwan) Laura Bothwell, Nazleen Khan, Aaron Kesselheim. (United States) 248. Strategies To Handle Missing Information in Predictive Modelling Using Routinely 258. Comparison of Case-Only Designs With Collected Data: Differences in Identified Traditional Study Designs: A Systematic Predictors and Model Performance [1015] Review [1025] Albert Roso, Irene Petersen, Gary Koen B Pouwels, Bianca Mulder, Eelko Hak. Collins, Montse Rué, Cristian Tebé, Mireia (Netherlands) Espallargues, Daniel Prieto-Alhambra, PRESS-UP Research Group. (Spain) 259. Extent of Publication Bias in Observational Studies Investigating Adverse Drug Events 249. Medical Record Validation of Algorithms for [1026] Ten Types of Cancer Within a United States Dixa B Thakrar, Iain D Tatt, Mikkel Z (US) Administrative Claims Database [1016] Oestergaard. (United Kingdom) Kathleen M Mortimer, Stephen M Ezzy, Jillian T Jessup, Robert V Gately, John D Seeger. 260. Application of Indirect Treatment (United States) Comparison Method for Pooling Data from Clinical Trials for Benefit-Risk Assessment 250. Assessment of Residual Confounding and [1027] Selection Bias in Studies of Anti-Diabetes Sampada K Gandhi, Lili Wang, Juhaeri Medications [1017] Juhaeri. (United States) Ayad K Ali, Stephen P Motsko, Jonathan L Swain. (United States)

91 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format MONDAY, AUGUST 24, 2015 Cont. 46 2:15 pm 312 Oral 47 2:30 pm 312 Oral Multiple Approaches To Improve Confounding Control 48 2:45 pm 312 Oral 1 10:30 am 302 Oral Those That Can Heal Can Harm; Those that Can Cure Can Kill 2 10:45 am 302 Oral 3 11:00 am 302 Oral 49 1:30 pm 311 Oral 4 11:15 am 302 Oral 50 1:45 pm 311 Oral 5 11:30 am 302 Oral 51 2:00 pm 311 Oral 6 11:45 am 302 Oral 52 2:15 pm 311 Oral 53 2:30 pm 311 Oral Cardiovascular Treatment and Safety Outcomes 54 2:45 pm 311 Oral 7 10:30 am 312 Oral Drug Use and Safety in Older People 8 10:45 am 312 Oral 9 11:00 am 312 Oral 55 1:30 pm 210 Oral 10 11:15 am 312 Oral 56 1:45 pm 210 Oral 11 11:30 am 312 Oral 57 2:00 pm 210 Oral 12 11:45 am 312 Oral 58 2:15 pm 210 Oral 59 2:30 pm 210 Oral Diabetes: Treatment and Outcomes I 60 2:45 pm 210 Oral 13 10:30 am 311 Oral Balancing Act: Benefits, Risks, and Costs 14 10:45 am 311 Oral 15 11:00 am 311 Oral 61 1:30 pm 208 Oral 16 11:15 am 311 Oral 62 1:45 pm 208 Oral 17 11:30 am 311 Oral 63 2:00 pm 208 Oral 18 11:45 am 311 Oral 64 2:15 pm 208 Oral 65 2:30 pm 208 Oral Pregnancy and Pediatrics Potpourri 66 2:45 pm 208 Oral 19 10:30 am 210 Oral Hormone Therapy: An Equal Opportunity Risk 20 10:45 am 210 Oral 21 11:00 am 210 Oral 67 1:30 pm 309 Oral 22 11:15 am 210 Oral 68 1:45 pm 309 Oral 23 11:30 am 210 Oral 69 2:00 pm 309 Oral 24 11:45 am 210 Oral 70 2:15 pm 309 Oral 71 2:30 pm Withdrawn By Author Measured Policy: Informing or Informed? 72 2:45 pm 309 Oral 25 10:30 am 208 Oral From Fantasy To Reality: Embedding Pragmatic Trials into 26 10:45 am 208 Oral Routine Clinical Care 27 11:00 am 208 Oral 28 11:15 am 208 Oral 73 5:00 pm – 6:30 pm Ballroom A/B Symposia 29 11:30 am 208 Oral An International Working Collaborative To Examine Global Drug 30 11:45 am 208 Oral Utilization: Opioid Use and Misuse A Boney Topic: Bisphosphonate Use and Outcomes 74 5:00 pm – 6:30 pm 302 Symposia 31 10:30 am 309 Oral 32 10:45 am 309 Oral Technical and Governance Challenges in Pharmacoepidemiology 33 11:00 am 309 Oral Data Integration 34 11:15 am 309 Oral 75 5:00 pm – 6:30 pm 312 Symposia 35 11:30 am 309 Oral 36 11:45 am 309 Oral Methods To Include Clinical Data Elements When Analyzing Observational Health Care Data Where Missing Data Are Expected Methods for Making Fair Comparisions 76 5:00 pm – 6:30 pm 311 Symposia 37 1:30 pm 302 Oral 38 1:45 pm 302 Oral Does the Increasing Specialization of Epidemiologic Societies 39 2:00 pm 302 Oral Ensure the Best Future for Our Profession? 40 2:15 pm 302 Oral 41 2:30 pm 302 Oral 77 5:00 pm – 6:30 pm 210 Symposia 42 2:45 pm 302 Oral Data Driven Regulatory Science Opioid Use and Abuse 78 5:00 pm – 6:30 pm 208 Symposia 43 1:30 pm 312 Oral Human-Algorithm Interaction To Define Variables from Free-Text 44 1:45 pm 312 Oral Notes in Electronic Health Records—Introduction and Examples 45 2:00 pm 312 Oral 92 79 5:00 pm – 6:30 pm 309 Symposia 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format MONDAY, AUGUST 24, 2015 Cont. 123 52 8:00 am – 6:00 pm Poster 124 53 8:00 am – 6:00 pm Poster Poster Session A: Spotlight Session-Biologics 125 54 8:00 am – 6:00 pm Poster 80 1 8:00 am – 6:00 pm Poster 126 55 8:00 am – 6:00 pm Poster 81 2 8:00 am – 6:00 pm Poster 127 56 8:00 am – 6:00 pm Poster 82 3 8:00 am – 6:00 pm Poster 128 57 8:00 am – 6:00 pm Poster 83 4 8:00 am – 6:00 pm Poster 129 58 8:00 am – 6:00 pm Poster 84 5 8:00 am – 6:00 pm Poster 130 59 8:00 am – 6:00 pm Poster 85 6 8:00 am – 6:00 pm Poster 131 60 8:00 am – 6:00 pm Poster 86 7 8:00 am – 6:00 pm Poster 132 61 8:00 am – 6:00 pm Poster 133 62 8:00 am – 6:00 pm Poster Poster Session A: Biologics 134 63 8:00 am – 6:00 pm Poster 135 64 8:00 am – 6:00 pm Poster 87 8 8:00 am – 6:00 pm Poster 136 65 8:00 am – 6:00 pm Poster 88 9 8:00 am – 6:00 pm Poster 137 66 8:00 am – 6:00 pm Poster 89 10 8:00 am – 6:00 pm Poster 138 67 8:00 am – 6:00 pm Poster 90 11 8:00 am – 6:00 pm Poster 139 68 8:00 am – 6:00 pm Poster 91 12 8:00 am – 6:00 pm Poster 140 69 8:00 am – 6:00 pm Poster Poster Session A: Spotlight Session-Drug Utilization Research/ 141 70 8:00 am – 6:00 pm Poster Health Services Research 142 71 8:00 am – 6:00 pm Poster 143 72 8:00 am – 6:00 pm Poster 195 13 8:00 am – 6:00 pm Poster 144 73 8:00 am – 6:00 pm Poster 196 14 8:00 am – 6:00 pm Poster 145 74 8:00 am – 6:00 pm Poster 197 15 8:00 am – 6:00 pm Poster 146 75 8:00 am – 6:00 pm Poster 198 16 8:00 am – 6:00 pm Poster 147 76 8:00 am – 6:00 pm Poster 199 17 8:00 am – 6:00 pm Poster 148 77 8:00 am – 6:00 pm Poster 200 18 8:00 am – 6:00 pm Poster 149 78 8:00 am – 6:00 pm Poster 201 19 8:00 am – 6:00 pm Poster 150 79 8:00 am – 6:00 pm Withdrawn by Author 202 20 8:00 am – 6:00 pm Poster 151 80 8:00 am – 6:00 pm Poster Poster Session A: Drug Utilization Research/Health Services 152 81 8:00 am – 6:00 pm Poster Research 153 82 8:00 am – 6:00 pm Poster 154 83 8:00 am – 6:00 pm Poster 92 21 8:00 am – 6:00 pm Poster 155 84 8:00 am – 6:00 pm Poster 93 22 8:00 am – 6:00 pm Poster 156 85 8:00 am – 6:00 pm Poster 94 23 8:00 am – 6:00 pm Poster 157 86 8:00 am – 6:00 pm Poster 95 24 8:00 am – 6:00 pm Poster 158 87 8:00 am – 6:00 pm Poster 96 25 8:00 am – 6:00 pm Withdrawn By Author 159 88 8:00 am – 6:00 pm Poster 97 26 8:00 am – 6:00 pm Poster 160 89 8:00 am – 6:00 pm Poster 98 27 8:00 am – 6:00 pm Poster 161 90 8:00 am – 6:00 pm Poster 99 28 8:00 am – 6:00 pm Poster 162 91 8:00 am – 6:00 pm Poster 100 29 8:00 am – 6:00 pm Poster 163 92 8:00 am – 6:00 pm Poster 101 30 8:00 am – 6:00 pm Poster 164 93 8:00 am – 6:00 pm Poster 102 31 8:00 am – 6:00 pm Poster 165 94 8:00 am – 6:00 pm Poster 103 32 8:00 am – 6:00 pm Poster 166 95 8:00 am – 6:00 pm Poster 104 33 8:00 am – 6:00 pm Poster 167 96 8:00 am – 6:00 pm Poster 105 34 8:00 am – 6:00 pm Poster 168 97 8:00 am – 6:00 pm Poster 106 35 8:00 am – 6:00 pm Poster 169 98 8:00 am – 6:00 pm Poster 107 36 8:00 am – 6:00 pm Poster 170 99 8:00 am – 6:00 pm Withdrawn by Author 108 37 8:00 am – 6:00 pm Poster 171 100 8:00 am – 6:00 pm Poster 109 38 8:00 am – 6:00 pm Poster 172 101 8:00 am – 6:00 pm Withdrawn by Author 110 39 8:00 am – 6:00 pm Poster 173 102 8:00 am – 6:00 pm Withdrawn by Author 111 40 8:00 am – 6:00 pm Poster 174 103 8:00 am – 6:00 pm Withdrawn by Author 112 41 8:00 am – 6:00 pm Poster 175 104 8:00 am – 6:00 pm Poster 113 42 8:00 am – 6:00 pm Poster 176 105 8:00 am – 6:00 pm Poster 114 43 8:00 am – 6:00 pm Poster 177 106 8:00 am – 6:00 pm Poster 115 44 8:00 am – 6:00 pm Poster 178 107 8:00 am – 6:00 pm Poster 116 45 8:00 am – 6:00 pm Poster 179 108 8:00 am – 6:00 pm Poster 117 46 8:00 am – 6:00 pm Poster 180 109 8:00 am – 6:00 pm Poster 118 47 8:00 am – 6:00 pm Poster 181 110 8:00 am – 6:00 pm Poster 119 48 8:00 am – 6:00 pm Poster 182 111 8:00 am – 6:00 pm Poster 120 49 8:00 am – 6:00 pm Poster 183 112 8:00 am – 6:00 pm Poster 121 50 8:00 am – 6:00 pm Poster 184 113 8:00 am – 6:00 pm Poster 122 51 8:00 am – 6:00 pm Poster 185 114 8:00 am – 6:00 pm Poster 93 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format MONDAY, AUGUST 24 Cont. 252 173 8:00 am – 6:00 pm Poster 253 174 8:00 am – 6:00 pm Poster 186 115 8:00 am – 6:00 pm Poster 254 175 8:00 am – 6:00 pm Poster 187 116 8:00 am – 6:00 pm Poster 255 176 8:00 am – 6:00 pm Poster 188 117 8:00 am – 6:00 pm Poster 256 177 8:00 am – 6:00 pm Poster 189 118 8:00 am – 6:00 pm Poster 257 178 8:00 am – 6:00 pm Poster 190 119 8:00 am – 6:00 pm Poster 258 179 8:00 am – 6:00 pm Poster 191 120 8:00 am – 6:00 pm Poster 259 180 8:00 am – 6:00 pm Poster 192 121 8:00 am – 6:00 pm Poster 260 181 8:00 am – 6:00 pm Poster 193 122 8:00 am – 6:00 pm Poster 261 182 8:00 am – 6:00 pm Poster 194 123 8:00 am – 6:00 pm Poster 262 183 8:00 am – 6:00 pm Poster Poster Session A: Drug Utilization Research/Health Services 263 184 8:00 am – 6:00 pm Poster Research 264 185 8:00 am – 6:00 pm Poster 265 186 8:00 am – 6:00 pm Poster 203 124 8:00 am – 6:00 pm Poster 266 187 8:00 am – 6:00 pm Poster 204 125 8:00 am – 6:00 pm Poster 267 188 8:00 am – 6:00 pm Poster 205 126 8:00 am – 6:00 pm Poster 268 189 8:00 am – 6:00 pm Poster 206 127 8:00 am – 6:00 pm Poster 269 190 8:00 am – 6:00 pm Poster 207 128 8:00 am – 6:00 pm Poster 270 191 8:00 am – 6:00 pm Poster 208 129 8:00 am – 6:00 pm Poster 271 192 8:00 am – 6:00 pm Poster 209 130 8:00 am – 6:00 pm Poster 272 193 8:00 am – 6:00 pm Poster 210 131 8:00 am – 6:00 pm Poster 273 194 8:00 am – 6:00 pm Poster 211 132 8:00 am – 6:00 pm Poster 274 195 8:00 am – 6:00 pm Poster 212 133 8:00 am – 6:00 pm Poster 275 196 8:00 am – 6:00 pm Poster 213 134 8:00 am – 6:00 pm Poster 276 197 8:00 am – 6:00 pm Poster 214 135 8:00 am – 6:00 pm Poster 277 198 8:00 am – 6:00 pm Poster 215 136 8:00 am – 6:00 pm Poster 278 199 8:00 am – 6:00 pm Poster 216 137 8:00 am – 6:00 pm Poster 279 200 8:00 am – 6:00 pm Poster 217 138 8:00 am – 6:00 pm Poster 280 201 8:00 am – 6:00 pm Poster 218 139 8:00 am – 6:00 pm Poster 281 202 8:00 am – 6:00 pm Poster 219 140 8:00 am – 6:00 pm Poster 282 203 8:00 am – 6:00 pm Poster 220 141 8:00 am – 6:00 pm Poster 283 204 8:00 am – 6:00 pm Poster 221 142 8:00 am – 6:00 pm Poster 284 205 8:00 am – 6:00 pm Poster 222 143 8:00 am – 6:00 pm Poster 285 206 8:00 am – 6:00 pm Poster 223 144 8:00 am – 6:00 pm Poster 286 207 8:00 am – 6:00 pm Poster 224 145 8:00 am – 6:00 pm Poster 287 208 8:00 am – 6:00 pm Poster 225 146 8:00 am – 6:00 pm Poster 288 209 8:00 am – 6:00 pm Poster 226 147 8:00 am – 6:00 pm Poster 289 210 8:00 am – 6:00 pm Poster 227 148 8:00 am – 6:00 pm Poster 290 211 8:00 am – 6:00 pm Poster 228 149 8:00 am – 6:00 pm Poster 291 212 8:00 am – 6:00 pm Poster 229 150 8:00 am – 6:00 pm Poster 292 213 8:00 am – 6:00 pm Poster 230 151 8:00 am – 6:00 pm Poster 293 214 8:00 am – 6:00 pm Poster 231 152 8:00 am – 6:00 pm Poster 294 215 8:00 am – 6:00 pm Poster 232 153 8:00 am – 6:00 pm Poster 295 216 8:00 am – 6:00 pm Poster 233 154 8:00 am – 6:00 pm Poster 296 217 8:00 am – 6:00 pm Poster 234 155 8:00 am – 6:00 pm Poster 297 218 8:00 am – 6:00 pm Poster 235 156 8:00 am – 6:00 pm Poster 298 219 8:00 am – 6:00 pm Poster 236 157 8:00 am – 6:00 pm Poster 299 220 8:00 am – 6:00 pm Poster 237 158 8:00 am – 6:00 pm Poster 300 221 8:00 am – 6:00 pm Poster 238 159 8:00 am – 6:00 pm Withdrawn by Author 301 222 8:00 am – 6:00 pm Poster 239 160 8:00 am – 6:00 pm Withdrawn by Author 302 223 8:00 am – 6:00 pm Poster 240 161 8:00 am – 6:00 pm Poster 303 224 8:00 am – 6:00 pm Poster 241 162 8:00 am – 6:00 pm Poster 304 225 8:00 am – 6:00 pm Poster 242 163 8:00 am – 6:00 pm Withdrawn by Author 305 226 8:00 am – 6:00 pm Poster 243 164 8:00 am – 6:00 pm Poster 306 227 8:00 am – 6:00 pm Poster 244 165 8:00 am – 6:00 pm Poster 307 228 8:00 am – 6:00 pm Poster 245 166 8:00 am – 6:00 pm Poster 246 167 8:00 am – 6:00 pm Poster Poster Session A: Spotlight Session-Vaccines 247 168 8:00 am – 6:00 pm Poster 308 229 8:00 am – 6:00 pm Poster 248 169 8:00 am – 6:00 pm Poster 309 230 8:00 am – 6:00 pm Poster 249 170 8:00 am – 6:00 pm Withdrawn by Author 310 231 8:00 am – 6:00 pm Poster 250 171 8:00 am – 6:00 pm Poster 311 232 8:00 am – 6:00 pm Poster 251 172 8:00 am – 6:00 pm Poster 312 233 8:00 am – 6:00 pm Poster 94 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format MONDAY, AUGUST 24 Cont. DUR: Beyond Drug Utilization Data 313 234 8:00 am – 6:00 pm Poster 360 8:00 am 311 Oral 314 235 8:00 am – 6:00 pm Poster 361 8:15 am 311 Oral 315 236 8:00 am – 6:00 pm Poster 362 8:30 am 311 Oral 363 8:45 am 311 Oral Poster Session A: Vaccines 364 9:00 am 311 Oral 316 237 8:00 am – 6:00 pm Poster 365 9:15 am 311 Oral 317 238 8:00 am – 6:00 pm Poster Psychotropic Medications in Pregnancy 318 239 8:00 am – 6:00 pm Poster 319 240 8:00 am – 6:00 pm Poster 366 8:00 am 210 Oral 320 241 8:00 am – 6:00 pm Poster 367 8:15 am 210 Oral 321 242 8:00 am – 6:00 pm Poster 368 8:30 am 210 Oral 322 243 8:00 am – 6:00 pm Poster 369 8:45 am 210 Oral 323 244 8:00 am – 6:00 pm Poster 370 9:00 am 210 Oral 324 245 8:00 am – 6:00 pm Poster 371 9:15 am 210 Oral 325 246 8:00 am – 6:00 pm Poster 326 247 8:00 am – 6:00 pm Poster Adherence: Past, Present and Future 327 248 8:00 am – 6:00 pm Poster 372 8:00 am 208 Oral 328 249 8:00 am – 6:00 pm Poster 373 8:15 am 208 Oral 329 250 8:00 am – 6:00 pm Poster 374 8:30 am 208 Oral 330 251 8:00 am – 6:00 pm Poster 375 8:45 am 208 Oral 331 252 8:00 am – 6:00 pm Poster 376 9:00 am 208 Oral 332 253 8:00 am – 6:00 pm Poster 377 9:15 am 208 Oral 333 254 8:00 am – 6:00 pm Poster 334 255 8:00 am – 6:00 pm Poster Rheumatoid Arthritis: Treatment and Outcomes 335 256 8:00 am – 6:00 pm Poster 378 8:00 am 309 Oral 336 257 8:00 am – 6:00 pm Poster 379 8:15 am 309 Oral 337 258 8:00 am – 6:00 pm Poster 380 8:30 am 309 Oral 338 259 8:00 am – 6:00 pm Poster 381 8:45 am 309 Oral 339 260 8:00 am – 6:00 pm Poster 382 9:00 am 309 Oral 340 261 8:00 am – 6:00 pm Poster 383 9:15 am 309 Oral 341 262 8:00 am – 6:00 pm Poster The Reality of Propensity Scores at the Limit Poster Session A: Spotlight Session-Molecular Epidemiology/ 384 1:00 pm 302 Oral Biomarkers/Pharmacogenetics 385 1:15 pm 302 Oral 342 263 8:00 am – 6:00 pm Poster 386 1:30 pm 302 Oral 343 264 8:00 am – 6:00 pm Poster 387 1:45 pm 302 Oral 344 265 8:00 am – 6:00 pm Poster 388 2:00 pm 302 Oral 345 266 8:00 am – 6:00 pm Poster 389 2:15 pm 302 Oral 346 267 8:00 am – 6:00 pm Poster Turning into the Future of Pharmacovigilance 347 268 8:00 am – 6:00 pm Poster 390 1:00 pm 312 Oral 391 1:15 pm 312 Oral TUESDAY, AUGUST 25 392 1:30 pm 312 Oral 393 1:45 pm 312 Oral The Built Environment: Multiple Data Systems and 394 2:00 pm 312 Oral Reproducibility of Research 395 2:15 pm 312 Oral 348 8:00 am 302 Oral Living with Cancer: Drugs and Outcomes 349 8:15 am 302 Oral 350 8:30 am 302 Oral 396 1:00 pm 311 Oral 351 8:45 am 302 Oral 397 1:15 pm 311 Oral 352 9:00 am 302 Oral 398 1:30 pm 311 Oral 353 9:15 am 302 Oral 399 1:45 pm 311 Oral 400 2:00 pm 311 Oral Nature or Nurture: Adherance or Genetic Determinance of 401 2:15 pm 311 Oral Cardiovascular Events Diabetes: Treatment and Outcomes II 354 8:00 am 312 Oral 355 8:15 am 312 Oral 402 1:00 pm 210 Oral 356 8:30 am 312 Oral 403 1:15 pm 210 Oral 357 8:45 am 312 Oral 404 1:30 pm 210 Oral 358 9:00 am 312 Oral 405 1:45 pm 210 Oral 406 2:00 pm 210 Oral 359 9:15 am 312 Oral 95 407 2:15 pm 210 Oral 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format

TUESDAY, AUGUST 25 Cont. 438 11 8:00 am – 6:00 pm Poster Older People and Their CNS Drugs 439 12 8:00 am – 6:00 pm Poster 440 13 8:00 am – 6:00 pm Poster 408 1:00 pm 208 Oral 441 14 8:00 am – 6:00 pm Poster 409 1:15 pm 208 Oral 442 15 8:00 am – 6:00 pm Poster 410 1:30 pm 208 Oral 443 16 8:00 am – 6:00 pm Poster 411 1:45 pm 208 Oral 444 17 8:00 am – 6:00 pm Poster 412 2:00 pm 208 Oral 445 18 8:00 am – 6:00 pm Poster 413 2:15 pm 208 Oral 446 19 8:00 am – 6:00 pm Poster 447 20 8:00 am – 6:00 pm Poster Neurodevelopmental Issues: Drugs and Outcomes 448 21 8:00 am – 6:00 pm Poster 414 1:00 pm 309 Oral 449 22 8:00 am – 6:00 pm Poster 415 1:15 pm 309 Oral 450 23 8:00 am – 6:00 pm Poster 416 1:30 pm 309 Oral 451 24 8:00 am – 6:00 pm Poster 417 1:45 pm 309 Oral 452 25 8:00 am – 6:00 pm Poster 418 2:00 pm 309 Oral 453 26 8:00 am – 6:00 pm Poster 419 2:15 pm 309 Oral 454 27 8:00 am – 6:00 pm Poster 455 28 8:00 am – 6:00 pm Poster Plenary Session: Edlavitch Award 456 29 8:00 am – 6:00 pm Poster 420 2:30 pm Ballroom A/B Oral 457 30 8:00 am – 6:00 pm Poster 458 31 8:00 am – 6:00 pm Poster Rapid-Cycle Analytics in Pharmacoepidemiology 459 32 8:00 am – 6:00 pm Poster 421 4:15 - 5:45 pm Ballroom A/B Symposia 460 33 8:00 am – 6:00 pm Poster 461 34 8:00 am – 6:00 pm Poster Pragmatic Randomized Trials in Practice: How Can We Overcome 462 35 8:00 am – 6:00 pm Poster the Hurdles? A CER SIG-Sponsored Symposium 463 36 8:00 am – 6:00 pm Poster 464 37 8:00 am – 6:00 pm Poster 422 4:15 - 5:45 pm 302 Symposia 465 38 8:00 am – 6:00 pm Poster Building a Sustainable Surveillance System To Monitor the Use 466 39 8:00 am – 6:00 pm Poster and Safety of Medical Products in Pregnancy 467 40 8:00 am – 6:00 pm Poster 468 41 8:00 am – 6:00 pm Poster 423 4:15 - 5:45 pm 312 Symposia 469 42 8:00 am – 6:00 pm Poster Historical Comparator Studies: Strengths, Limitations, and 470 43 8:00 am – 6:00 pm Poster Analytical Considerations in Using Historical Pooled Clinical Data 471 44 8:00 am – 6:00 pm Poster 472 45 8:00 am – 6:00 pm Poster for Evaluating Efficacy and Safety of New Therapies 473 46 8:00 am – 6:00 pm Poster 424 4:15 - 5:45 pm 311 Symposia 474 47 8:00 am – 6:00 pm Poster 475 48 8:00 am – 6:00 pm Poster PROTECT: The Challenges and Successes 476 49 8:00 am – 6:00 pm Poster 425 4:15 - 5:45 pm 210 Symposia 477 50 8:00 am – 6:00 pm Poster 478 51 8:00 am – 6:00 pm Poster Challenges of Introducing New Vaccines in Resource-Limited Settings 479 52 8:00 am – 6:00 pm Poster 426 4:15 - 5:45 pm 208 Symposia 480 53 8:00 am – 6:00 pm Poster 481 54 8:00 am – 6:00 pm Poster Evaluating Risk Evaluation and Mitigation Strategies (REMS): Lessons Learned and Future Opportunities With a Focus on Opioid Poster Session B: Spotlight Session-Pediatrics Analgesics 482 55 8:00 am – 6:00 pm Poster 483 56 8:00 am – 6:00 pm Poster 427 4:15 - 5:45 pm 309 Symposia 484 57 8:00 am – 6:00 pm Poster Poster Session B: Spotlight Session-Medicines in Pregnancy 485 58 8:00 am – 6:00 pm Poster 486 59 8:00 am – 6:00 pm Poster 428 1 8:00 am – 6:00 pm Poster 487 60 8:00 am – 6:00 pm Poster 429 2 8:00 am – 6:00 pm Poster 488 61 8:00 am – 6:00 pm Poster 430 3 8:00 am – 6:00 pm Poster 489 62 8:00 am – 6:00 pm Poster 431 4 8:00 am – 6:00 pm Poster 432 5 8:00 am – 6:00 pm Poster Poster Session B: Pediatrics 433 6 8:00 am – 6:00 pm Poster 490 63 8:00 am – 6:00 pm Poster 434 7 8:00 am – 6:00 pm Poster 491 64 8:00 am – 6:00 pm Poster 435 8 8:00 am – 6:00 pm Poster 492 65 8:00 am – 6:00 pm Poster Poster Session B: Medicines in Pregnancy 493 66 8:00 am – 6:00 pm Poster 494 67 8:00 am – 6:00 pm Poster 436 9 8:00 am – 6:00 pm Poster 495 68 8:00 am – 6:00 pm Poster 437 10 8:00 am – 6:00 pm Poster 96 496 69 8:00 am – 6:00 pm Poster 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format TUESDAY, AUGUST 25 Cont. 553 126 8:00 am – 6:00 pm Poster 554 127 8:00 am – 6:00 pm Poster 497 70 8:00 am – 6:00 pm Poster 555 128 8:00 am – 6:00 pm Poster 498 71 8:00 am – 6:00 pm Poster 556 129 8:00 am – 6:00 pm Poster 499 72 8:00 am – 6:00 pm Poster 557 130 8:00 am – 6:00 pm Poster 500 73 8:00 am – 6:00 pm Poster 558 131 8:00 am – 6:00 pm Poster 501 74 8:00 am – 6:00 pm Poster 559 132 8:00 am – 6:00 pm Poster 502 75 8:00 am – 6:00 pm Poster 560 133 8:00 am – 6:00 pm Poster 503 76 8:00 am – 6:00 pm Poster 561 134 8:00 am – 6:00 pm Poster 504 77 8:00 am – 6:00 pm Poster 562 135 8:00 am – 6:00 pm Poster 505 78 8:00 am – 6:00 pm Poster 563 136 8:00 am – 6:00 pm Poster 506 79 8:00 am – 6:00 pm Poster 564 137 8:00 am – 6:00 pm Poster 507 80 8:00 am – 6:00 pm Poster 565 138 8:00 am – 6:00 pm Poster 508 81 8:00 am – 6:00 pm Poster 566 139 8:00 am – 6:00 pm Poster 509 82 8:00 am – 6:00 pm Poster 567 140 8:00 am – 6:00 pm Poster Poster Session B: Spotlight Session-Medical Devices 568 141 8:00 am – 6:00 pm Poster 569 142 8:00 am – 6:00 pm Poster 510 83 8:00 am – 6:00 pm Poster 570 143 8:00 am – 6:00 pm Poster 511 84 8:00 am – 6:00 pm Poster 571 144 8:00 am – 6:00 pm Poster 512 85 8:00 am – 6:00 pm Poster 572 145 8:00 am – 6:00 pm Poster 513 86 8:00 am – 6:00 pm Poster 573 146 8:00 am – 6:00 pm Poster 514 87 8:00 am – 6:00 pm Poster 574 147 8:00 am – 6:00 pm Poster 515 88 8:00 am – 6:00 pm Poster 575 148 8:00 am – 6:00 pm Poster 516 89 8:00 am – 6:00 pm Poster 576 149 8:00 am – 6:00 pm Poster 517 90 8:00 am – 6:00 pm Poster 577 150 8:00 am – 6:00 pm Poster Poster Session B: Medical Devices 578 151 8:00 am – 6:00 pm Poster 579 152 8:00 am – 6:00 pm Poster 518 91 8:00 am – 6:00 pm Poster 580 153 8:00 am – 6:00 pm Poster 519 92 8:00 am – 6:00 pm Poster 581 154 8:00 am – 6:00 pm Poster 520 93 8:00 am – 6:00 pm Poster 582 155 8:00 am – 6:00 pm Poster 521 94 8:00 am – 6:00 pm Poster 583 156 8:00 am – 6:00 pm Poster 522 95 8:00 am – 6:00 pm Poster 584 157 8:00 am – 6:00 pm Poster 523 96 8:00 am – 6:00 pm Poster 585 158 8:00 am – 6:00 pm Poster 524 97 8:00 am – 6:00 pm Poster 586 159 8:00 am – 6:00 pm Poster 525 98 8:00 am – 6:00 pm Poster 587 160 8:00 am – 6:00 pm Poster 526 99 8:00 am – 6:00 pm Poster 588 161 8:00 am – 6:00 pm Poster 527 100 8:00 am – 6:00 pm Poster 589 162 8:00 am – 6:00 pm Poster 528 101 8:00 am – 6:00 pm Poster 590 163 8:00 am – 6:00 pm Poster Poster Session B: Safety End Point Studies 591 164 8:00 am – 6:00 pm Poster 592 165 8:00 am – 6:00 pm Poster 529 102 8:00 am – 6:00 pm Poster 593 166 8:00 am – 6:00 pm Poster 530 103 8:00 am – 6:00 pm Poster 594 167 8:00 am – 6:00 pm Poster 531 104 8:00 am – 6:00 pm Poster 595 168 8:00 am – 6:00 pm Poster 532 105 8:00 am – 6:00 pm Poster 533 106 8:00 am – 6:00 pm Poster Poster Session B: Spotlight Session-Comparative Effectiveness 534 107 8:00 am – 6:00 pm Poster Research (CER) 535 108 8:00 am – 6:00 pm Poster 596 169 8:00 am – 6:00 pm Poster 536 109 8:00 am – 6:00 pm Poster 597 170 8:00 am – 6:00 pm Poster 537 110 8:00 am – 6:00 pm Poster 598 171 8:00 am – 6:00 pm Poster 538 111 8:00 am – 6:00 pm Poster 599 172 8:00 am – 6:00 pm Poster 539 112 8:00 am – 6:00 pm Poster 600 173 8:00 am – 6:00 pm Poster 540 113 8:00 am – 6:00 pm Poster 601 174 8:00 am – 6:00 pm Poster 541 114 8:00 am – 6:00 pm Poster 602 175 8:00 am – 6:00 pm Poster 542 115 8:00 am – 6:00 pm Poster 603 176 8:00 am – 6:00 pm Poster 543 116 8:00 am – 6:00 pm Poster 544 117 8:00 am – 6:00 pm Poster Poster Session B: Comparative Effectiveness Research (CER) 545 118 8:00 am – 6:00 pm Poster 604 177 8:00 am – 6:00 pm Poster 546 119 8:00 am – 6:00 pm Poster 605 178 8:00 am – 6:00 pm Poster 547 120 8:00 am – 6:00 pm Poster 606 179 8:00 am – 6:00 pm Poster 548 121 8:00 am – 6:00 pm Poster 607 180 8:00 am – 6:00 pm Poster 549 122 8:00 am – 6:00 pm Poster 608 181 8:00 am – 6:00 pm Poster 550 123 8:00 am – 6:00 pm Poster 609 182 8:00 am – 6:00 pm Poster 551 124 8:00 am – 6:00 pm Poster 610 183 8:00 am – 6:00 pm Poster 552 125 8:00 am – 6:00 pm Poster 97 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format TUESDAY, AUGUST 25 Cont. 669 243 8:00 am – 6:00 pm Poster 670 244 8:00 am – 6:00 pm Poster 611 184 8:00 am – 6:00 pm Poster 671 245 8:00 am – 6:00 pm Poster 612 185 8:00 am – 6:00 pm Poster 672 246 8:00 am – 6:00 pm Poster 613 186 8:00 am – 6:00 pm Poster 673 247 8:00 am – 6:00 pm Withdrawn by Author 614 188 8:00 am – 6:00 pm Poster 615 189 8:00 am – 6:00 pm Poster Poster Session B: AsPEN 616 190 8:00 am – 6:00 pm Poster 674 248 8:00 am – 6:00 pm Poster 617 191 8:00 am – 6:00 pm Poster 675 249 8:00 am – 6:00 pm Poster 618 192 8:00 am – 6:00 pm Poster 676 250 8:00 am – 6:00 pm Poster 619 193 8:00 am – 6:00 pm Poster 677 251 8:00 am – 6:00 pm Poster 620 194 8:00 am – 6:00 pm Poster 678 252 8:00 am – 6:00 pm Poster 621 195 8:00 am – 6:00 pm Poster 679 253 8:00 am – 6:00 pm Poster 622 196 8:00 am – 6:00 pm Poster 680 254 8:00 am – 6:00 pm Poster 623 197 8:00 am – 6:00 pm Poster 681 255 8:00 am – 6:00 pm Poster 624 198 8:00 am – 6:00 pm Poster 682 256 8:00 am – 6:00 pm Poster 625 199 8:00 am – 6:00 pm Poster 683 257 8:00 am – 6:00 pm Poster 626 200 8:00 am – 6:00 pm Poster 684 258 8:00 am – 6:00 pm Poster 627 201 8:00 am – 6:00 pm Poster 685 259 8:00 am – 6:00 pm Withdrawn by Author 628 202 8:00 am – 6:00 pm Poster 686 260 8:00 am – 6:00 pm Poster 629 203 8:00 am – 6:00 pm Poster 687 261 8:00 am – 6:00 pm Poster 630 204 8:00 am – 6:00 pm Poster 688 262 8:00 am – 6:00 pm Poster 631 205 8:00 am – 6:00 pm Poster 632 206 8:00 am – 6:00 pm Poster WEDNESDAY, AUGUST 26 Poster Session B: Burden of Disease/Epidemiology of Illness 633 207 8:00 am – 6:00 pm Poster Censoring Left to Right 634 208 8:00 am – 6:00 pm Poster 689 8:30 am 302 Oral 635 209 8:00 am – 6:00 pm Poster 690 8:45 am 302 Oral 636 210 8:00 am – 6:00 pm Poster 691 9:00 am 302 Oral 637 211 8:00 am – 6:00 pm Poster 692 9:15 am 302 Oral 638 212 8:00 am – 6:00 pm Poster 693 9:30 am 302 Oral 639 213 8:00 am – 6:00 pm Poster 694 9:45 am 302 Oral 640 214 8:00 am – 6:00 pm Poster 641 215 8:00 am – 6:00 pm Poster DUR: Psych! 642 216 8:00 am – 6:00 pm Poster 695 8:30 am 312 Oral 643 217 8:00 am – 6:00 pm Poster 696 8:45 am 312 Oral 644 218 8:00 am – 6:00 pm Poster 697 9:00 am 312 Oral 645 219 8:00 am – 6:00 pm Poster 698 9:15 am 312 Oral 646 220 8:00 am – 6:00 pm Poster 699 9:30 am 312 Oral 647 221 8:00 am – 6:00 pm Poster 700 9:45 am 312 Oral 648 222 8:00 am – 6:00 pm Poster 649 223 8:00 am – 6:00 pm Poster Maternal Disease and Pregnancy Outcomes 650 224 8:00 am – 6:00 pm Poster 701 8:30 am 311 Oral 651 225 8:00 am – 6:00 pm Poster 702 8:45 am 311 Oral 652 226 8:00 am – 6:00 pm Poster 703 9:00 am 311 Oral 653 227 8:00 am – 6:00 pm Poster 704 9:15 am 311 Oral 654 228 8:00 am – 6:00 pm Poster 705 9:30 am 311 Oral 655 229 8:00 am – 6:00 pm Poster 706 9:45 am 311 Oral 656 230 8:00 am – 6:00 pm Poster 657 231 8:00 am – 6:00 pm Poster Novel Anticoagulants: A Changing Paradigm 658 232 8:00 am – 6:00 pm Poster 707 8:30 am 210 Oral 659 233 8:00 am – 6:00 pm Poster 708 8:45 am 210 Oral 660 234 8:00 am – 6:00 pm Poster 709 9:00 am 210 Oral 661 235 8:00 am – 6:00 pm Poster 710 9:15 am 210 Oral 662 236 8:00 am – 6:00 pm Poster 711 9:30 am 210 Oral 663 237 8:00 am – 6:00 pm Poster 712 9:45 am 210 Oral 664 238 8:00 am – 6:00 pm Poster 665 239 8:00 am – 6:00 pm Poster Vaccines Around the World Poster Session B: Spotlight Session-AsPEN 713 8:30 am 208 Oral 714 8:45 am 208 Oral 666 240 8:00 am – 6:00 pm Poster 715 9:00 am 208 Oral 667 241 8:00 am – 6:00 pm Poster 716 9:15 am 208 Oral 98 668 242 8:00 am – 6:00 pm Poster 717 9:30 am 208 Oral 2015 ICPE 718 9:45 am 208 Oral 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format WEDNESDAY, AUGUST 26 Cont. Complex Relations: Cancer, Diabetes, and Heart Disease Pharmacoepidemiology of Anti-Infectives and Steroids 750 2:45 pm 210 Oral 751 1:45 pm 210 Oral 719 8:30 am 309 Oral 752 2:00 pm 210 Oral 720 8:45 am 309 Oral 753 2:15 pm 210 Oral 721 9:00 am 309 Oral 754 2:30 pm 210 Oral 722 9:15 am 309 Oral 755 1:30 pm 210 Oral 723 9:30 am 309 Oral 724 9:45 am 309 Oral Who Knows What about Risk The New FDA Pregnancy Label—And How To Fill It 756 1:30 pm 208 Oral 757 1:45 pm 208 Oral 725 10:30 - Noon Ballroom A/B Symposia 758 2:00 pm 208 Oral Exploring Innovative Methods To Identify Patient Subgroup 759 2:15 pm 208 Oral 760 2:30 pm 208 Oral Treatment Response 761 2:45 pm 208 Oral 726 10:30 - Noon 302 Symposia Coming from the Gut: Gastrointestinal Pharmacoepidemiology Worldwide Database Networks: Methodological Challenges for 762 1:30 pm 309 Oral Observational Drug Effect Research 763 1:45 pm 309 Oral 727 10:30 - Noon 312 Symposia 764 2:00 pm 309 Oral 765 2:15 pm 309 Oral Protecting and Promoting Public Health Through 766 2:30 pm 309 Oral Pharmacovigilance: Approaches for Measuring the Impact of 767 2:45 pm 309 Oral Pharmacovigilance Systems Poster Session C: Pharmacovigilance 728 10:30 - Noon 311 Symposia 768 1 8:00 am – 1:45 pm Poster Identifying Cases in Electronic Health Care Databases: Pitfalls 769 2 8:00 am – 1:45 pm Poster and Best Practices 770 3 8:00 am – 1:45 pm Poster 771 4 8:00 am – 1:45 pm Poster 729 10:30 - Noon 210 Symposia 772 5 8:00 am – 1:45 pm Poste Generating Real-World Safety and Effectiveness Evidence for 773 6 8:00 am – 1:45 pm Poster 774 7 8:00 am – 1:45 pm Poster Biosimilars: Current Issues and Methodological Considerations 775 8 8:00 am – 1:45 pm Poster 730 10:30 - Noon 208 Symposia 776 9 8:00 am – 1:45 pm Poster 777 10 8:00 am – 1:45 pm Poster Safety Surveillance of New Oral Anticoagulants Within the Mini- 778 11 8:00 am – 1:45 pm Poster Sentinel Program – Progress, Challenges, and Future Directions 779 12 8:00 am – 1:45 pm Poster 780 13 8:00 am – 1:45 pm Poster 731 10:30 - Noon 731 Symposia 781 14 8:00 am – 1:45 pm Poster It's Wicked Hard To Find What You're Looking For 782 15 8:00 am – 1:45 pm Poster 783 16 8:00 am – 1:45 pm Poster 732 1:30 pm 302 Oral 784 17 8:00 am – 1:45 pm Poster 733 1:45 pm 302 Oral 785 18 8:00 am – 1:45 pm Poster 734 2:00 pm 302 Oral 786 19 8:00 am – 1:45 pm Poster 735 2:15 pm 302 Oral 787 20 8:00 am – 1:45 pm Poster 736 2:30 pm 302 Oral 788 21 8:00 am – 1:45 pm Poster 737 2:45 pm 302 Oral 789 22 8:00 am – 1:45 pm Poster Safety of Psychotropic Drugs 790 23 8:00 am – 1:45 pm Poster 791 24 8:00 am – 1:45 pm Poster 738 1:30 pm 312 Oral 792 25 8:00 am – 1:45 pm Poster 739 1:45 pm 312 Oral 793 26 8:00 am – 1:45 pm Poster 740 2:00 pm 312 Oral 794 27 8:00 am – 1:45 pm Poster 741 2:15 pm 312 Oral 795 28 8:00 am – 1:45 pm Poster 742 2:30 pm 312 Oral 796 29 8:00 am – 1:45 pm Withdrawn by Author 743 2:45 pm 312 Oral 797 30 08:00 am – 1:45 pm Poster Our Aging Population 798 31 08:00 am – 1:45 pm Poster 799 32 08:00 am – 1:45 pm Poster 744 1:30 pm 311 Oral 745 1:45 pm 311 Oral Poster Session C: Spotlight Session-Benefit Risk Assessment, 746 2:00 pm 311 Oral Communication and Evaluation (BRACE) 747 2:15 pm 311 Oral 748 2:30 pm 311 Oral 800 33 8:00 am – 1:45 pm Poster 801 34 8:00 am – 1:45 pm Poster 749 2:45 pm 311 Oral 99 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format WEDNESDAY, AUGUST 26 Cont. 853 86 8:00 am – 1:45 pm Poster 854 87 8:00 am – 1:45 pm Poster 802 35 8:00 am – 1:45 pm Poster 855 88 8:00 am – 1:45 pm Poster 803 36 8:00 am – 1:45 pm Poster 856 89 8:00 am – 1:45 pm Poster 804 37 8:00 am – 1:45 pm Poster 857 90 8:00 am – 1:45 pm Poster 805 38 8:00 am – 1:45 pm Poster 858 91 8:00 am – 1:45 pm Poster 806 39 8:00 am – 1:45 pm Poster 859 92 8:00 am – 1:45 pm Poster 807 40 8:00 am – 1:45 pm Poster Poster Session C: Adherence Poster Session C: Benefit Risk Assessment, Communication and Evaluation (BRACE) 860 93 8:00 am – 1:45 pm Poster 861 94 8:00 am – 1:45 pm Poster 808 41 8:00 am – 1:45 pm Poster 862 95 8:00 am – 1:45 pm Poster 809 42 8:00 am – 1:45 pm Poster 863 96 8:00 am – 1:45 pm Poster 810 43 8:00 am – 1:45 pm Poster 864 97 8:00 am – 1:45 pm Poster 811 44 8:00 am – 1:45 pm Poster 865 98 8:00 am – 1:45 pm Poster 812 45 8:00 am – 1:45 pm Poster 866 99 8:00 am – 1:45 pm Poster 813 46 8:00 am – 1:45 pm Poster 867 100 8:00 am – 1:45 pm Poster 814 47 8:00 am – 1:45 pm Poster 868 101 8:00 am – 1:45 pm Poster 815 48 8:00 am – 1:45 pm Poster 869 102 8:00 am – 1:45 pm Poster 816 49 8:00 am – 1:45 pm Poster 870 103 8:00 am – 1:45 pm Poster 817 50 8:00 am – 1:45 pm Poster 871 104 8:00 am – 1:45 pm Poster 818 51 8:00 am – 1:45 pm Poster 872 105 8:00 am – 1:45 pm Poster 819 52 8:00 am – 1:45 pm Poster 873 106 8:00 am – 1:45 pm Poster 820 53 8:00 am – 1:45 pm Poster 874 107 8:00 am – 1:45 pm Poster 821 54 8:00 am – 1:45 pm Poster 875 108 8:00 am – 1:45 pm Poster 822 55 8:00 am – 1:45 pm Poster 876 109 8:00 am – 1:45 pm Poster 823 56 8:00 am – 1:45 pm Poster 877 110 8:00 am – 1:45 pm Poster 824 57 8:00 am – 1:45 pm Poster 878 111 8:00 am – 1:45 pm Poster Poster Session C: Risk Management/Risk Minimization/ 879 112 8:00 am – 1:45 pm Poster 880 113 8:00 am – 1:45 pm Poster Communication 881 114 8:00 am – 1:45 pm Poster 825 58 8:00 am – 1:45 pm Poster 882 115 8:00 am – 1:45 pm Poster 826 59 8:00 am – 1:45 pm Poster 883 116 8:00 am – 1:45 pm Poster 827 60 8:00 am – 1:45 pm Poster 884 117 8:00 am – 1:45 pm Poster 828 61 8:00 am – 1:45 pm Poster 885 118 8:00 am – 1:45 pm Poster 829 62 8:00 am – 1:45 pm Poster 886 119 8:00 am – 1:45 pm Poster 830 63 8:00 am – 1:45 pm Poster 887 120 8:00 am – 1:45 pm Poster 831 64 8:00 am – 1:45 pm Poster 888 121 8:00 am – 1:45 pm Poster 832 65 8:00 am – 1:45 pm Poster 889 122 8:00 am – 1:45 pm Poster 833 66 8:00 am – 1:45 pm Poster 890 123 8:00 am – 1:45 pm Poster 834 67 8:00 am – 1:45 pm Poster 891 124 8:00 am – 1:45 pm Poster 835 68 8:00 am – 1:45 pm Poster 892 125 8:00 am – 1:45 pm Poster 836 69 8:00 am – 1:45 pm Poster Poster Session C: Spotlight Session-Databases Poster Session C: Pharmacoeconomics/Outcomes Research 893 126 8:00 am – 1:45 pm Poster 837 70 8:00 am – 1:45 pm Poster 894 127 8:00 am – 1:45 pm Poster 838 71 8:00 am – 1:45 pm Poster 895 128 8:00 am – 1:45 pm Poster 839 72 8:00 am – 1:45 pm Poster 896 129 8:00 am – 1:45 pm Poster 840 73 8:00 am – 1:45 pm Poster 897 130 8:00 am – 1:45 pm Poster 841 74 8:00 am – 1:45 pm Poster 898 131 8:00 am – 1:45 pm Poster 842 75 8:00 am – 1:45 pm Poster 899 132 8:00 am – 1:45 pm Poster 843 76 8:00 am – 1:45 pm Poster 900 133 8:00 am – 1:45 pm Poster 844 77 8:00 am – 1:45 pm Poster Poster Session C: Databases 845 78 8:00 am – 1:45 pm Poster 846 79 8:00 am – 1:45 pm Poster 901 134 8:00 am – 1:45 pm Poster 847 80 8:00 am – 1:45 pm Poster 902 135 8:00 am – 1:45 pm Poster 848 81 8:00 am – 1:45 pm Poster 903 136 8:00 am – 1:45 pm Poster 849 82 8:00 am – 1:45 pm Poster 904 137 8:00 am – 1:45 pm Poster 850 83 8:00 am – 1:45 pm Poster 905 138 8:00 am – 1:45 pm Poster 851 84 8:00 am – 1:45 pm Poster 906 139 8:00 am – 1:45 pm Poster 907 140 8:00 am – 1:45 pm Poster Poster Session C: Spotlight Session-Adherence 908 141 8:00 am – 1:45 pm Poster 852 85 8:00 am – 1:45 pm Poster 909 142 8:00 am – 1:45 pm Poster 100 910 143 8:00 am – 1:45 pm Poster 2015 ICPE 31st ICPE ABSTRACT INDEX

Pub. Poster Presentation Pub. Poster Presentation # # Time Room Format # # Time Room Format WEDNESDAY, AUGUST 26 Cont. 973 206 8:00 am – 1:45 pm Poster 974 207 8:00 am – 1:45 pm Poster 911 144 8:00 am – 1:45 pm Withdrawn by Author 975 208 8:00 am – 1:45 pm Poster 912 145 8:00 am – 1:45 pm Withdrawn by Author 976 209 8:00 am – 1:45 pm Poster 913 146 8:00 am – 1:45 pm Poster 977 210 8:00 am – 1:45 pm Poster 914 147 8:00 am – 1:45 pm Poster 978 211 8:00 am – 1:45 pm Poster 915 148 8:00 am – 1:45 pm Poster 979 212 8:00 am – 1:45 pm Poster 916 149 8:00 am – 1:45 pm Poster 980 213 8:00 am – 1:45 pm Poster 917 150 8:00 am – 1:45 pm Poster 981 214 8:00 am – 1:45 pm Poster 918 151 8:00 am – 1:45 pm Poster 982 215 8:00 am – 1:45 pm Poster 919 152 8:00 am – 1:45 pm Poster 983 216 8:00 am – 1:45 pm Poster 920 153 8:00 am – 1:45 pm Poster 921 154 8:00 am – 1:45 pm Poster Poster Session C: Methods 922 155 8:00 am – 1:45 pm Poster 984 217 8:00 am – 1:45 pm Poster 923 156 8:00 am – 1:45 pm Poster 985 218 8:00 am – 1:45 pm Poster 924 157 8:00 am – 1:45 pm Poster 986 219 8:00 am – 1:45 pm Poster 925 158 8:00 am – 1:45 pm Poster 987 220 8:00 am – 1:45 pm Poster 926 159 8:00 am – 1:45 pm Poster 988 221 8:00 am – 1:45 pm Poster 927 160 8:00 am – 1:45 pm Poster 989 222 8:00 am – 1:45 pm Poster 928 161 8:00 am – 1:45 pm Poster 990 223 8:00 am – 1:45 pm Poster 929 162 8:00 am – 1:45 pm Poster 991 224 8:00 am – 1:45 pm Poster 930 163 8:00 am – 1:45 pm Poster 992 225 8:00 am – 1:45 pm Poster 931 164 8:00 am – 1:45 pm Poster 993 226 8:00 am – 1:45 pm Poster 932 165 8:00 am – 1:45 pm Poster 994 227 8:00 am – 1:45 pm Poster 933 166 8:00 am – 1:45 pm Poster 995 228 8:00 am – 1:45 pm Poster 934 167 8:00 am – 1:45 pm Poster 996 229 8:00 am – 1:45 pm Poster 935 168 8:00 am – 1:45 pm Poster 997 230 8:00 am – 1:45 pm Poster 936 169 8:00 am – 1:45 pm Poster 998 231 8:00 am – 1:45 pm Poster 937 170 8:00 am – 1:45 pm Poster 999 232 8:00 am – 1:45 pm Poster 938 171 8:00 am – 1:45 pm Poster 1000 233 8:00 am – 1:45 pm Poster 939 172 8:00 am – 1:45 pm Poster 1001 234 8:00 am – 1:45 pm Poster 940 173 8:00 am – 1:45 pm Poster 1002 235 8:00 am – 1:45 pm Poster 941 174 8:00 am – 1:45 pm Poster 1003 236 8:00 am – 1:45 pm Poster 942 175 8:00 am – 1:45 pm Poster 1004 237 8:00 am – 1:45 pm Poster 943 176 8:00 am – 1:45 pm Poster 1005 238 8:00 am – 1:45 pm Poster 944 177 8:00 am – 1:45 pm Poster 1006 239 8:00 am – 1:45 pm Withdrawn by Author 945 178 8:00 am – 1:45 pm Poster 1007 240 8:00 am – 1:45 pm Poster 946 179 8:00 am – 1:45 pm Poster 1008 241 8:00 am – 1:45 pm Poster 947 180 8:00 am – 1:45 pm Poster 1009 242 8:00 am – 1:45 pm Poster 948 181 8:00 am – 1:45 pm Poster 1010 243 8:00 am – 1:45 pm Poster 949 182 8:00 am – 1:45 pm Poster 1011 244 8:00 am – 1:45 pm Poster 950 183 8:00 am – 1:45 pm Poster 1012 245 8:00 am – 1:45 pm Poster 951 184 8:00 am – 1:45 pm Poster 1013 246 8:00 am – 1:45 pm Poster 952 185 8:00 am – 1:45 pm Poster 1014 247 8:00 am – 1:45 pm Poster 953 186 8:00 am – 1:45 pm Poster 1015 248 8:00 am – 1:45 pm Poster 954 187 8:00 am – 1:45 pm Poster 1016 249 8:00 am – 1:45 pm Poster 955 188 8:00 am – 1:45 pm Poster 1017 250 8:00 am – 1:45 pm Poster 956 189 8:00 am – 1:45 pm Poster 1018 251 8:00 am – 1:45 pm Poster 957 190 8:00 am – 1:45 pm Poster 1019 252 8:00 am – 1:45 pm Poster 958 191 8:00 am – 1:45 pm Poster 1020 253 8:00 am – 1:45 pm Poster 959 192 8:00 am – 1:45 pm Poster 1021 254 8:00 am – 1:45 pm Poster 960 193 8:00 am – 1:45 pm Poster 1022 255 8:00 am – 1:45 pm Poster 961 194 8:00 am – 1:45 pm Poster 1023 256 8:00 am – 1:45 pm Poster 962 195 8:00 am – 1:45 pm Poster 1024 257 8:00 am – 1:45 pm Poster 963 196 8:00 am – 1:45 pm Poster 1025 258 8:00 am – 1:45 pm Poster 964 197 8:00 am – 1:45 pm Poster 1026 259 8:00 am – 1:45 pm Poster 965 198 8:00 am – 1:45 pm Poster 1027 260 8:00 am – 1:45 pm Poster 966 199 8:00 am – 1:45 pm Poster 1028 261 8:00 am – 1:45 pm Poster 967 200 8:00 am – 1:45 pm Poster 1029 262 8:00 am – 1:45 pm Withdrawn by Author 968 201 8:00 am – 1:45 pm Poster 1030 263 8:00 am – 1:45 pm Poster 969 202 8:00 am – 1:45 pm Poster 1031 264 8:00 am – 1:45 pm Poster 970 203 8:00 am – 1:45 pm Poster 1032 265 8:00 am – 1:45 pm Poster 971 204 8:00 am – 1:45 pm Poster 972 205 8:00 am – 1:45 pm Poster 101 2015 ICPE MEETING NOTES

______ADVERTISERS INDEX ______z Analysis Group...... 13 z Amgen...... 56 ______z Anolinx...... 17 z Ariad...... 57 ______z Bayer...... 22 ______z Boston Health Economics...... 59 z Celgene...... 52 ______z Covance...... 30 z Clinical Practice Research Datalink (CPRD)...... 24 ______z Degge Group, Ltd / DGI, LLC...... 50 ______z Department of Clinical Epidemiology, Aarhus University Hospital...... 41 ______z Doctor Evidence...... 61 z Eli Lilly & Company...... 15 ______z Evidera...... 35 z HealthCore, Inc...... 19 ______z IMS Health...... 49 ______z Kantar Health...... 36 z Maccabitech...... 21 ______z Optum...... 47 z Pfizer...... 32 ______z Quintiles...... 10 ______z RTI Health Solutions...... 37 z Takeda...... 53 ______z Truven Health Analytics...... 46 z UBC...... 27 ______z Wiley Publications...... 106 ______

______

______

______

______

______

______

______

______

______

102 2015 ICPE MEETING NOTES

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

103 2015 ICPE MEETING NOTES

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

______

104 2015 ICPE 32nd

2 0 1 6

International Conference on Pharmacoepidemiology & Therapeutic Risk Management The Convention Center Dublin FOR ABSTRACTS CALL Meeting info: pharmacoepi.org Abstract Submission Deadline: February 17, 2016 You are Invited to Submit Scholarships & Student Awards an Abstract ISPE will award a limited number of Scholarship scholarships to help defray conference ISPE invites you to submit an abstract for an oral/poster Submission Deadline presentation, workshop or symposium at the 32nd ICPE in Dublin, MARCH 1, 2016 expenses. Information will be posted on Ireland. This pre-eminent conference on pharmacoepidemiology will pharmacoepi.org be an invaluable scientific experience and will allow you to experience ISPE will grant several student awards to recognize and encourage Dublin’s dynamic and lively personality. student excellence in pharmacoepidemiology. The Scientific Program Guidelines For Submissions Committee oversees the selection of awards, which will be presented at the 2016 ICPE Annual Meeting of ISPE Members & Awards The deadline for receipt of all abstracts is Ceremony. Abstract Submission February 17, 2016. Please visit pharmacoepi.org, Deadline for submission guidelines. The online submission Sponsorships, Exhibits & FEBRUARY 17, 2016 site will be operational by mid-December 2015. Academic Showcase Questions about abstract submissions and technical issues should ISPE offers organizations, institutions and academic programs be directed to Coe Truman at [email protected] or by opportunities to support the conference while sharing their products telephone +1.507.403.2305. Note, submissions will not be accepted and services with attendees. A Conference Sponsorship & Exhibitor until the online submission site is open in December 2015. Prospectus will be posted on pharmacoepi.org/meetings/32ICPE. Reviewing/Registration Save the Dates! August 25-28, 2016 The ISPE Scientific Program Committee will review all abstracts in April The Convention Center Dublin 2016. All submitters will be notified by email in early June 2016. All Dublin, Ireland presenters and panelists (workshop/symposia) must register to attend the 2016 ICPE. Please visit pharmacoepi.org/meetings/32ICPE for updated conference information. Pharmacoepidemiology PDS & Drug Safety

Official Journal of the International Society for Pharmacoepidemiology Editor-In-Chief: Professor Brian L. Strom Pharmacoepidemiology & Drug Safety provides an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology.

Free online access for ISPE members via the society website

Impact Congratulations to Factor The Ronald D. Mann Best 2.939* Article of 2014 Awards Winners *2014 Journal Citation Reports®(Thomson Reuters)

First Prize Honorable Mention: Risk of Guillain–Barré syndrome following pandemic Chronic opioid use emerging after bariatric surgery influenza A(H1N1) 2009 vaccination in Germany Marsha A. Raebel, Sophia R. Newcomer, Elizabeth A. Jürgen Prestel, Peter Volkers, Dirk Mentzer, Helmar Bayliss, Denise Boudreau, Lynn DeBar, Thomas E. Elliott, C. Lehmann, Hans-Peter Hartung, and Brigitte Keller- Ameena T. Ahmed, Pamala A. Pawloski, David Fisher, Stanislawski, for the GBS Study Group Sengwee Toh and William Troy Donahoo Volume 23, Issue 11, November 2014, Pages: 1192-1204 Volume 23, Issue 12, December 2014, Pages: 1247–1257 Honorable Mention: Honorable mention: Trimethoprim use before pregnancy and risk of The ecology of prescription opioid abuse in the USA: congenital malformation: reanalyzed using a case geographic variation in patients’ use of multiple crossover design and a case-time-control design prescribers (“doctor shopping”) Yuelian Sun, Chun Sen Wu and Jørn Olsen Douglas C. McDonald and Kenneth E. Carlson Volume 23, Issue 10, October 2014, Pages: 1076–1083 Volume 23, Issue 12, December 2014, Pages: 1258–1267

For more information on these top papers and other journal features, please visit www.pdsjournal.org Print ISSN: 1053-8569 • Online ISSN: 1099-1557 • 2015 Volume: 24 • Frequency: Monthly 163704 Back Bay/ AMTRAK Station entrance on Boylston St. on Boylston entrance Walking Connector Path age r arking Ga o P s t s e c c A Star Market Star ) (RING ROAD Taxi Stand Taxi e c an r t Ent e t r S Tower Prudential ation t r anspo r T

Public NEWBURY STREET NEWBURY 3-2-1 Connect Map & Complex Hotel entrance on entrance Ave. Massachusetts

Floo

h y r n

e P

s

ICPE l

ans

Hynes Convention Center Prudential Plaza Entrance 900 Boylston Street HYNES CONVENTION CENTER Boston, Massachusetts 02115 : ph: 617.954.2800 fx: 617.954.3326 Plaza Level P

r www.AdvantageBOSTON.com W l o a

o Plaza Level z

m

South a st

c Lobby L a 31 e p M v a

e c W M M W i l

Coat Room t AUGUST 23-26, 2015 Business

i

Center e BOSTON, MA USA s

, Show Office r eet

S t f International Conference on Pharmacoepidemiology Exhibit Hall B l & Therapeutic Risk Management o Exhibit Hall B

Exhibit Hall A o First Aid (38,770 sq ft) (36,900 sq ft)

r Cafeteria

p Main l Lobby a n Truck Access from s Show Office Ramp Dalton Street a Coffee Main Lobby 20’ x 14’

Show Office n House Exhibit Hall A d

o Public Safety Office t Pre-function Hall A Pre-function Hall B h e r Up M v Down M

107 108 109 110 111 a l The Capital Towne u Stove Grille Key Service Corridor Floo

a & Spirits b Pre-function Lobby Public Use l 101 102 103 104 105 W h Non-Public e Meeting Exhibit W Access y r r

n Food Restaurant e

Boylston Hallway

e Services

Space s P

s o

Restrooms Elevator Escalator Freight Sidewalk (Lower Level) l u Drop-Off ans Permanent Concessions Pay Phone

r (Lower Level)

c

e

s :

The MassHacyhunessetts ConCvoentiovneCnenttieonr AuthCoriety nowtners and operates the Boston Convention & Ex hibition Center and the Hynes Convention Center. S 900 Boylston Street r Level 2 e

o Boston, Massachusetts 02115 c

W o ph: 617.954.2800 fx: 617.954.3326 on

m www.AdvantageBOSTON.com

c Level 2 South Sheraton Entrances d

a Lobby

p L I

a 5 e

M c v

i Low roof

W M M W t e

i High roof l

e Show Office

s Exhibit Hall C Low roof (balcony)

,

High roof f

Show Office l

o Exhibit Hall D

o Veterans Memorial

Auditorium (25,760 Exhibit Hall C Exhibit Hall D r sq ft) (37,750 sq ft) (37,300 sq ft)

p

l a (4,000 Person

n Seating Capacity)

s

a

n

d

o

t

h Pre-function Auditorium Pre-function Hall C Pre-function Hall D

e

r

v Up M

a

l Dressing 207 208 209 210

u Room

a Key

Service Corridor b

l Pre-function Lobby Public Use

e Floo 200 201 202 203 204 205 W 206 Non-Public M r Meeting Exhibit Access W

e

Food s h

Services o y Boylston Hallway

r u n Restrooms Elevator Escalator Freight

r e Drop-Off Permanent Concessions Pay Phone P

c s (Lower Level)

l e

ans s

The Massachusetts Convention Center Authority owns and operates the Boston Convention & Exhibition Center and the Hynes Convention Center.

:

Hynes Convention Center W Third Level T 900 Boylston Street r h o Boston, Massachusetts 02115

i o ph: 617.954.2800 fx: 617.954.3326 South rd m www.AdvantageBOSTON.com Lobby I Catering - Cleaning Services

6 c

Level 3 L a

M e p v a

e c Ballroom i 1,200 fixed seats l

Kitchen t C

i e s

, f

l o Exhibit Hall D o Veterans Memorial (Below)

Ballroom r Auditorium (Below)

B

p

l

a A/V B all r oom n s

a n Balcony Ballroom d A o M W 310 311

t

h Service Corridor e Catering

r Offices Private M v Kitchen W a 302 304 306 309 312

y er l o

Suite u 300 F

m a b (Executive Suite) Down

l B all r oo e 301 303 305 307 308 W M 313 Key r e Pre-function Lobby Public Use s

o Non-Public Boylston Hallway

Meeting Exhibit u Access r Restrooms Elevator Escalator Freight Drop-Off c (Lower Level) e Boylston Street s

The Massachusetts Convention Center Authority owns and operates the Boston Convention & Exhibition Center and the Hynes Convention Center. I

7